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SUMÁRIO 
 
O principal objectivo desta tese foi desenvolver um método simples e barato para a 
detecção de ácidos nucleicos em amostras biológicas, baseado nas propriedades 
colorimétricas de nanopartículas de ouro. As nanopartículas de ouro foram sintetizadas e 
funcionalizadas com oligonucleotídeos de DNA modificados com um grupo tiol 
(nanossondas de ouro), permitindo assim reconhecer uma sequência alvo de interesse. As 
nanossondas de ouro foram caracterizadas e utilizadas num método colorimétrico para a 
detecção de DNA, com uma resolução ao nível de uma base, seguindo uma abordagem 
non-cross-linking – após um aumento da força iónica, as nanossondas de ouro agregam e a 
solução muda de vermelho para azul devido à deslocação para comprimentos de onda 
maiores da banda de ressonância de plasmónica superficial (SPR), típica das 
nanopartículas de ouro; a presença de um alvo complementar à sequência da nanossonda, 
previne a agregação das nanossondas de ouro e a solução mantêm a sua cor vermelha 
original. Foi também avaliada a utilização de nanopartículas de liga ouro:prata 
funcionalizadas com oligonucleotídeos modificados com um grupo tiol (nanossondas de liga 
ouro:prata) para o desenvolvimento de um método non-cross-linking em multiplex. 
 
Considerando a disponibilidade de amostras clínicas e os interesses comerciais da STAB 
VIDA, Lda., foram seleccionados três alvos biológicos para levar a cabo a prova do conceito 
da detecção de mutações pontuais/polimorfismos de base única (SNP) e desenvolver o 
método de non-cross-linking - mutações pontuais associadas a β-talassémia; um SNP (i.e. 
DOR1C/G) associado ao gene Diabetes and Obesity Regulated (DOR), associado a 
diabetes e obesidade; um tag SNP (i.e. CYP1846G/A) localizado no gene do citocromo 
P450 2D6 (CYP2D6), associado a uma forma não funcional do CYP2D6 que é responsável 
pelo metabolismo de xenobióticos. 
 
De forma a optimizar o método, foram efectuados estudos para melhor compreender o 
mecanismo envolvido na detecção non-cross-linking. O uso de Microscopia de Força 
Atómica (AFM), espectroscopia de fluorescência e medidas de mobilidade electroforética 
(análise de Ferguson) permitiram clarificar a natureza das forças envolvidas na agregação 
diferencial colorimétrica do método non-cross-linking e optimizar as nanossondas de ouro 
para a descriminação de SNP/mutações pontuais à temperatura ambiente. 
 
Demonstrou-se que o método non-cross-linking pode ser utilizado na detecção de 
SNP/mutações pontuais à temperatura ambiente, com uma sensibilidade de 73 e 75 nM 
para amplicões ssDNA/dsDNA e oligonucleotídeos ssDNA, respectivamente. 
X 
  
XI 
ABSTRACT 
 
The main objective of this thesis was to develop a simple and inexpensive method for nucleic 
acid detection in biological samples based on the colorimetric properties of gold 
nanoparticles. Gold nanoparticles were synthesized and functionalized with thiol-modified 
DNA oligonucleotides (Au-nanoprobes) able to recognize a target sequence of interest. 
These Au-nanoprobes were characterized and then used in a colorimetric method for DNA 
detection with a single base resolution based on a non-cross-linking approach - upon 
increasing ionic strength, Au-nanoprobes aggregate and the solution changes color from the 
original red to blue, due to the red-shift of the typical Surface Plasmon Resonance (SPR) 
band of gold nanoparticles; the presence of a complementary target to the probe sequence, 
prevents aggregation of the Au-nanoprobes and the solution remains red. The use of gold-
silver alloy nanoparticles functionalized with thiol-modified DNA oligonucleotides (AuAg-
nanoprobes) to further develop a multiplex non-cross-linking method was also assessed. 
 
To carry out the proof-of-concept for single base mutation/Single nucleotide polymorphism 
(SNP) detection and further develop this non-cross-linking method, three different targets 
were selected considering clinical samples availability and the commercial interests of STAB 
VIDA, Lda. Single point mutations associated to β-thalassemia were chosen for the proof-of-
concept. Later, to further evaluate the versatility of the method, two other targets were 
chosen: an SNP within the Diabetes and Obesity Regulated (DOR) gene (i.e. DOR1C/G), 
associated with diabetes and obesity; and a tag SNP within the Cytochrome P450 2D6 
(CYP2D6) gene (i.e. CYP1846G/A), associated to a non-functional CYP2D6, which is 
responsible for the metabolism of xenobiotics. 
 
Studies were also conducted to better understand the underlying mechanisms involved in the 
non-cross-linking detection, towards the optimization of the method. The use of Atomic Force 
Microscopy (AFM), fluorescent spectroscopy and electrophoretic mobility measurements 
(Ferguson analysis) allowed clarifying the nature of the forces involved in the differential 
colorimetric non-cross-linking aggregation and further optimize the Au-nanoprobe design to 
SNP/single point mutation discrimination at room temperature. 
 
It has been demonstrated that the non-cross-linking method can be used for detection of 
SNP/single point mutations at room temperature. The detection sensitivity of the non-cross-
linking method using Au-nanoprobes was determined to be 73 and 75 nM for ssDNA/dsDNA 
amplicons and ssDNA oligonucleotide targets, respectively. 
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3 
The unraveling of the human genome has revolutionized the understanding of many aspects 
of human disease at the molecular level, and provided a host of opportunities to identify new 
disease markers.[1] Since then, other large-scale biological projects have emerged, such as 
the Encyclopedia of DNA Elements (ENCODE), which aims to identify all of the functional 
elements in the human genome,[2] or the International HapMap Project, which aims to 
determine the haplotype structure of human chromosomes in various ethnic groups.[3] 
Several types of DNA variations can be found in the human genome (e.g. insertions and/or 
deletions of one or more bases, duplications, polymorphisms, etc.), but the most common 
are single nucleotide polymorphisms (SNPs), accounting for around 68% of all detected 
changes.[4] There are millions of different SNPs that can be located in very different genomic 
regions – in coding regions where they may modify the activity of a protein (non-synonymous 
SNP/missense SNP); in the boundary exon/intron where they may modify the splicing 
process; other intronic SNPs and synonymous SNPs (base changes in the coding region that 
do not lead to an amino acid change) can also change mRNA stability with potential 
implications for gene expression. This can also occur as a consequence of SNPs located in 
the promoter region or intragenic regions, in the latter case as a consequence of enhancing 
mechanisms.[5-7] All this individual genetic variability has been associated with individual 
susceptibility to several multifactorial diseases, such as cancer, diabetes, and to the 
individual response to therapeutics.[8,9] For this reason, the use of molecular tools for 
genotyping is becoming increasingly more important as the understanding of disease 
susceptibility and progression markers improves. However, the number of SNPs estimated to 
commonly occur in the human genome is approximately 10 million, which, with present 
technology, hampers the complete genotyping of an individual at an affordable cost. This is 
where the HapMap Project comes in handy, by identifying the common haplotypes in four 
populations from different parts of the world and also identifying "tag" SNPs which uniquely 
identify these haplotypes. Haplotypes are a combination of alleles at multiple loci that are 
located nearby each other within a chromosome. Hence, they undergo recombination only 
very rarely and are, usually, inherited in blocks across generations. Alleles are alternative 
DNA sequence variations at the same physical gene locus, which may result in different 
phenotypic traits. The conjugation of alleles in a person’s chromosomes is what is known as 
a genotype. Since the number of tag SNPs that contain most of the information about the 
patterns of genetic variation is estimated to be between 300,000 to 600,000, one can virtually 
genotype a whole-genome just by characterizing a far fewer fraction of the 10 million 
estimated SNPs. 
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Figure 1.1 – Relation between SNPs, haplotypes and tag SNPs. Adjacent SNPs identified in the 
genome of multiple individuals are compiled into haplotypes, then tag SNPs allow to uniquely identify 
each haplotype. 
 
Different disease and metabolic susceptibilities can be a consequence of genetic variants 
present in a single gene (i.e. single-gene or Mendelian disorders), or in a combination of 
multiple genes (i.e. polygenic disorders), or of a combination of genetic variants and 
environmental factors (i.e. multifactorial disorders). In the case of Mendelian disorders, more 
than 4000 disorders have been described and many more are being discovered each year 
(for a list of Mendelian disorders go to Online Mendelian Inheritance in Man (OMIM) 
database - http://www.nslij-genetics.org/search-omim.html).[10] These include autosomal 
dominant, autosomal recessive, X-linked, Y-linked and mitochondrial-related disorders. 
Autosomal dominant disorders occur when only one mutated autosomal allele is necessary 
to express a disease’s phenotype, while autosomal recessive disorders require that both 
autosomal alleles are mutated for the disease’s phenotype to be expressed. Hence, 
characterization of both alleles is compulsory in genetic testing, to identify homozygous and 
heterozygous patterns. X-linked, Y-linked and mitochondrial-related disorders occur when 
the mutations that lead to the disorder are located in genes on the X-chromosome, Y-
chromosome or mitochondrial DNA, respectively. 
While true single-gene disorders are relatively rare, most inherited disorders are actually 
multifactorial, meaning that other factors (e.g. environment) can influence the probability of 
an individual that carries a specific disorder-associated mutation(s) being affected with a 
specific genetic disease.[11,12] It is worth emphasizing that genetic testing should always be 
associated with other sources of information (e.g. family health and ethnic background, 
lifestyle, etc.), in order to conduct a more precise risk assessment and better seize the 
benefits of the post-genomic era information.[13] Moreover, genetic testing should always be 
considered as a predisposition assessment tool rather than predictive diagnostics. 
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Now, one of the great challenges of modern molecular detection is to integrate all this new 
genetic information into procedures suitable for implementation in rapid, cost-effective and 
reliable assays. While some of which are already used in the contemporary clinical laboratory 
in a regular basis, others are still in development. 
 
1.1 Molecular Diagnostics – state of art 
Current molecular diagnostic methods rely in several types of technological platforms: i) 
enzymatic amplification; ii) restriction enzyme analysis; iii) hybridization analysis; iv) 
chromatographic analysis; v) melting analysis or vi) DNA sequencing. 
Several enzymatic-based amplification methods are available, including PCR, self-sustained 
sequence replication (3SR) and strand displacement amplification (SDA).[14] Among these 
amplification methods, PCR is considered the gold standard in nucleic acid detection and 
has become the most predominant technology in molecular diagnostics. PCR is a very 
specific technique based on the use of a thermo stable DNA polymerase that, after a thermal 
cycling process, is able to exponentially amplify a short fragment of DNA (amplicon) from just 
a few copies of a DNA template, using a set of primer oligonucleotides and deoxynucleoside 
triphosphates (dNTPs).[15,16] PCR has been used to discriminate templates that differ by only 
a single nucleotide residue, through a strategy known as amplification refractory mutation 
system (ARMS) or allele-specific PCR, which relies on designing the primer 3’-end 
nucleotide to overlap the polymorphic residue.[17] The amplification efficiency is greatly 
reduced when a mismatch between the 3’-end of the primer and the template occurs, due to 
a lack of 3’ to 5’ exonuclease activity in Taq polymerase (the DNA polymerase commonly 
used in PCR). The confirmation of a successful amplification by PCR is, usually, carried out 
by electrophoresis in a gel matrix and using a DNA intercalating fluorescent dye to help 
visualize the amplicon fragments. However, the presence of an amplicon of the expected 
length cannot confirm the specificity of the reaction, i.e. the genetic makeup of the product. 
At most, is an indication that the PCR has targeted the specific template for which the 
primers where designed. This is particularly important because PCR is very sensitive to 
contaminations that may lead to the amplification of spurious amplicons with the expected 
size. 
More recently, the development of a Real-time PCR method, which uses DNA 
oligonucleotide probes that fluoresce when hybridized with a complementary DNA, has 
partially circumvented this issue due to the inherent increased specificity of using a probe.[18] 
Real-time PCR also allows target DNA template quantification in real-time through the 
quantification of fluorescence emitted by the probes. Apart from the probes, a fluorescent 
dsDNA intercalating dye can also be used for real-time quantification of amplification, but 
with the inconvenience of reduced specificity.[19] 
6 
Besides the Real-time PCR, several other variants of the PCR method have been developed 
to achieve a specific goal (e.g. multiplex PCR, asymmetric PCR, nested PCR, reverse 
transcription PCR, etc.). In the case of asymmetric PCR, one of the strands of the DNA 
template is preferentially amplified by using a great excess of the primer that hybridizes with 
the chosen strand.[20] This procedure yields a mix of dsDNA and ssDNA amplicons, which 
can be ideal to probe hybridization due to circumventing double strand competition, i.e. 
hybridization kinetics competition between probe/dsDNA, and dsDNA reannealing. However, 
this PCR method is inefficient and requires extra cycles of PCR due to the slow linear 
amplification later in the reaction, after the limiting primer has been used up. Nevertheless, 
the reaction inefficiency can be reduced if the primers melting temperature (Tm) is calculated 
using the nearest-neighbor formula which takes into account the primer differential 
concentration.[21] This is what is considered in the Linear-after-the-exponential (LATE)-PCR 
method.[22] 
Isothermal amplification methods have also been developed to overcome the need for 
expensive thermal cycling machinery required by the PCR (e.g. strand displacement 
amplification, rolling circle amplification (RCA), loop-mediated isothermal amplification 
(LAMP)).[23] Among these, LAMP gathers the best properties for molecular diagnosis in 
clinical laboratory and at point-of-care (POC). The method relies on autocycling strand 
displacement DNA synthesis by a Bst DNA polymerase in presence of a template DNA, 
dNTPs and a set of four primers (two inner and two outer), that together recognize six distinct 
sequences on the template DNA.[24] Through this approach, the specificity of the method is 
greatly enhanced when compared to other amplification-based methods and 109 to 1010 fold 
amplification is usually achieved after 1 hour at a constant temperature (e.g. 60ºC). LAMP’s 
final amplification product presents a stem-loop DNA structure, encompassing alternate 
inverted repeats of the target sequence with multiple loops that appear with a ladder-like 
pattern in agarose gel electrophoresis, which hampers size analysis or its direct use in other 
techniques, such as sequencing. Nevertheless, product amplification can also be followed in 
real-time by photometry due to the turbidity caused by increasing quantity of magnesium 
pyrophosphate in solution, as result of a successful amplification.[25] LAMP has also shown to 
be efficient in the presence of known PCR inhibitors such as blood, serum, plasma or 
heparin[26, 27] and to work without an initial heat denaturation of the template DNA.[28] 
Restriction enzymes can also be used to characterize DNA due to their ability to cut DNA at 
a specific nucleotide sequence known as restriction sites. A restriction fragment length 
polymorphism (RFLP) analysis can be performed to characterize genotypes by digesting 
DNA with one or more restriction enzymes and later analyze the resulting DNA fragments 
patterns by gel electrophoresis.[29] In the presence of a polymorphism within the restriction 
site, the resulting fragments’ lengths will differ. However, restriction enzyme-based analyses 
can only be used to characterize the DNA sequences that are recognized by the available 
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restriction enzymes and do not allow to determine the exact position of the polymorphism 
within their restriction sites. 
Hybridization assays are a fundamental tool in molecular genetics, taking advantage of the 
ability for individual single-stranded nucleic acid molecules to form double-stranded 
molecules, i.e. to hybridize. Hybridization takes place when the interacting single-stranded 
molecules have a sufficiently high degree of base complementarity, accordingly to Watson-
Crick base pairing (Guanine-Cytosine and Thymine-Adenine).[30] Standard hybridization 
assays use a labeled (e.g. fluorescent, radioactive) nucleic acid probe to identify a related 
DNA or RNA molecules, i.e. with a significantly high degree of sequence similarity, within a 
sample of unlabeled nucleic acid molecules. Well known hybridization assays that rely on 
such probes include Southern and Northern blot,[31,32] fluorescent in situ hybridization (FISH) 
assays,[33] and, more recently, DNA-microarrays/chips technologies.[34] In the latter, a high-
throughput DNA analysis can be performed due to highly density arrays of DNA 
oligonucleotides that are functionalized in chips made of glass, silicon, or plastic. The target 
hybridization is usually spotted by using fluorophore- or chemiluminescence-labeled targets 
or probes - in this case hybridization occurs in a sandwich conformation between the 
immobilized DNA oligonucleotide, the target and the probe. Applications for this technology 
include gene expression analysis and genotyping for point mutations, SNPs and short 
tandem repeats (STRs). In general, hybridization assays are very specific and sensitive 
(depending on the labeling). However, despite the specificity of Watson-Crick base pairing, 
mismatches between the target nucleic acid and the probe can only be detected in highly 
stringent conditions and normally require controlled temperatures. Also, background noise 
can be a problem in hybridization assays due to non-specific probe hybridization. 
Melting analysis has been historically used to characterize physical states of DNA, determine 
base contents and detect sequence differences between two ssDNA sequences of different 
sources (i.e. by forming heteroduplexes).[35] This was usually done by characterizing the 
dissociation profiles of DNA following the hyperchromic effect of DNA in the UV spectrum 
along a temperature ramp. Since then, this technique has evolved along the years, mainly 
due to the development of the Real-time PCR technique which gave rise to DNA intercalating 
dyes and fluorescent probes that can also be used to characterize dsDNA melting profiles.[36] 
More recently, a high resolution melting (HRM) analysis has urged with the development of 
new high-resolution instruments and novel saturation dyes which do not inhibit PCR when 
used at concentrations that yield maximum fluorescence (saturation).[37] So now, melting 
curves can be used for mutation scanning, sequence matching and multiplex genotyping, in 
a fast and accurate way.[38] 
Chromatography can be used to separate, purify and characterize nucleic acids. For 
example, denaturing high performance liquid chromatography (DHPLC) allows to analyze 
genetic variations, such as mutations and chromosomal breakpoints.[39] The method exploits 
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the differential retention of homo- and heteroduplex DNA species on a reversed-phase 
chromatographic column under conditions of partial thermal denaturation. Liquid 
chromatography-mass spectrometry (LC-MS) is another technique that can be used to 
analyze DNA samples, along with other mass spectrometry methods (e.g. MALDI-MS, ESI-
MS).[40] 
Despite all these technologies and methods developed for DNA genotyping, DNA 
sequencing is the ultimate reference technique for DNA characterization, allowing 
determination of the precise sequence of a DNA strand. Nevertheless, this technique is 
usually still the last resource method due to the associated high cost, laborious and time 
consuming procedures. The most popular DNA sequencing techniques are based on the 
Sanger method which relies on a chain-termination approach.[41] Basically, this method uses 
normal dNTPs as well as dideoxynucleosides triphosphate (ddNTPs) to halt chain elongation 
by a DNA polymerase. This yields DNA fragments of different lengths that can be later 
separated and analyzed by electrophoresis. Through this chain-termination approach it is 
only possible to sequence fairly short strands (100 to 1000 bp). Longer sequences must be 
subdivided into smaller fragments and subsequently re-assembled to give the overall 
sequence. More recently, the high demand for low-cost sequencing has driven to the 
development of high-throughput second generation sequencing technologies. These include 
microelectrophoretic methods, sequencing by hybridization, real-time observation of single 
molecules, and cyclic-array sequencing (e.g. pyrosequencing).[42] 
 
To summarize, current molecular diagnostic methods have come a long way towards better, 
faster, cost-effective and reliable assays. Nevertheless, most are still time consuming and 
require expensive equipment (e.g. Real-time PCR, DNA sequencing), expensive reagents 
(e.g. fluorescent dyes, DNA polymerases) and highly specialized laboratories and personnel. 
In the end, all this restricts their use at the POC or in a larger number of laboratories, 
especially in countries with fewer resources available to healthcare. Working at the 
nanoscale may allow decreasing the costs associated with genetic tests without jeopardizing 
sensibility and reliability, thus making them available to a broader population worldwide. 
 
1.2 Nanotechnology 
Nanotechnology involves the study and control of matter on a nanometer (one billionth of a 
meter) scale – for reference, the DNA double-helix has a diameter of 2 nm. Its birth has been 
associated with Richard Feynman and his famous talk "There's plenty of room at the bottom" 
at an American Physical Society meeting at Caltech on December 29th, 1959.[43] Since then, 
nanotechnology has led to the development of new materials and devices with a wide-range 
of applications, such as in electronics, mechanics, medicine, etc. 
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Two main approaches can been used to create structures at the nanoscale: the “bottom-up” 
approach, where nanostructures are built from molecular components; and the “top-down” 
approach, where nanostructures are eroded from larger structures. Top-down techniques 
suffer from the need to remove large amounts of material, while bottom-up techniques 
usually suffer from poor monodispersity due to the need to arrest growth at the same point 
for all the nanostructures. Some tools and techniques have been developed to help with the 
delicate task of working at the nanoscale, such as scanning probe-based microscopes (e.g. 
Atomic Force Microscopy – AFM), lithography techniques (e.g. electron beam lithography; 
dip pen lithography), self-assembly techniques (e.g. DNA mediated assembly) and chemical 
synthesis (e.g. colloidal chemistry, supramolecular chemistry).[44-48] While lithography 
techniques are commonly used for top-down approaches, the others are mostly bottom-up 
techniques. 
In particular, AFM can be used to manipulate nanostructures, but it is more commonly used 
to characterize the three-dimensional profiles of structures at the nanoscale and measure 
interacting forces. The AFM device consists of a cantilever with a sharp tip that is used to 
scan a sample in a flat surface or manipulate the nanostructures. In the scanning mode, 
when the tip is brought into proximity of the sample surface, forces between the tip and the 
sample lead to a deflection of the cantilever according to Hooke's law.[49] These forces can 
be of different natures: mechanical contact forces, van der Waals forces, electrostatic forces, 
magnetic forces, etc. The deflection is then, typically, measured by a laser that reflects from 
the top of the surface of the cantilever into a photodiode array during the scanning procedure. 
One of the main applications of AFM is also to study and image biological molecules and 
structures, such as DNA, proteins, membranes, cells, etc.[50] 
 
1.2.1 Nanobiotechnology 
The synergy between nanotechnology and biotechnology has created a new area of 
technology development and application - nanobiotechnology. Although this is a very recent 
area, nanobiotechnology can be considered a field that concerns the utilization of biological 
systems, such as cells, cellular components, nucleic acids, and proteins, to fabricate 
functional nanostructures comprised of organic and inorganic materials. But, it also concerns 
the development and application of instruments, originally designed to generate and 
manipulate nanostructured materials (e.g. AFM), to study fundamental biological processes 
and structures. Within this perspective, medicine and molecular diagnostics are two of the 
main areas to benefit from nanobiotechnology, where the unique properties of nanomaterials 
and nanostructures can give rise to new techniques and methods with enhanced capabilities 
and efficiency, towards a better healthcare system.[51,52] In particular, the use of 
nanotechnology (materials, devices or systems) for molecular diagnostics purposes has 
defined a new field, known as nanodiagnostics. This burgeoning field of interest has been 
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generating new and improved techniques to meet the demands of clinical diagnostics for 
increased sensitivity and specificity at lower costs.[53] 
Several different approaches have been considered for the development of nanodiagnostics 
techniques and methods: nanoscale visualization (e.g. scanning probe microscopy), 
nanofluidics, nanoarrays, microcantilevers, nanophotonics, microbalances, nanoelectrodes, 
nanopores, nanowires/nanotubes, nanoparticles, etc.[53-57] 
Among these new approaches, nanoparticles (NPs) are one of the most common 
approaches for developing biosensing markers, due to their simplicity, physicochemical 
malleability and high surface areas.[58] These can measure between 1 to 100 nm in diameter 
and be composed of one or more inorganic compounds, such as noble metals, heavy metals, 
iron, etc. Most of them exhibit size-related properties that differ significantly from those 
observed on microparticles or bulk materials. Thus, depending on their size and composition 
we can observe peculiar properties, such as quantum confinement in semiconductor 
nanocrystals, surface plasmon resonance in some metal NPs and superparamagnetism in 
magnetic materials.[59] 
 
1.2.2 Quantum dots 
Semiconductor nanocrystals, commonly known as Quantum dots (QDs), have found a place 
in modern biological analysis mainly due to their significant fluorescent optical properties, 
presenting higher quantum yields and photostability than conventional organic dyes.[60] In 
addition, their narrow emission spectra can also be easily tuned and simultaneous excitation 
of multiple fluorescence colors is possible with a single wavelength within the UV spectrum. 
Larger QDs emit a red fluorescent light while smaller QDs emit a blue fluorescent light, being 
this coloration directly related to the energy levels of the QDs. These nanocrystals can be 
made of several semiconductor materials, such as cadmium, selenium, lead, and other 
heavy metals, following simple chemical synthesis protocols. Unfortunately, their composition 
also yields QDs a high in vivo toxicity, especially after suffering oxidative and/or photolytic 
degradation of their core coatings, which releases heavy metal toxic ions into the 
surrounding medium. Nevertheless, recent incorporations of a stable polymer coating have 
been made to try circumventing this issue, but toxicity studies with these NPs still remain 
inconclusive.[61] 
 
1.2.3 Noble metal nanoparticles 
The physico-chemical properties (e.g. optical, catalytic, electrochemical activity, etc.) of noble 
metal NPs have also been of interest in many biological applications, such as in medicine 
and molecular diagnostics. In particular, gold NPs (AuNPs) are among the most extensively 
studied nanomaterials and have led to the development of innumerous techniques and 
methods for molecular diagnostics, imaging, drug delivery and therapeutics.[62-65] 
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One of the most explored properties of AuNPs is their surface plasmon resonance (SPR) – a 
collective oscillation of conduction electrons on the NPs surface, that can be generated 
through the interaction of electromagnetic waves with the NPs surface electrons (Figure 1.2 
– A). This SPR presents them with exceptionally high absorption coefficients and scattering 
properties that allow for higher sensitivity in optical detection methods than conventional 
organic dyes.[66] 
 
 
Figure 1.2 – SPR of metal NPs. (A) The interaction of the electromagnetic waves with the metal NPs 
surface electrons generates a surface plasmon resonance. (B) The inter-particle distance of AuNPs 
affects their SPR band peak suffering a red-shift when inter-particle distance decreases. 
 
Typically, colloidal solutions of spherical AuNPs are red due to their SPR absorption band 
centered at ca. 520 nm. This band is weakly dependant on the size of the particle and the 
refractive index of the surrounding media, but strongly changes with shape and inter-particle 
distance.[67] In the latter case, the aggregation of AuNPs leads to a pronounced color 
transition from red to blue due to plasmon coupling between NPs (Figure 1.2 - B).[68]  
 
 
Figure 1.3 – Nanoparticle composition effect in SPR. The metal composition of gold-silver alloy 
NPs affects their SPR band peak and concomitant color, red-shifting with increasing ratio of gold. 
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In addition, nanoparticle composition in an alloy or core-shell conformation can also affect 
the SPR band (e.g. gold-silver NPs – see Figure 1.3)[69] or can further enhance functionality 
of NPs (e.g. AuNPs with magnetic core).[70] 
The SPR properties of dispersed spherical metal NPs can be quantitatively predicted by Mie 
theory, which represents an analytical solution of Maxwell's equations for the scattering of 
electromagnetic radiation by spherical particles composed of an absorbing or non-absorbing 
material.[71] Based on this, some approaches have been made to calculate the absorption 
and scattering efficiencies and extinction coefficient of AuNPs with different sizes and 
shapes.[66] 
 
1.2.3.1 AuNPs synthesis 
The successful utilization of AuNPs in biological assays relies on the availability of synthetic 
methods capable of generating NPs with the desired characteristics, namely high solubility in 
water and adequate morphology, size dispersion and surface functionalities. Numerous 
synthetic strategies for the preparation of AuNPs have been reported.[72-74] Most of these 
strategies are based on a chemical or electrochemical reduction of a gold(III) precursor 
compound in the presence of a capping agent (i.e. a compound that binds to the nanoparticle 
surface blocking its growth beyond the nanometer range and stabilizing the colloid in a 
particular solvent). Experimental conditions of the synthesis, namely reducing agents, 
reaction time, temperature and capping agents, normally dictate the outcome of AuNPs’ size 
and shape. The use of capping agents with strong affinity for gold (e.g. thiol capping agents) 
usually leads to a higher level of monodispersed AuNPs.[75] However, the choice of the 
capping agent for AuNPs synthesis should also be carefully made accordingly to the final 
intended functionalization and application. For example, AuNPs with strong binding capping 
agents can hamper further biological functionalization of the NPs and AuNPs only soluble in 
organic solvents cannot interact with most biological targets present in aqueous media. Due 
to these reasons, one of the most commonly used method for the synthesis of spherical 
AuNPs is the citrate reduction method of Turkevich et al.[76] This simple method produces 
fairly stable and reasonable monodispersed AuNPs in water with high-yield that can be easily 
functionalized with biological markers that are modified with functional groups presenting a 
higher binding affinity than citrate capping (e.g. thiol and amino groups). The size of the 
AuNPs can be easily controlled by varying the concentration of citrate in solution, with higher 
AuNPs being formed in the presence of lower citrate concentrations.[77] Additionally, alloy 
gold-silver NPs (AuAgNPs) can also be easily synthesized via a citrate co-reduction reaction 
with the two metals.[78] 
To achieve a greater monodispersion, AuNPs can be synthesized in organic solvents but this 
requires an additional step of extraction of the NPs into water so that they can be further 
used in biological applications.[75,79] 
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1.2.3.2 AuNPs functionalization 
The unique optical properties and high surface areas of AuNPs make them ideal candidates 
for developing biomarker platforms. Due to the high affinity binding of thiol to gold surfaces, 
citrate-capped AuNPs can be easily functionalized with biological molecules harboring a thiol 
moiety, such as thiol-modified ssDNA oligonucleotides. The chemical immobilization of such 
thiol-modified oligonucleotides on AuNPs, also known as Au-nanoprobes, has led to the 
development of novel detection technologies for clinical application.[62] In 1996, Mirkin and 
co-workers have successfully conjugated thiol-modified ssDNA oligonucleotides with AuNPs 
for the first time following a “salt aging” approach (herein designated as classic method).[80] In 
this procedure, the concentration of NaCl is gradually increased to neutralize non-specific 
adsorption, which can hamper thiol linkage to the AuNPs’ surface. In order to assess NP 
functionalization, Mirkin’s group also developed a fluorescent-based method to determine the 
surface coverage of thiol-modified oligonucleotides adsorbed on the AuNPs’ surface (i.e. Au-
nanoprobe density).[81] The method relies on AuNP functionalization with fluorescent modified 
thiol-oligonucleotides, which can be displaced by a strong reducing agent (e.g. 
mercaptoethanol) and quantified through fluorescence spectroscopy. Others have used a 
ssDNA intercalating dye instead of a fluorescence-labeled oligonucleotide and measured 
directly the Au-nanoprobe density.[82] In both cases, removal of the thiol-oligonucleotides 
from the AuNPs’ surface is crucial, as fluorescence signal may be distorted, quenched or 
enhanced, due to fluorescence resonance energy transfer (FRET) to the AuNP or near-field 
coupling between the fluorescent dye and AuNPs, respectively.[83, 84] 
The gradual increase in electrolyte concentration (up to ~0.7 M NaCl) over the course of 
oligonucleotide deposition significantly increases probe density on the surface.[81,85] The use 
of a spacer (e.g. poly(dT), PEG) between the recognition sequence and the alkanethiol 
moiety also leads to an increase in Au-nanoprobe density. The non-specific binding affinity of 
deoxynucleosides (dA, dT, dC and dG) to the AuNPs’ surface can also affect the Au-
nanoprobe density during functionalization, with dT oligonucleotide based sequences leading 
to denser Au-nanoprobes than dA, dC or dG based sequences.[86] The use of ultrasounds 
during the “salt aging” procedure can further increase Au-nanoprobe density, while reducing 
the salt aging procedure from 2 days to just a few hours with increased reproducibility in Au-
nanoprobe functionalization.[85] The addition of surfactant molecules (e.g. SDS, Tween-20) 
prior to salt aging also allows a faster “salt aging” and improves reproducibility, as surfactant 
molecules decrease the tendency of NPs to aggregate and coalesce, particularly at high salt 
concentrations, while reducing non-specific binding. A high temperature (~55 °C) during the 
“salt aging” procedure yields Au-nanoprobes with densities similar to those obtained with 
ultrasounds. More elaborated approaches have also been designed to control the number 
and position of oligonucleotides in AuNP surface, such as by making use of DNA 
nanostructures,[87] or through a solid phase anisotropic synthesis-like method.[88] 
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More recently, other noble metal NPs were also functionalized with thiol-modified DNA 
oligonucleotides to be used as nanoprobes, namely silver NPs and Ag/Au core-shell 
NPs.[89,90] However, DNA-functionalized AgNPs are considerably less stable than Au-
nanoprobes, mostly due to a lower efficiency of thiol adsorption to the AgNPs’ surface.[89] 
 
1.2.3.3 AuNPs/Au-nanoprobes stability 
The stability of citrate-capped AuNPs to increasing temperature and salt concentrations is 
significantly enhanced by derivatization of their surfaces with thiol-modified 
oligonucleotides.[80] Au-nanoprobes can easily withstand moderate salt concentrations (0.1 M 
NaCl) and temperatures in which citrate-capped AuNPs immediately aggregate. 
Nevertheless, in some cases, the Au-nanoprobes can still also irreversibly aggregate at 
higher salt concentrations (e.g. 2 M NaCl).[91] A higher surface coverage of the AuNPs with 
thiol-modified oligonucleotides provides higher stability against salt-induced aggregation, 
which is further enhanced by functionalization with longer thiol-modified oligonucleotides.[86] 
The salt valence is also relevant to Au-nanoprobe salt-induced aggregation, as shown by 
Stakenborg et al.,[92] as bivalent salts (e.g. MgCl2) induce aggregation of 30 nm Au-
nanoprobes at lower ionic strengths than monovalent salts (e.g. NaCl). Moreover, the 
referred 30 nm Au-nanoprobes were thermally stable only up to 55ºC; at higher temperatures 
(75-95ºC) these Au-nanoprobes aggregated within 15 minutes. Still, Au-nanoprobe stability is 
ultimately dictated by their intrinsic properties, such as length and density. 
A common theory for describing the stability of colloidal systems, such as Au-nanoprobes, is 
the Derjaguin–Landau–Verwey–Overbeek (DLVO) theory.[93] The standard DLVO theory 
suggests that the stability of a colloidal system is determined by the sum of attractive van der 
Waals forces and repulsive electrical double-layer forces that exist between particles as they 
approach each other due to Brownian motion. The balance between the attraction potential 
energy (ФA) plot and the repulsion potential energy (ФR) plot yields a total potential energy 
(ФT) plot that allows predicting the overall stability of the NPs. In the case of two spherical 
NPs with equal radius, the attraction potential energy can be calculated by the Hamaker 
integral approximation (Eq. 1), where A is the Hamaker constant (e.g. for gold NPs, A = 
2.5 10-9J [94]), Rs is the nanoparticle radius and d is the distance between the centers of two 
particles.[95] 
 
 
 
 
The repulsion potential energy can be calculated according to the Derjaguin approximation 
(Eq. 2), where RS is the NPs radius, kB is the Boltzmann constant, T is the absolute 
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temperature, n∞ is the total ion concentration in the bulk solution, Υ is the reduced surface 
potential and κ is a function of the ionic composition (i.e. inverse Debye length). 
 
 
 
According to these equations, the attraction potential energy increases in magnitude without 
limit as the particles approach each other. Simultaneously, the repulsive potential energy 
rises exponentially when particles get closer, reaching a finite value when they are in contact. 
The NPs may also undergo a form of irreversible aggregation, designated as coagulation, or 
a reversible aggregation, designated as flocculation. These two types of aggregation can be 
predicted by the DLVO theory, and are usually associated to a primary (in the case of 
coagulation) or secondary (in the case of flocculation) minimum in the total potential energy 
curve.[96] When the NPs are close to each other, the attractive van der Waals forces 
predominate and a deep minimum (i.e. primary minimum) is observed in the total potential 
energy curve, which is associated with the coagulation of NPs. However, an energy barrier 
located a little farther away from the nanoparticles’ surface must first be overcome to reach 
this minimum, as the electric repulsion potential dominates the van der Waals attraction 
potential. Usually, if the barrier is greater than ~10 kB.T, the collisions of two NPs produced 
by Brownian motion will not overcome the barrier and coagulation will not occur. 
Nevertheless, the NPs can still flocculate if a secondary minimum is present further away 
from the surface, i.e. before the energy barrier is reached. 
The presence of an electrolyte in the colloidal solution influences the Debye length as 
predicted by the following equation: 
 
 
 
where  is the dielectric constant, 0 is the permittivity of free space,  is the Avogadro 
number, e is the elementary charge and I is the ionic strength of the electrolyte. Therefore, 
an increase in electrolyte concentration decreases the double-layer thickness mostly due to 
charge screening. Moreover, it may give rise to a secondary-minimum in the total potential 
energy curve (i.e. aids flocculation) and decreases the energy barrier due to a decrease in 
the repulsive potential energy, which may lead to coagulation (see Figure 1.4). 
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Figure 1.4 – Schematic diagrams of the variation of the repulsive (ФR), attractive (ФA) and total (ФT) 
potential energy with nanoparticle separation according to DLVO theory and increasing ionic strength 
– from (A) to (C).
[96]
 
 
Besides the electrolyte concentration, the repulsive potential also depends on the valence of 
electrolyte counter-ions. A well known generalization that agrees with the DLVO theory and 
considers this valence effect of added electrolyte in the stability of NPs is the Schulze-Hardy 
rule.[96] According to this rule, the Critical Coagulation Concentration (CCC) value of 
electrolyte required to coagulate the NPs can be related by a ratio of 1:0.0156:0.0014, for 
ions of valence 1, 2, and 3, respectively. 
Although the DLVO theory can generally predict the stability of most colloidal systems, it 
should be noted that it is based on several assumptions and simplifications, and that it does 
not reflect the reality of all factors involved in the stability of the colloid. Apart from the van 
der Waals and the electrical double-layer forces, other interactions between charged NPs 
can influence their stability, such as hydration forces, hydrophobic forces, steric hindrance, 
among others. 
 
1.2.4 Gold nanoparticle based molecular detection 
Along with the optical properties of AuNPs, other physico-chemical properties (e.g. 
electrochemical activity) have been explored to develop highly sensitive methods for nucleic 
acid detection, some of which have already been successfully applied to biological samples. 
A list of these methods can be found in Appendix I, sorted by technological approach (i.e. 
colorimetrical, spectroscopy, electrochemical, etc.), detection limit and type of target (RNA, 
ssDNA, dsDNA, etc). Among these detection methods based on AuNPs, colorimetric 
approaches have been the most explored and, due to their simplicity and portability, are one 
the most promising for future diagnostic methods at point-of-care. Some of these methods 
are based on the color change generated by the plasmon coupling between AuNPs upon 
aggregation, while other methods rely on AuNPs just as a colorful reporter (i.e. making use of 
their superb scattering and/or absorbance properties).[80,82,97-99] 
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1.2.4.1 Methods using Non-functionalized AuNPs 
In the case of the method developed by Li et al., the differential propensity of ssDNA and 
dsDNA adsorption to AuNPs is explored.[97] Due to the electrostatic interaction between the 
free bases of ssDNA and the negatively charged surface of AuNPs with a citrate capping, 
ssDNA confers an increased stability to the AuNPs upon increasing ionic strength. Based on 
this observation, Li and co-workers combined AuNPs with citrate capping with a PCR 
procedure, using ssDNA probes complementary to the amplicon. This way, when PCR 
amplification is successful, the ssDNA probes will have a complementary target to hybridize 
and form a dsDNA that will not adsorb to the surface of AuNPs. Hence, the AuNPs will 
aggregate upon an increasing ionic strength, changing color from red to blue. On the other 
hand, when PCR amplification fails, ssDNA probes will remain available to adsorb to surface 
of AuNPs and prevent aggregation upon addition of an electrolyte (Figure 1.5). Although this 
is a very simple and elegant approach, it requires a fine tuning of the PCR protocol in order 
for all primers (also in ssDNA form) to be consumed, such as to avoid a false negative. 
Moreover, a false negative can also arise from an amplification reaction that is not carried out 
due to other factors other than the lack of a complementarity target DNA in solution (e.g. 
inactive polymerase, lack of dNTPs, etc). A careful primer and probe design should also be 
taken into consideration to avoid hairpin or primer dimer formation that may lead to a false 
positive result. 
 
 
Figure 1.5 – Detection of PCR-amplified targets by bare AuNPs. (A) Schematic of the method and 
(B) colorimetric results for complementary and non-complementary targets.
[97]
 
 
1.2.4.2 Methods using functionalized AuNPs 
1.2.4.2.1 Cross-linking method 
AuNPs functionalized with thiol-modified oligonucleotides (Au-nanoprobes) have been used 
in detection approaches, increasing the specificity of the methods when compared to those 
using non-functionalized NPs that rely on non-specific interactions between ssDNA and 
AuNPs. In fact, functionalization of AuNPs with thiol-modified oligonucleotides led to the first 
application of AuNPs in nucleic acid detection.[80] In their approach, Mirkin and co-workers 
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functionalized AuNPs with oligonucleotides modified with a thiol group at their 3’- and 5’-ends, 
whose sequences were contiguous and complementary to a target in a tail-to-tail (or head-to-
tail) conformation, and were used to identify the target DNA sequence. When hybridization 
occurs between the sequences of the Au-nanoprobes and the target DNA, the Au-
nanoprobes are drawn together and form a cross-linked network, leading to the aggregation 
of the AuNPs (Figure 1.6). 
 
 
Figure 1.6 – Cross-linking method. Schematic of the method and a colorimetric result of Au-
nanoprobes in absence (red solution) or presence (blue solution) of a complementary DNA target.
[100]
 
 
This cross-linking aggregation promotes a change of color of the solution from red to blue, 
which can be observed by the naked eye in solution or spotted on reverse-phase silica plate, 
or can be followed by visible spectroscopy. This method allows detection of single base 
mismatches by controlling the denaturation temperature of the cross-linked nanostructures, 
as they present a sharp melting transition.[101] 
 
1.2.4.2.2 Non-cross-linking method 
Since the development of the Au-nanoprobes by Mirkin and co-workers, other methods for 
nucleic acid detection have been described using just one Au-nanoprobe, instead of the two 
required for cross-linking. 
 
Sato’s non-cross-linking approach 
One of these methods has been developed by Sato and co-workers, which described a 
differential aggregation of the Au-nanoprobe in presence of complementary, mismatched or 
non-complementary targets, induced by an increasing ionic strength of the solution.[82] This 
non-cross-linking method was firstly developed with synthetic oligonucleotides with 
sequences of the same length as the Au-nanoprobe. So, when the complementary target 
sequences fully hybridize with the Au-nanoprobe, heteroduplexes with a blunt-end are 
formed and the Au-nanoprobe becomes less stable to an increasing ionic strength and 
aggregates, changing color from red to blue. In the presence of non-complementary targets 
or a target with a mismatch at the end of the Au-nanoprobe, these blunt-end heteroduplexes 
are not formed and the Au-nanoprobe remains dispersed and red, at the same ionic strength 
that led complementary/Au-nanoprobe complexes to aggregate. Unfortunately, this approach 
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has a limitation of application in real biological samples, since real biological targets are 
usually longer than the sequence of the Au-nanoprobe, and hence do not confer a blunt-end 
heteroduplex hybridization that is essential for the application of this method. To circumvent 
this limitation, Sato and co-workers used a PCR amplification followed by a single base 
primer extension approach to test biological samples and detect SNP at room temperature 
(Figure 1.7).[102] 
 
 
Figure 1.7 – Sato's non-cross-linking method for SNP detection. Au-nanoprobe hybridizes with 
the primer from single-base extension, after the PCR and washing steps. The resulting blunt end 
heteroduplexes provided by fully complementary targets leads to Au-nanoprobe aggregation upon 
increasing ionic-strength, while the Au-nanoprobes hybridized to mismatched targets remain 
dispersed.
[102]
 
 
Our non-cross-linking approach 
Following a simpler approach for nucleic acid detection in biological samples, our group has 
developed a non-cross-linking method that can be used to detect specific DNA and/or RNA 
with a longer sequence than the Au-nanoprobe sequence.[91,103,104] In this approach, the 
detection is achieved by color comparison upon salt addition, between solutions containing 
the Au-nanoprobe and either a complementary or a non-complementary target sequence. 
While the presence of a complementary target prevents aggregation upon salt addition and 
the solution remains red, the non-complementary targets do not prevent Au-nanoprobe 
aggregation, resulting in a visible change of color from red to blue (Figure 1.8). 
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Figure 1.8 – Non-cross-linking method. Au-nanoprobe alone (“Blank”) or in presence of a 
complementary (“Positive”) or non-complementary (“Negative”) target are submitted to a 
denaturation/hybridization step, to allow target hybridization, and then the ionic strength of solution is 
increased to reveal the colorimetric result. 
 
1.2.4.2.3 Other methods 
Apart from the methods based on a color variation, other methods have been developed 
using the AuNPs of the Au-nanoprobes as a reporter. One example is the method for 
detecting nucleic acid sequences through the hybridization with Au-nanoprobes in a 
chromatographic stripe (also known as dipstick), as described by Glynou et al.[98] In this 
approach, similarly to current pregnancy tests, biotinylated PCR products are hybridized to a 
specific oligo(dA)-tailed probe and loaded on the chromatographic stripe. As the buffer 
migrates through the stripe, the biotinylated PCR products are immobilized by streptavidin 
spotted in a specific location of the stripe. Finally, to detect the presence of the DNA target in 
the streptavidin spot, poly-dT Au-nanoprobes are used to hybridize with the poly-dA probe 
(Figure 1.9). Other variants of this technique have also been described by Kalogianni and co-
workers to fit a specific application (e.g. SNP detection and multiplex analysis).[105,106,107] 
However, although the detection procedure on this method is simple and easily portable, just 
like pregnancy tests are, the method also requires a previous target DNA preparation 
protocol that is laborious and requires specialized technicians. 
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Figure 1.9 – Dip-stick method. Schematic of the method and an example of a positive (two bands) 
and a negative (one band) strip-test result.
[98]
 
 
Using a high-throughput approach, Mirkin and co-workers also used Au-nanoprobes to 
substitute the conventional fluorescent labeled probes usually used to report target 
hybridization in a microarray platform.[99] In their method, the scattered light incident on the 
AuNPs of Au-nanoprobes is registered by a CCD camera and used as a signal to report 
complementary target hybridization. Moreover, if an additional step of silver(I) reduction is 
performed over the Au-nanoprobes surface, the scattering intensity increases and, 
consequently, the sensibility of the method also increases, such as up to 200 fM of genomic 
DNA can be detected (Figure 1.10).[108] The detection of single base mismatches is also 
possible at controlled temperatures and increased selectivity is observed when Au-
nanoprobes are used instead of standard fluorescent probes. 
 
 
Figure 1.10 – Au-nanoprobe microarray. Schematic of microarray approach by using the Au-
nanoprobe as a reporter and silver reduction to enhance signal.
[99] 
 
This method is already being commercialized by Nanosphere, Inc. (known as Verigene® 
system) and was one of the first nanotechnology-based diagnostic platforms to be approved 
by U.S. Food and Drug Administration (FDA). 
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The favorable optical properties of AuNPs can be further explored by different spectroscopic 
techniques. For instance, Au-nanoprobes can be encoded with Raman reporter molecules 
generating enhanced Raman signals that allow for the detection of specific nucleic acids by 
surface-enhanced Raman spectroscopy (SERS).[109] Additionally, the long-range plasmon 
coupling of AuNPs through a cross-linking hybridization approach generates an increase in 
SERS signal intensities by 40−200-fold (Figure 1.11).[110] 
 
 
Figure 1.11 – Cross-linking nucleic acid detection by SERS. The presence of complementary 
targets promotes the plasmon coupling between Au-nanoprobes encoded with a Raman reporter 
molecule and generates an enhanced Raman signal.
[110]
 
 
The electrochemical properties of Au-nanoprobes can also be used to report hybridization in 
a microarray platform following different electrochemical strategies (Figure 1.12).[111] 
 
 
Figure 1.12 – Electrochemical DNA detection. Schematic of the different strategies used for the 
integration of Au-nanoprobes into DNA sensing systems: (A) direct detection of Au-nanoprobes 
anchored onto the surface of the genosensor; (B) conductometric detection; (C) enhancement with 
silver or gold following detection; (D) Au-nanoprobes as carriers of other AuNPs; (E) Au-nanoprobes 
as carriers of other electroactive labels.
[111] 
 
For instance, the hybridization of an Au-nanoprobe with a sequence anchored onto the 
surface of a conventional electrochemical sensor can be directly assessed by stripping or 
differential pulse voltammetry, or through a conductometric technique. The electrochemical 
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signal can be further enhanced by silver/gold reduction, or by using other AuNPs or 
electroactive labels attached to the Au-nanoprobe. 
 
1.2.4.3 Other noble metal nanoparticle based molecular detection 
Most nanoparticle based methods for nucleic acids detection have so far relied only on 
AuNPs, mainly due to their ease of functionalization with thiol-modified oligonucleotides. 
Nonetheless, more recently, Mirkin and coworkers have also used Ag/Au core-shell NPs 
functionalized with thiol-modified oligonucleotides to detect nucleic acid targets following the 
same cross-linking approach that was developed with Au-nanoprobes (see Section 
1.2.4.2.1).[90] In their approach, the Ag/Au core-shell and pure-gold nanoprobes presented 
identical results, but with different optical properties (i.e. different colors). This allowed to 
establish a two-color-change-based method for parallel SNP analysis, providing a convenient 
cross-check and an assay control that offer a more accurate readout when compared to the 
single-color-change methods. 
Apart from the Au/Ag core-shell NPs, silver NPs functionalized with thiol-modified 
oligonucleotides have also been used for the molecular detection of nucleic acids, following 
the cross-linking approach.[112] 
 
 
1.3 Scope of Thesis 
Most current molecular diagnostic methods for DNA and RNA characterization are still time 
consuming and require expensive equipment and reagents, and highly specialized 
laboratories and personnel. Therefore, their use in a larger number of laboratories or even at 
POC, and by a wider population, especially in countries with fewer resources, is still not 
viable. This limits the benefits from the post-genomic era that could greatly improve patient 
care through more efficient disease prevention and customized therapies. 
 
Considering this issue, the main objective of this thesis was to develop a simple and 
inexpensive colorimetric method/kit for nucleic acid detection in biological samples, with 
especial focus being given to the single base mutation/SNPs detection in DNA. The method 
to be developed should be performed with a minimal setup protocol and independently from 
any expensive and specialized equipment, without compromising specificity, sensibility and 
reliability. Additionally, it should be affordable, quick and user-friendly to enable its use in a 
larger number of laboratories or at POC by unspecialized personnel. This way, the current 
demand for near-patient nucleic acid testing can be met. 
 
Towards these objectives, a colorimetric method for DNA detection with a single base 
resolution was developed based on the non-cross-linking approach taken by our group. The 
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method had already been successfully applied to eukaryotic gene expression studies without 
retro-transcription or PCR amplification,[91] but its application to DNA and single base 
mutation/SNPs detection remained unexplored, and the underlying principles of this non-
cross-linking method had not been clarified. Therefore, three different targets - single point 
mutations/SNP involved in β-thalassemia, diabetes or xenobiotic metabolism - have been 
selected to carry out the proof-of-concept for SNP detection and further develop the method. 
Additionally, studies were conducted to better understand the underlying mechanisms 
involved in the non-cross-linking detection, towards the optimization of the method. 
 
1.3.1 Target selection 
Genetic targets were chosen considering clinical samples availability and the commercial 
interests of STAB VIDA, Lda. related to targets that could potentially benefit from point-of-
care diagnosis, such as those related to nutrigenomics/nutrigenetics and 
pharmacogenomics/pharmacogenetics. Additionally, target selection was focused on those 
designated by EuroGentest, a Network of Excellence for test development, harmonization, 
validation and standardization of services in human genetics, within which STAB VIDA, Lda. 
was an active partner. Considering all these aspects, -thalassemia related mutations were 
the first targets to be tested for the proof-of-concept. Not only were there plenty of DNA 
samples but thalassemias are also a model for single gene disorders.[11] Later, to further 
evaluate the versatility of the method, two other targets were chosen: Diabetes and Obesity 
Regulated (DOR) gene, associated with diabetes and obesity;[113] and Cytochrome P450 2D6 
(CYP2D6) gene, which is involved in the metabolism of xenobiotics.[114] 
 
1.3.1.1 Beta-thalassemia 
Hemoglobin is a metalloprotein responsible by oxygen-transportation in human red blood 
cells. It is tetramer constituted by two α- and two -globin subunits that are covalently 
attached to the prosthetic oxygen-binding heme group.[115] In healthy adults, over 95% of 
hemoglobin is constituted by α2 2 subunits (Hemoglobin A), between 1% and 3% is 
constituted by α2δ2 subunits (Hemoglobin A2) and less than 1% is constituted by α2γ2 
subunits (Hemoglobin F, the fetal hemoglobin). The α-subunits are encoded by two α globin 
genes (α2 and α1) located on chromosome 16, while the γ-, δ- and -subunits are encoded 
by their respective genes (Gγ and Aγ, δ and ) located in a cluster on chromosome 11.[115] 
Mutations within these clusters of globin genes can lead to hemoglobinopathies, which are 
one of the most prevalent single-gene disorders found in humans.[116] These disorders can be 
the result of a reduced synthesis of one or more of the globin subunits (i.e. thalassemias) or 
of the synthesis of structurally abnormal hemoglobin variants, or a combination of these two 
cases. Among them, thalassemias make up the vast majority and can be classified according 
to which globin subunit synthesis is affected (e.g. in β-thalassemia, production of the β-globin 
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subunit is affected). The reduced synthesis of a specific globin subunit causes the formation 
of abnormal hemoglobin and, hence, unhealthy red blood cells are formed, causing anemia. 
The severity of symptoms often depends on the nature of the genotype. In the case of -
thalassemia, mutations that prevent any formation of β-subunits are classified as β0, while 
mutations that allow some expression of β-subunits are classified as β+. Clinically, -
thalassemias are usually classified as: -thalassemia minor, which is associated with the 
heterozygous forms, -/β+ or -/β0, and also known as -thalassemia trait; -thalassemia 
intermedia, often associated with the homozygous form, β+/β+; -thalassemia major, 
associated with the hetero- or homozygous forms, β+/β0 or β0/β0, and also known as Cooley’s 
anemia.[117] Nevertheless, the clinical phenotype of β-thalassemia may also be modified by 
the coinheritance of other genetic factors at the secondary and tertiary levels mapped 
outside the β-globin gene cluster or by environmental factors.[118] 
More than 200 different mutations in the gene encoding the hemoglobin β-chain (HBB) have 
been associated with β-thalassemias, some of them with high-prevalence within specific 
populations (for more detail, go to HbVar: Database of Human Hemoglobin Variants and 
Thalassemia Mutations - http://globin.cse.psu.edu/hbvar/menu.html).[119] Prevalence of -
thalassemia is higher in the Mediterranean, Middle East, Transcaucasus, Central Asia, 
Indian subcontinent, and Far East populations, although it is also common in populations of 
African heritage.[120] The most common mutations associated to -thalassemias are point 
mutations in the HBB gene, except for the 619 bp deletion that accounts for 20% of the -
thalassemias in Asian Indians.[121] 0-thalassemia alleles usually result from nonsense, 
frame-shift, or splicing mutations, while β+-thalassemia alleles result from mutations in the 
promoter area (either the CACCC or TATA box), the polyadenylation signal, the 5' or 3' non-
coding region, or by splicing abnormalities. β-thalassemia may also result from a deletion of 
the locus control region, located 5 to 25 Kb upstream from globin gene.[122] 
Genetic testing for screening mutations within the HBB gene is currently available in many 
clinical laboratories and is used to predict the clinical phenotype in some cases, as well as in 
pre-symptomatic diagnosis of at-risk family members and prenatal diagnosis. Commonly 
occurring mutations of the HBB gene are usually detected by allele-specific priming (also 
known as ARMS-PCR), allele-specific oligonucleotide hybridization, restriction enzyme 
analysis or direct sequencing analysis, in the case of point mutations, and by Gap-PCR, in 
the case of deletions.[123] 
 
1.3.1.2 DOR1 
Human DOR has been reported as a nuclear co-activator that enhances the transcriptional 
activity of several nuclear receptors.[113] This nuclear receptor co-factor was found to be 
down-regulated in skeletal muscle and heart of obese mice and humans, and is located at 
the chromosome 20q11.22, close to loci linked to human obesity[124-126] and type 2 
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diabetes.[127-129] In fact, a G/C polymorphism in the proximal promoter of the human DOR 
gene, named DOR1, has been associated with obesity and type 2 diabetes in humans. This 
polymorphism influences the expression level of the DOR gene, in which DOR1C is the 
protective allele and leads to higher transcription activation. Currently, the mechanisms 
behind the down-regulation of the DOR gene in humans and mouse are still being 
investigated with the aim to identify possible targets for prevention or treatment of metabolic 
diseases.[130] So far, DOR is known to physically interact with the thyroid hormone receptor 
TRα1 and T3-responsive promoters, and therefore is believed to play a role in the onset and 
pathophysiology of obesity and type 2 diabetes in man.[113] Presently, genotyping of DOR1 is 
carried out by RFLP, using a DdeI restriction enzyme that overlaps the polymorphism. Only 
the DOR1C allele harbors a restriction site for this enzyme within the polymorphism locus 
and, hence, it is digested at that position (Baumgartner B, personal communication). 
 
1.3.1.3 CYP2D6 
Cytochrome P450 (CYP450) is a very large and diverse superfamily of hemoproteins, 
including 57 genes coding for the various CYP450 enzymes that are responsible for the 
metabolism of xenobiotics, including most of the pharmaceutical drugs. These genes are 
highly polymorphic and these differences can quantitatively or qualitatively reduce or 
enhance the enzymatic activity and, therefore, xenobiotic metabolism of a given individual.[131] 
CYP2D6 is one of the most polymorphic CYP450 genes, and is constituted by 9 exons, 
spanning 4.4 Kb of human chromosome 22 (22q13.1). CYP2D6 is organized in tandem with 
two pseudogenes - CYP2D7 and CYP2D8P. Despite constituting just a small fraction of the 
CYP450 enzymes present in liver, the CYP2D6 is found to be involved in the phase I 
metabolism of approximately 20% of the commonly prescribed drugs, including 
antidepressants, antihypertensive, beta-blockers, antipsychotics, and others.[132] The 
variability of CYP2D6 gene is considerably high between individuals and so far 122 alleles, 
characterized by over 130 SNPs, have been described (see 
http://www.cypalleles.ki.se/cyp2d6.htm for allele nomenclature). Many of these alleles lead to 
a significant or total loss of activity. Correlation between CYP2D6’s genotype/phenotype may 
allow adjusting the dosage or the prescription of alternative therapies based on the 
genotyping of each individual,[114] which could reduce the risk of adverse reactions and/or 
failed treatments due to over- or sub-dosage. According to the level of metabolism, it is 
possible to classify the phenotype of an individual in one of four groups:[114] 
- Ultrarapid metabolizer (UM) – alleles with multiple copies of the functional gene lead 
to a significant increase in the CYP2D6 expression, and therefore to a greater-than-normal 
CYP2D6 function; the treatment of individuals with this phenotype can fail due to drug sub-
dosage; 
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- Extensive metabolizer (EM) – association of one or two totally functional alleles; 
these subjects have normal CYP2D6 function; 
- Intermediate metabolizers (IM) – association of one allele translating to a reduced 
activity and one allele translating to no activity; these subjects metabolize drugs at a rate 
somewhere between the poor and extensive metabolizers and can be victims of over-dosage; 
- Poor metabolizer (PM) – association of two alleles that translate for an inactive 
protein; these subjects have little or no CYP2D6 function, incurring in a risk of over-dosage. 
 
CYP2D6 allele frequency is known to vary amongst racial/ethnic groups.[133] In European 
Caucasians, 71% of the CYP2D6 alleles code for a normal enzymatic activity, while 26% 
represent non-functional alleles. Within these non-functional alleles, the most frequent is the 
CYP2D6*4 allele, where over 75% of PMs Caucasians individuals carry this allele. In Asians 
individuals, the frequency of functional alleles represents only 50% of the CYP2D6 alleles, 
and 41% hold the CYP2D6*10 allele associated to a reduced enzymatic function, thus, 
contributing to this population slower metabolism. The frequency of functional alleles in 
Africans and African Americans individuals is also 50%, while 35% hold a reduced function 
allele, mainly CYP2D6*17. 
 
Current genotyping methodologies of CYP2D6 are based in PCR-based assays, such as 
real-time PCR,[134] multiplex allele-specific PCR,[135] PCR with RFLP analysis,[136] multiplex 
primer extension PCR,[137] among others. High-throughput assays have also been recently 
developed and used, such as pyrosequencing[138] and the CYP450 GeneChip from Affymetrix, 
which is based on microarray technology.[139] Nonetheless, these high-throughput methods 
often require special laboratory facilities and equipment, and therefore allele-specific PCR 
and RFLP analysis are still the most widely used, despite being more laborious and low 
throughput. 
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2.1 Materials 
2.1.1 Equipment 
- UV-Vis Spectrophotometer Cary 50 (Varian, USA) 
- UV-Vis-NIR Spectrophotometer Cary 5000 with Peltier thermostatted accessory (Varian, 
USA) 
- UV-Vis Spectrophotometer UV Mini-1240 (Shimadzu, Germany) 
- UV-Vis Spectrophotometer Nanodrop ND-1000 (Nanodrop Technologies, USA) 
- Fluorescence Spectrophotometer Cary Eclipse with Peltier thermostatted accessory (Varian, 
USA) 
- Microplate reader Infinite M200 with Absorbance module (Tecan, Switzerland) 
- Zetasizer Nano ZS system, 4 mW He-Ne laser - 633 nm (Malvern Instruments, UK) 
- Real-time rotary analyzer Rotor-Gene 6000 (Corbett Research, UK) 
- Thermal Cycler DNA Engine (Bio-Rad, USA) 
- Thermal Cycler Tgradient (Biometra, Germany) 
- Gel Doc XR+ Molecular Imager system (Bio-Rad, USA) 
- Gel Logic 100 Imaging system (Kodak, USA) 
- Digital SLR camera Rebel XSi (Canon, USA) 
- Ultrasonic bath Elmasonic S10H (Elma, Germany) 
- Wide Mini-Sub Cell GT electrophoresis cell with PowerPac Basic power supply (Bio-Rad, 
USA) 
- E-Gel® iBase™ Power System with E-Gel® Safe Imager Invitrogen, USA) 
- pH meter Basic 20 with combined glass electrode 5209 (Crison, Spain) 
 
2.1.2 Specialized Materials 
- Quartz absorption cells – 105.202-QS (Hellma, Germany) 
- Quartz fluorescence cells for magnetic stirrers – 119.004F-QS (Hellma, Germany) 
- Quartz fluorescence cells – 105.254-QS (Hellma, Germany) 
- 384 well small volume, LoBase Polystyrene microplates, black – Cat.No.788096 (Greiner 
Bio-One, Germany) 
- NAP-5 columns (GE Healthcare, Sweden) 
- Zeta potential cells (Malvern Instruments, UK) 
- E-Gel® EX pre-cast gel, 2% (Invitrogen, USA) 
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2.1.3 Chemical reagents 
Reagent CAS number Distributor 
Agarose 9012-36-6 Invitrogen 
Ammonium chloride 12125-02-9 Merck 
Ampicillin 69-53-4 Sigma-Aldrich 
Bacteriological agar 9002-18-0 Difco 
Betaine 107-43-7 Sigma-Aldrich 
Bromophenol blue 115-39-9 Merck 
Chloroform 67-66-3 Merck 
DL-Dithiothreitol (DTT) solution, 1M 3483-12-3 Fluka 
Ethidium bromide 1239-45-8 Sigma-Aldrich 
Ficoll 26873-85-8 Sigma-Aldrich 
Formamide 75-12-7 Fluka 
Glycerol 56-81-5 Sigma-Aldrich 
Gold(III) chloride trihydrate 16961-25-4 Sigma-Aldrich 
H2O ultra pure 7732-18-5 Fluka 
Hydrochloric acid 7647-01-0 BDH 
Lithium chloride 7447-41-8 Merck 
Magnesium chloride 7786-30-3 Merck 
Methyl sulfoxide (DMSO) 67-68-5 Sigma-Aldrich 
Mineral oil 8042-47-5 Sigma-Aldrich 
Nitric acid 7697-37-2 Merck 
Phenol 108-95-2 Fluka 
PIPES 5625-37-6 Sigma-Aldrich 
Potassium chloride 7447-40-7 Merck 
Proteinase K 39450-01-6 Roche 
Ribonuclease A 9001-99-4 Sigma 
Silver nitrate 7761-88-8 Merck 
Sodium chloride 7647-14-5 Merck 
Sodium citrate tribasic dihydrate 6132-04-3 Sigma-Aldrich 
Sodium Dodecyl Sulfate (SDS) 151-21-3 Sigma-Aldrich 
Sodium hydroxide 1310-73-2 Merck 
Sodium phosphate dibasic dihydrate 10028-24-7 Merck 
Sodium phosphate monobasic monohydrate 10049-21-5 Merck 
Trisodium citrate 03-04-6132 Merck 
Triton-X 100 9002-93-1 Sigma 
Tryptone 91079-40-2 Difco 
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Reagent (cont.) CAS number Distributor 
Xylene cyanol 2650-17-1 BDH 
Yeast extract 8013-01-2 USB 
Zinc chloride 7646-85-7 Sigma-Aldrich 
 
 
2.1.4 Solutions 
Phosphate buffer (10 mM) 
According to the desired pH: 
pH Na2HPO4 (mM) NaH2PO4 (mM) 
6.5 3.03 6.97 
7 5.77 4.23 
7.5 8.15 1.85 
8 9.32 0.68 
Sterilize by autoclaving and store at 4ºC. 
 
PBS 
0.1M NaCl 
10mM phosphate buffer of desired pH 
Sterilize by autoclaving and store at 4ºC. 
 
AGE I 
0.5 M NaCl 
50 mM phosphate buffer pH 7 
Sterilize by autoclaving and store at 4ºC. 
 
AGE II 
2% (w/v) SDS 
10 mM phosphate buffer pH 8 
Sterilize by filtration (0.22 μm) and store at 4ºC. Warm up to 25ºC before use. 
 
AGE III 
1.5 M NaCl 
0.01% (w/v) SDS 
10 mM phosphate buffer pH 8 
Sterilize by filtration (0.22 μm) and store at 4ºC. Warm up to 25ºC before use. 
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TB 
10 mM PIPES 
15 mM CaCl2 
250 mM KCl 
55 mM MnCl2 
Adjust pH to 6.7 with KOH or HCl. Sterilize by filtration (0.22 μm) and store at 4ºC. 
 
AL I 
50 mM Glucose 
25 mM Tris-HCl pH 8 
10mM EDTA pH 8 
Sterilize by autoclaving and store at 4ºC. 
 
AL II 
200 mM NaOH 
1% (w/v) SDS 
Prepare fresh before use (room temperature). 
 
AL III 
3M sodium acetate (adjust pH to 4.8 with glacial acetic acid) 
Store at 4ºC and keep in ice during use. 
 
TBE buffer (5x) 
446 mM Tris base 
445 mM boric acid 
10 mM EDTA (pH8) 
Store at room temperature. 
 
LB medium (Luria-Bertani medium) 
1% (w/v) tryptone 
0.5% (w/v) yeast extract 
171 mM NaCl 
Adjust to pH 7 with NaOH. Sterilize by autoclaving and store at 4ºC. 
NOTE: For solid medium, add 1.4% (w/v) of Agar. 
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SOB medium 
2% (w/v) tryptone 
0.5% (w/v) yeast extract 
10 mM NaCl 
2.5 mM KCl 
10 mM MgCl2 * 
10mM MgSO4* 
Adjust to pH 7 with NaOH. Sterilize by autoclaving and store at 4ºC. 
*NOTE: Add sterile MgCl2 and MgSO4 just before use. 
 
SOC medium 
Same as SOB medium plus add 20 mM glucose (sterile) after autoclaving SOB medium and 
cooling down to 60ºC or less. 
 
2.1.5 Biological material 
2.1.5.1 Enzymes 
- Taq DNA polymerase (GE Healthcare, Sweden) 
- Extensor Long PCR enzyme Mix - ThermoPrime Taq DNA polymerase + proprietary 
thermostable proofreading enzyme (ABGene, UK) 
- HindIII restriction enzyme (Fermentas, Canada) 
- BamHI restriction enzyme (Amersham Biosciences, Sweden) 
- MvaI restriction enzyme (Fermentas, Canada) 
- DdeI restriction enzyme (Fermentas, Canada) 
- RNase A endoribonuclease (Fermentas, Canada) 
 
2.1.5.2 DNA size markers 
- GeneRuler™ DNA Ladder Mix, ready-to-use (Fermentas, Canada) 
 
2.1.5.3 Kits 
- GeneJET™ PCR Cloning Kit (Fermentas, Canada) 
- GFX™ PCR DNA and Gel Band Purification Kit (GE Healthcare, Sweden) 
- Quant-iT™ OliGreen® ssDNA Assay Kit (Invitrogen, USA) 
 
2.1.5.4 E. coli strains 
- Escherichia coli JM107 
 
2.1.5.5 Oligonucleotides 
All oligonucleotides were acquired from STAB VIDA, Lda. (Portugal) 
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2.1.5.5.1 Unmodified oligonucleotides 
Primers 
Designation Sequence (5’ to 3’) Tm (ºC) 
bGlobF ACTCCCAGGAGCAGGGAGGGCAGG 
69 
bGlobR CAGATCCCCAAAGGACTCAAAGAACCTCTG 
bGlobLongF AACGTGGATGAAGTTGGTGGTGAGG 
68 
bGlobLongR CACTGACCTCCCACATTCCC 
Pex4-5’ CTGGTCCTCTGACTGCTC 
58 
Pex4-3’ CATTGAAGTCTCATGGAAGCC 
pJET1Fw GCCTGAACACCATATCCATCC 
57 
pJET1Rev GCAGCTGAGAATATTGTAGGAGATC 
CYP2D6F GTTATCCCAGAAGGCTTTGCAGGCTTCA 
66 
CYP2D6R GCCGACTGAGCCCTGGGAGGTAGGTA 
CYPex1F GAGCCCATTTGGTAGTGAGGCAGG 
62 
CYPex1R CCTCTGCCGCCCTCCAGGACC 
CYPex2F CTGGCTTGACAAGAGGCCCTGACC 
CYPex2R CGGAAATCTGTCTCTGTCCCCACC 
CYPex3F CACGCGCACGTGCCCGTCCCAC 
CYPex3R AGTTCCCGCTTTGTGCCCTTCTGC 
CYPex4F AGGCGACCCCTTACCCGCATCTCC 
CYPex4R CCTGCAGAGACTCCTCGGTCTCTC 
CYPex5F AGGAGGGATTGAGACCCCGTTCTG 
CYPex5R CCACCGTGGCAGCCACTCTCACC 
CYPex6F CGTTCTGTCCCGAGTATGCTCTCG 
CYPex6R CTCGGCCCCTGCACTGTTTCCCAG 
CYPex7F GCTGACCCATTGTGGGGACGCATG 
CYPex7R TGCTGAGCTGGGGTGAGGAGGGC 
CYPex8F CAGTCCCCACTCTCACCCTGCATC 
CYPex8R GAAGGGGACAGGGAGCCGGG 
CYPex9F AGCCAGGCTCACTGACGCCCC 
CYPex9R TGATCCCAACGAGGGCGTGAGCAG 
DOR1F AGGAGCCGGTAGGAGGGAGTGGAG 
60 DOR1Fass AGGAGCCGGTAGGAGGGAGTGGAGATCCTC 
DOR1R CGCCGGCGGAGACAGACAAAG 
 
 
37 
Synthetic ssDNA targets 
Designation Sequence (5’ to 3’) 
DOR1G_XL 
GGCCGCTGCGGCGGGGCTCAGGGCACAAATTGGAACGTTCAAACAGCTGATT
GTGACGTC 
DOR1C_XL 
GGCCGCTGCGGCGGGGCTCACGGCACAAATTGGAACGTTCAAACAGCTGATT
GTGACGTC 
DOR1G_20 GGCCGCTGCGGCGGGGCTCACGGCACAAATTGGAACGTTG 
DOR1G_16 GGCCGCTGCGGCGGGGCTCACGGCACAAATTGGAAGGTTC 
DOR1G_4 GGCCGCTGCGGCGGGGCTCACGGGACAAATTGGAACGTTC 
DOR1TA GGCCGCTGCGGCGGGGCTCATGGCACAAATTGGAACGTTC 
DOR1AA GGCCGCTGCGGCGGGGCTCAAGGCACAAATTGGAACGTTC 
DOR1CA GGCCGCTGCGGCGGGGCTCACGGCACAAATTGGAACGTTC 
DOR1GA GGCCGCTGCGGCGGGGCTCAGGGCACAAATTGGAACGTTC 
CYP1846C GGCCGCTGCGGCGGGGCTCACTGGGGGTGGGAGATGCGGG 
CYP1846T GGCCGCTGCGGCGGGGCTCATTGGGGGTGGGAGATGCGGG 
 
2.1.5.5.2 Thiol modified (probes) 
NOTE: All the following oligonucleotides are 5’-thiol-(CH2)6 modified. Resuspend in 100 μL of 
1 M DTT and incubate for 1 h at room temperature. Afterwards, add 900 μL of sterile milli-Q 
H2O to achieve a final concentration of 0.1M DTT. Store oligonucleotides at -20ºC. 
Designation Sequence (5’ to 3’) 
Genbank 
Acc. No. 
bGlob AACCTTGATACCAAC NG_000007 
DOR1G GAACGTTCCAATTTGTGCCG 
AL109824 
DOR1C GAACGTTCCAATTTGTGCCC 
DOR1T GAACGTTCCAATTTGTGCCT 
DOR1A GAACGTTCCAATTTGTGCCA 
CYP1846G CCCGCATCTCCCACCCCCAG 
NG_008376 
CYP1846A CCCGCATCTCCCACCCCCAA 
CYP1846G_XL ACGGGGAAGGCGACCCCTTACCCGCATCTCCCACCCCCAG 
CYP1846A_XL ACGGGGAAGGCGACCCCTTACCCGCATCTCCCACCCCCAA 
 
 
Probe design: 
β-thalassemia probe 
The probe sequence was designed so as to harbor three of the most frequent mutations 
causing β-thalassemia in the Mediterranean and Portuguese populations, namely β0IVS1, 
nt1 (G>A); β+IVS1, nt2 (T>C); and β+IVS1, nt6 (T>C).[140] A 15 nt probe oligonucleotide 
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sequence (bGlob probe) was derived from the β-globin gene sequence (GenBank accession 
no. NG_000007) so as to overlap the region harboring the previously described mutations, 
placing the β0IVS1, nt1 (G>A) mismatch at the 3’-end of the thiol-modified oligonucleotide. 
Because of the sequence homology to the HBB pseudogene 1 (HBBP1, 77% sequence 
homology with HBB) a specific PCR amplification of the specific HBB target region may be 
needed. 
 
 
Figure 2.1 – Globin gene cluster map with corresponding location of primers and probe 
sequences and the position of the three most frequent mutations causing β-thalassemia in the 
Mediterranean and Portuguese populations. Black boxes in gene cluster represent exons. 
 
 
DOR1 probes 
To detect and characterize the alleles associated to DOR1 (dbSNP rs#: rs237825), two 20 nt 
probe oligonucleotide (DOR1C and DOR1G probes) were derived from the DOR/TP53INP2 
gene sequence (GenBank accession no. AL109824). Moreover, the G/C polymorphism was 
designed to be located at the 3’-end of the thiol-modified oligonucleotide. The DOR1C and 
DOR1G probe sequence are fully complementary to the DOR1C and DOR1G alleles, 
respectively. Additionally, two other probes harboring an identical sequence to DOR1G/C 
probes but varying in the 3’-end nucleotide (A or T) were also designed to fully characterize 
the method (DOR1A and DOR1T probes). 
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Figure 2.2 – DOR/TP53INP2 locus map with corresponding location of primers and probes 
sequences. Black boxes in gene cluster represent exons. Note: DdeI restriction digests the C^TCAG 
sequence, but not G^TCAG sequence. 
 
CYP2D6 probes 
The CYP2D6*4 allele variant leads to an inactive CYP2D6 enzyme due to a splicing defect, 
and is the most frequently found non-functional allele in European Caucasians. For this 
reason, it was the selected target to further study the single base mismatch resolution of the 
non-cross-linking method. Two 20 nt probes were designed to overlap the CYP2D6 gene and 
harbor the tag SNP associated to the non-functional CYP2D6*4 haplotype (i.e. 1846G/A SNP, 
dbSNP rs#:rs3892097) at their 3’-end (CYP1846G and CYP1846A probes). The sequences 
were derived from the CYP2D6 gene reference sequence (GeneBank ref. NG_008376). The 
CYP1846A probe is fully complementary to the CYP2D6*4 allele variant, while the 
CYP1846G probe is fully complementary to any of the other allele variants, such as 
CYP2D6*1 (the reference allele). Note that, unfortunately, the CYP1846G probe is also fully 
complementary to the CYP2D7 pseudogene which holds a 97% sequence homology with the 
CYP2D6 gene.[141] Therefore a specific amplification of CYP2D6 gene prior to detection may 
be necessary for a correct SNP analysis. 
Additionally, two 40 nt probe sequences were also designed by extending the 5’-end of the 
previously described probe sequence with 20 nt derived from the reference sequence 
(CYP1846G_XL and CYP1846C_XL probes). 
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Figure 2.3 – CYP2D6 loci map with corresponding location of primers and probes sequences. 
Black boxes in gene cluster represent exons. Note: MvaI restriction digests the CC^WGG sequence, 
but not CC^WAG sequence. 
 
 
2.1.5.5.3 Fluorescent modified 
Designation Sequence (5’ to 3’) Modification 
FAM probe TGAGCCCCGCCGCAGCGGCC 3’-FAM 
 
2.1.5.6 Genomic DNA 
Human genomic DNA samples for: 
- -thalassemia studies were kindly provided by Prof. Leonor Osório-Almeida from Centro de 
Investigação em Genética Molecular Humana, Departamento de Ciências da Vida, 
Faculdade de Ciências e Tecnologia, Universidade Nova de Lisboa, 2829-516 Caparica, 
Portugal; 
- CYP2D6 studies were kindly provided by Prof. Ronny DeCorte from Laboratory for Forensic 
Genetics and Molecular Archaeology, Centre for Human Genetics, Katholieke Universiteit 
Leuven, 3000 Leuven, Belgium; 
- DOR1 studies were kindly provided by Dr. Bernhard Baumgartner from Institute of 
Veterinary Medicine, Department of Molecular Biology of Livestock, University of Göttingen, 
Burckhardtweg 2, 37077 Göttingen, Germany. 
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2.2 Methods 
2.2.1 Molecular biology 
2.2.1.1 Preparation of competent E. coli cells (adapted from Inoue et al.[142]) 
1. E. coli cells were inoculated on a LB agar plate and incubated at 37ºC overnight. 
2. A large colony was inoculated in 125 mL SOB in a 500 mL flask, at 20ºC with 
vigorous shaking to OD600 = 0.5 (normally 24 - 36 hours). 
3. The flask was placed on ice for 10 min. 
4. Cells were pelleted by spinning at 1663 g for 10 min at 4ºC. 
5. The cells were gently resuspended in 40 mL ice-cold TB and stored on ice for 10 min. 
6. Cells were pelleted by spinning at 1663 g for 10 min at 4ºC. 
7. The cells were gently resuspended in 5 mL ice-cold TB and 350 μL DMSO (DMSO 
was stored at -20ºC o/n before use). 
8. Competent cells were aliquoted in 200 μl fractions and stored at -80ºC. 
 
2.2.1.2 Cloning 
2.2.1.2.1 Ligation 
1. The amplicons of interest were submitted to electrophoresis on agarose gels 
(conditions varied according to the amplicon’s size). 
2. The amplicon’s band of interest was extracted, avoiding exposure to UV light, and 
purified using the GFX™ PCR DNA and Gel Band Purification Kit, following 
manufacturer's instructions and using 50 μL of sterile milli-Q H2O as eluent. 
3. Using the GeneJET™ PCR Cloning Kit, 100 ng of the extracted DNA was inserted 
into a linearized blunt-end pJET1 cloning vector, following the manufacturer’s Sticky-End 
protocol. 
 
2.2.1.2.2 Transformation 
1. Two microliters of the ligation product were added to 20 uL of E.coli competent cells 
and stored on ice for 30 minutes. A purified pUC19 plasmid was used as positive control 
and as negative control the ligation product was replaced by sterile milli-Q H2O. 
2. The cells were then submitted to a heat shock at 42ºC for 90 seconds and rapidly 
transferred to ice. 
3. After 2 minutes on ice, 80 μL of SOC medium were added and the cells were 
incubated for 1 hour at 37ºC. 
4. After incubation, 100 μL of the transformed competent cells were cultured on LB agar 
plates with 100 μg/mL ampicillin. 
5. The plates were left at room temperature until liquid had been absorbed and then 
incubated at 37ºC o/n. 
6. A selected transformed colony was resuspended in 25 μL of sterile milli-Q H2O. 
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7. Two microliters of transformed cells were used to perform PCR using pJET1Fw and 
pJET1Rev primers to confirm insert ligation. The remaining cells were inoculated in 2 mL 
of LB medium with 100 μg/mL ampicillin and incubated at 37ºC o/n with agitation. 
8. Stock solutions of the transformed cells were prepared by adding 300 μL of glycerol 
to 700 μL of culture, and stored at -80ºC. The remaining volume of culture was used to 
extract and purify the cloned plasmid, following the “Plasmid extraction and purification” 
protocol (step 2 onward). 
 
2.2.1.3 Plasmid extraction and purification 
1. An E. coli colony was inoculated in 2 mL of LB medium and 100 μg/mL ampicillin and 
incubated at 37ºC o/n with agitation. 
2. Cells were pelleted by spinning at 16,707 g for 2 min at 4ºC in 1.5 mL eppendorfs. 
3. The supernatant was discarded and the pellet was resuspended in 100 μL of ice-cold 
AL I solution. 
4. After 5 minutes on ice, 200 μL of AL II solution was added and mixed by inversion. 
5. After 5 minutes on ice, 150 μL of AL III solution was added and vigorously mixed by 
vortex. 
6. After 5 minutes on ice, the lysate was centrifuged at 21,460 g for 5 minutes at 0ºC. 
7. The supernatant was transferred to a sterile eppendorf and 2 volumes of ice-cold 100% 
ethanol were added. 
8. The plasmid DNA was left to precipitate at -20ºC o/n (or at -80ºC for 2 hours). 
9. Afterwards, the precipitate was centrifuged at 21,460 g for 15 minutes at 0ºC and the 
supernatant was discarded. 
10. The pellet was washed with 500 μL of ice-cold 70% ethanol. 
11. The pellet was left to dry at room temperature (or with the help of a speed-vac) and 
resuspended in 50 μL of sterile milli-Q H2O. 
12. RNase A was added to a final concentration of 25 μg/ml and incubated for 1 hour at 
37ºC. 
13. Two extractions with 1 volume of phenol were performed, followed by one extraction 
with chloroform. 
14. To precipitate the plasmid DNA, the procedures from step 7 to 11 were repeated. 
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2.2.1.4 Enzyme mediated amplification 
2.2.1.4.1 Reaction mixtures 
Standard PCR  Long PCR 
1  Taq buffer  1  Long PCR buffer no.2 
0.5 µM Fw primer  0.5 μM Fw primer 
0.5 µM Rev primer  0.5 μM Rev primer 
0.2 mM dNTP  0.5 mM dNTP 
0.04 U/μL Taq polymerase  0.05 U/μL Long PCR enzyme mix 
200 ng Template DNA  200 ng Template DNA 
     
Asymmetric PCR   
1  Taq buffer    
0.01 µM  Fw primer (asymmetric)    
1 µM Rev primer    
0.2 mM dNTP    
0.04 U/μL Taq polymerase    
200 ng Template DNA    
 
2.2.1.4.2 Reaction programs 
Standard PCR  Long PCR 
1. 5 min 94ºC   1. 2 min 94ºC  
2. 30 sec 94ºC   2. 20 sec 95ºC  
3. 30 sec Tm* 30x  3. 30 sec Tm* 10x 
4. 45 sec 72ºC   ┘  4. 2 min 68ºC   ┘ 
5. 7 min 72ºC   5. 20 sec 95ºC  
6. pause 4ºC   6. 30 sec Tm* 25x (+2 sec/cycle in step 7) 
     7. 2 min 68ºC   ┘ 
     8. 10 min 68ºC  
     9. pause 4ºC  
         
Asymmetric PCR    
1. 5 min 94ºC       
2. 30 sec 94ºC       
3. 30 sec Tm* 40x      
4. 45 sec 72ºC   ┘      
5. 7 min 72ºC       
6. pause 4ºC       
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2.2.1.5 Target sequence preparation 
2.2.1.5.1 β-thalassemia 
Genomic DNA samples from both heterozygous and homozygous individuals harboring one 
of three most frequent mutations causing β-thalassemia in the Mediterranean and 
Portuguese populations (β0IVS1, nt1 (G>A); β+IVS1, nt2 (T>C); β+IVS1, nt6 (T>C)) were 
used as template for PCR amplification. Additionally, a 8668 bp plasmid harboring a normal 
HBB gene insert (i.e. plasmid p158 - see Appendix IV for plasmid sequence) was also used, 
either as template or as target for Au-nanoprobe hybridization. Both genomic samples and 
plasmid have been previously characterized by direct sequencing. As controls, samples 
without these mutations were used. 
A 396 and 1559 bp fragment of the HBB gene, harboring the junction between intron 1 and 
exon 1, were PCR amplified from genomic DNA or p158 plasmid by using the bGlobF and 
bGlobR or bGlobLongF and bGlobLongR primers, respectively (Figure 2.1). These fragments 
were used as complementary or mismatched targets for the bGlob Au-nanoprobe. The 
plasmid p158 was also directly used as a target in Au-nanoprobe non-cross-linking assays or 
in a linearized form, by digesting it with BamHI restriction enzyme, to be used in AFM studies. 
 
Negative controls 
Two unrelated 355 and 1565 bp amplicons were also amplified by using the Pex4-5’ and 
Pex4-3’ or the CYPex4F and CYPex7R primers, respectively; and used as non-
complementary targets of the bGlob Au-nanoprobe. The shorter fragment was amplified from 
genomic DNA and harbored a sequence from the p53 gene, while the longer fragment was 
amplified from pCYP2D6*1 plasmid and harbored a sequence from the CYP2D6 gene. 
 
2.2.1.5.2 DOR1 
Fully characterized genomic DNA samples from both heterozygous and homozygous 
individuals for the DOR1 polymorphism were used as template for PCR amplification. In 
addition, two plasmids vectors pDOR1C and pDOR1G with a DOR insert, respectively 
harboring either the DOR1C or DOR1G alleles were used in optimization protocols. These 
plasmids have been characterized by direct sequencing upon reception, by using DOR1F 
and DOR1R primers (see Appendix IV for plasmids sequences), and were used as template 
reference materials for PCR amplification. 
A 563 bp fragment of the DOR gene promoter, harboring the DOR1 region, was PCR 
amplified from either genomic or plasmid DNA by using the DOR1F and DOR1R primers, 
and further used as complementary/mismatched targets of DOR1C and DOR1G Au-
nanoprobes (Figure 2.2). Due to the high %GC content of the DOR region (>70%), the PCR 
amplification of this fragment was only possible when using 6% DMSO, which is known to 
enhance the PCR amplification of high %GC templates.[143] 
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Simultaneously, the resulting amplicons were also characterized by restriction digestion 
using the DdeI restriction enzyme. The digestion of DOR1C amplicon with DdeI restriction 
enzyme yields two fragments of ~280 and ~230 bp, while the digestion of DOR1G yields two 
fragments of ~330 and ~230 bp (see Appendix IV, Figure A.3 - A). 
A set of 40 nt oligonucleotides, named DOR1CA and DOR1GA, were also ordered to be 
used as complementary ssDNA targets for DOR1G and DOR1C Au-nanoprobes, 
respectively. The first 20 nt at 3’-end of these ssDNA targets are complementary to the Au-
nanoprobes.  
Alternatively, ssDNA was produced by asymmetric PCR using DOR1R and DOR1Fass 
primers in a ratio of 1:100. The excess of DOR1Fass primer allows to linearly amplify the 
ssDNA strand that is complementary to the Au-nanoprobes, after the DOR1R is consumed 
by the exponential amplification that yields the dsDNA. Therefore, two fragments are 
produced by the asymmetric PCR amplification, corresponding to the dsDNA and ssDNA 
amplicon. The resulting amplicons were analyzed by electrophoresis (see Appendix IV, 
Figure A.3 - B) and the resulting ssDNA and dsDNA fragments were extracted and purified 
for further analysis. 
 
Negative controls 
An unrelated 577 bp fragment harboring a fraction of CYP2D6 gene was also amplified by 
PCR using CYPex5F and CYPex6R primers, and 6% DMSO, to be used as a non-
complementary target of both DOR1C and DOR1G Au-nanoprobes. Additionally, 40 nt 
oligonucleotides with an unrelated sequence were used as non-complementary synthetic 
targets (e.g. CYP1846C targets). Non-complementary ssDNA targets were also produced by 
using the CYPex5F and CYPex6R primers under the same asymmetric PCR conditions as 
for the complementary/mismatched targets. 
 
2.2.1.5.3 CYP2D6 
Genomic DNA samples from both CYP2D6*1/*1 and CYP2D*4/*4 homozygous individuals 
and CYP2D6*1/*4 heterozygous individual were available to be used as templates for PCR 
amplification. These samples had been previously characterized by RFLP analysis. 
To generate an “unlimited” reference material of both CYP2D6*1 and *4 alleles, a 5101 bp 
fragment harboring the CYP2D6 gene was amplified by Long PCR using CYP2D6F and 
CYP2D6R primers, which specifically flank this gene,[144] and by using as template, the 
previously characterized genomic DNA of homozygous individuals (CYP2D6*1/*1 and 
CYP2D6*4/*4) (see Appendix IV, Figure A.4 - A). 
The resulting ~5.1 Kb fragments were purified by excising the respective gel bands and 
cloned into a pJET1 vector yielding a ~8322 bp plasmids. These plasmids were then fully 
characterized by direct sequencing using previously described primers flanking the CYP2D6 
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exons, namely CYPex1F to 9F and CYPex1R to 9R,[145] and the pJET vector primers, 
pJET1Fw and JET1Rev (see Appendix IV for pCYP2D6*1 and pCYP2D6*4 plasmids 
sequences). 
A 226 bp fragment of the CYP2D6 exon 4 was amplified by PCR from either genomic or 
plasmid DNA by using the CYPex4F and CYPex4R primers, and further used as 
complementary/mismatched targets of CYP1846G and CYP1846A Au-nanoprobes. These 
fragments were further characterized by restriction digestion using MvaI restriction enzyme. 
Within the exon 4 of CYP2D6, the CYP2D6*1 allele harbors one restriction site for this 
enzyme, which is not present in CYP2D6*4 allele.[146] Therefore, the digestion of CYP2D6*1 
amplicon with MvaI restriction enzyme yields two fragments of ~31 and ~195 bp, while 
CYP2D6*4 amplicon remains unaltered (see Appendix IV, Figure A.4 – B). 
Additionally, a set of 40 nt oligonucleotides were ordered, named CYP1864C and CYP1864T, 
to be used as complementary ssDNA targets for CYP1864G and CYP1864A Au-nanoprobes, 
respectively. The first 20 nt at 3’-end of these ssDNA targets are complementary to these Au-
nanoprobes. Alternatively, ssDNA was produced by asymmetric PCR using CYPex4R and 
CYPex4F primers in a ratio of 1:100. 
 
Negative controls 
As non-complementary target, the previously described 396 bp fragment harboring the HBB 
gene sequence was used. Additionally, 40 nt oligonucleotides with an unrelated sequence 
were used as ssDNA synthetic targets (e.g. DOR1GA targets). Non-complementary ssDNA 
targets were also produced by using the bGlobF and bGlobR primers under the same 
asymmetric PCR conditions as for the complementary/mismatched targets 
 
2.2.1.6 ssDNA and dsDNA extraction 
The resulting product of asymmetric PCR was run in a 2% pre-cast gel on E-Gel® iBase™ 
Power System and isolated according to the manufacture instructions. 
 
 
2.2.2 Nanotechnology 
2.2.2.1 Synthesis of Nanoparticles 
NOTE: All glass materials used for the synthesis of NPs were previously immersed o/n in 
freshly prepared aqua regia (1:3, HNO3:HCl) and later vigorously washed with milli-Q H2O 
(18.2 MΩ.cm at 25 °C). All metal materials used during synthesis were covered with Teflon 
and Milli-Q H2O was used in all solutions. 
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2.2.2.1.1 AuNPs synthesis (adapted from Lee and Meisel[147]) 
1. In a 500 mL round bottom flask, 250 mL of 1 mM HAuCl4 were brought to a boil while 
vigorously stirring. 
2. While in reflux, 25 mL of 38.8 mM sodium citrate were quickly added and the mixture 
was kept refluxing for 15 minutes with continuous stirring. 
3. The colloidal solution was left to cool to room temperature while keeping the 
continuous stirring. 
4. The colloidal solution was then transferred to a 250 mL Erlenmeyer flask with a 
ground glass cap, covered with aluminium foil and stored in the dark at room temperature. 
5. AuNPs concentration was determined by the Lambert–Beer law assuming a 
calculated molar absortivity for the plasmon resonance band maximum (526 nm) of 
2.33×108 M−1 cm−1. 
6. Morphological characterization of the AuNP was performed by Transmission Electron 
Microscopy (TEM) and Dynamic Light Scattering (DLS). 
 
2.2.2.1.2 Alloy AuAgNPs synthesis (adapted from Link et al.[78]) 
1. In a 250 mL round bottom flask, 95 mL of 0.134 mM HAuCl4 and 0.132mM AgNO3 
were brought to a boil while vigorously stirring. 
2. While in reflux, 5 mL of 34 mM sodium citrate were quickly added and the mixture 
was kept refluxing for 15 minutes with continuous stirring. 
3. The colloidal solution was left to cool to room temperature while keeping continuous 
stirring. 
4. Afterwards the colloidal solution was decanted, after centrifuging at 233 x g for 20 min, 
to remove silver precipitate. 
5. The colloidal solution was then transferred to a 100 mL Erlenmeyer flask with a 
ground glass cap, covered with aluminium foil and stored in the dark at room temperature. 
6. AuAgNPs concentration was determined by the Lambert–Beer law assuming a 
calculated molar absortivity for the plasmon resonance band maximum (460 nm) of 
1.19×1010 M−1 cm−1. 
7. Morphological characterization of the alloy AuAgNPs was performed by TEM and 
DLS, while the Au:Ag ratio was determined by Inductively Coupled Plasma (ICP). 
 
2.2.2.2 Synthesis of nanoprobes 
2.2.2.2.1 AuNPs functionalization - classical method (adapted from Storfhoff et al.[101]) 
1. One volume of thiol-modified oligonucleotide was extracted with two volumes of ethyl 
acetate. 
2. The organic phase was discarded after centrifuging for 5 minutes at 21,460 g. 
3. Steps 1 and 2 were repeated two more times. 
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4. The remaining aqueous phase was further purified through a desalting NAP-5 column, 
accordingly to manufacturer’s instructions, using 10 mM phosphate buffer as eluent. 
5. The purified thiol-modified oligonucleotide was quantified by UV/Vis spectroscopy 
using the extinction coefficient at 260 nm provided by the manufacturer. 
6. In a polypropylene 25 mL vial with a conical skirted base, the purified thiol-modified 
oligonucleotide was mixed with a ~14 nM AuNPs solution in a 1:200 (AuNP:oligos) ratio. 
7. After 16 h at room temperature, a certain volume of AGE I solution was slowly added 
to achieve a final concentration of 10 mM phosphate buffer, 0.1 M NaCl. 
8. After at least 40h at room temperature, the functionalized AuNP were distributed in 
1.5 mL eppendorfs and centrifuged at 21,460 g for 20 minutes. 
9. The supernatant was discarded and the resulting oily pellet was washed twice with 1 
mL/epp of PBS solution (pH 7) and finally redispersed in 500 μL/epp of the same solution. 
The resulting solutions of each eppendorf were then gathered in a polypropylene 25 mL 
vial with a conical skirted base. 
10. The final concentration of functionalized AuNPs was determined accordingly to step 5 
of the “AuNPs synthesis” protocol. 
11. Aliquots of functionalized AuNPs were prepared by diluting the resulting 
functionalized AuNPs solution (stock solution) with PBS solution to a final concentration of 
15 nM in AuNPs. Both stock and aliquot solutions were stored in the dark at 4ºC until 
further use. 
 
2.2.2.2.2 AuNPs functionalization - Ultrasound method (adapted from Hurst et al.[85]) 
1. Steps 1 to 5 of the “AuNP functionalization – classical method” protocol were followed. 
2. Typically, in a polypropylene 25 mL vial with a conical skirted base, the purified thiol-
modified oligonucleotide was mixed with a ~14 nM AuNP solution in a 1:200 (AuNP:oligos) 
ratio. Other ratios have also been tested for optimization. 
3. AGE II solution was then added to achieve a final concentration of 10 mM phosphate 
buffer, 0.01% (w/v) SDS. The solution vial was then submersed in an ultrasound bath for 
10 seconds and let to rest at room temperature for 20 minutes. 
4. Afterwards, the ionic strength of the solution was sequentially increased in 50 mM 
increments by adding a certain volume of AGE III solution up to a final concentration of 10 
mM phosphate buffer, 0.3 M NaCl, 0.01% (w/v) SDS. After each increment, the vial was 
submersed in an ultrasound bath for 10 seconds and let to rest at room temperature for 20 
minutes before the next increment. NOTE: Other final concentrations of NaCl (0.1, 0.5 and 
0.7M) were also tested during optimization. 
5. After an o/n period at room temperature, the functionalized AuNPs were distributed in 
1.5 mL eppendorfs and centrifuged at 21,460 g for 20 minutes. 
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6. The supernatant was discarded and the resulting oily pellet was washed twice with 1 
mL/epp of 10 mM phosphate buffer (pH 8) and once with 1 mL/epp of PBS solution (pH 8). 
7. The supernatant was then finally redispersed in 500 μL/epp of the same PBS solution 
(pH 8). The resulting solutions of each eppendorf were then gathered in a polypropylene 
25 mL vial with a conical skirted base. 
8. Steps 10 and 11 of the “AuNPs functionalization – classic method” protocol were 
followed. 
 
2.2.2.2.3 AuAg alloy NPs functionalization 
The “AuNP functionalization – ultrasound method” protocol was followed except for the 
following alterations: 
1. In step 2, the AuNPs solution was substituted by a ~0.1 nM alloy AuAgNPs solution 
and the ratio was 1:62000 (AuAgNP:oligo). 
2. In step 4, the AGE III solution was added up to a final concentration of 10 mM 
phosphate buffer, 0.1 M NaCl, 0.01% (w/v) SDS. 
 
2.2.2.3 Nanoprobes stability assays 
1. A solution containing the Au-nanoprobe or AuAg-nanoprobe alone was prepared by 
heating for 10 minutes at 95ºC a certain amount (i.e. 10uL/assay of 15 nM Au-nanoprobe 
or 0.3 nM AuAg-nanoprobe). 
2. The solution was then allowed to cool down for 30 minutes at room temperature and 
10 μL/assay were mixed with different volumes of a concentrated salt solution (variable 
accordingly to type of salt) and using 10 mM phosphate buffer (pH variable) to fulfill a total 
volume of 60 μL (Au- and AuAg-nanoprobe final concentration of 2.5 nM and 0.05 nM, 
respectively). Other Au-nanoprobe concentrations were also tested during optimization. 
3. For kinetic assays, UV–visible spectroscopic measurements were registered every 18 
seconds for a total time of 30 minutes, starting 30 seconds after salt addition. 
4. For all other assays, UV-visible spectroscopic measurements and digital photographs 
were registered 15 minutes after salt addition. 
 
2.2.2.4 Non-cross-linking hybridization assay 
1. Assay solutions containing the Au- or AuAg-nanoprobes and target DNA were 
prepared by mixing the appropriate DNA sample (final concentration varied) with the Au- 
or AuAg-nanoprobe solution (final concentration 2.5 nM or 0.05 nM, respectively), and by 
using 10 mM phosphate buffer (pH variable) to fulfill the final volume. A blank solution was 
prepared by replacing the DNA for an equivalent volume of 10 mM phosphate buffer. 
2. The solutions were heated for 10 min at 95ºC and then allowed to cool down for 30 
minutes at room temperature. 
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3. A concentrated salt solution (volume accordingly to type of salt) was added to the 
solutions to a final volume of 60 μL (or 30 μL). 
4. UV-visible spectroscopic measurements and digital photographs were registered 15 
minutes after salt addition. 
 
2.2.2.5 Multiplex non-cross-linking hybridization assay 
1. The protocol “Non-cross-linking hybridization assay” was followed, but instead of just 
adding just one nanoprobe, both Au- and AuAg-nanoprobes where mixed in solution. 
 
2.2.2.6 Fluorescent assays 
2.2.2.6.1 Determination of Au-nanoprobes’ density (adapted from Sato et al.[82]) 
1. Thiol-modified oligonucleotides were displaced from the AuNPs’ surface via addition 
of DTT (final concentration 100 mM) to 2.5 nM Au-nanoprobes in a total volume of 100 μL 
1x TE. 
2. Standard solutions were prepared by sequentially diluting (concentration range: 7.81 
to 250 nM) an oligonucleotide harboring the same sequence as the Au-nanoprobes under 
the same conditions as Au-nanoprobes’ samples. 
3. After 48 h at room temperature, both standard and sample solutions were centrifuged 
at 21,460 g for 20 minutes and 50 μL of the supernatant were used to quantify the ssDNA 
in solution by using the Quant-iT™ OliGreen® ssDNA Assay kit accordingly to the 
manufacturer instructions. 
 
2.2.2.6.2 Determination of Au-nanoprobes’ hybridization efficiency (adapted from 
Demers et al.[81]) 
1. The Au-nanoprobe (final concentration 2.5 nM) was mixed with an excess of target 
oligonucleotide and fluorescein-modified oligonucleotide (final concentrations of 1 
μM/each) in a total volume of 100 µl of 10 mM phosphate buffer (pH8). Other pH values 
were also tested for optimization. 
2. After 10 minutes of denaturation at 95 °C, the solutions were allowed to hybridize for 
30 minutes at room temperature. 
3. The solutions were centrifuged at 21,460 g for 20 minutes and washed twice with 200 
μL of 10 mM phosphate buffer (pH 8). 
4. The precipitate was redispersed in 100 μL of 10 mM phosphate buffer (pH8). 
5. Samples were denatured using sodium hydroxide (final concentration of 0.05 M) and 
let to rest for 2 h at room temperature. 
6. Calibration curve was generated by preparing a sequential dilution of the fluorescein-
modified oligonucleotide (concentration range: 0.0016 – 0.1 μM) under the same 
conditions as the samples. 
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7. Solutions were then centrifuged at 21,460 g for 20 min and 60 μL of the supernatant 
was taken to capture fluorescence spectra using an Ultra-Micro quartz cell. 
8. To correct for loss of Au-nanoprobe during the washing process, 60 μL of 10 mM 
phosphate buffer (pH 8) were added to the pellet and the absorption spectra were 
registered using an Ultra-Micro quartz cell. 
 
2.2.2.7 Other analysis 
2.2.2.7.1 AFM analysis (sample preparation) 
AFM analysis were carried out by Dr. Peter Eaton from REQUIMTE, Departamento de 
Química, Faculdade de Ciências, Universidade do Porto, 4169-007 Porto, Portugal, as 
described in Eaton et al.[148] 
 
1. To prepare the AFM samples of DNA material alone (linearized plasmid and 
amplicons), all samples were precipitated with 1 volume of 100% (v/v) isopropanol, 
washed twice with 1 volume of 70% (v/v) ethanol and left to dry at room temperature to be 
later resuspended in a buffer suitable for deposition for AFM experiments as described by 
Eaton et al.[148] 
2. To prepare the AFM samples of Au nanoprobes alone or with DNA, all the steps of 
the “Non-cross-linking hybridization assay” protocol, except for salt addition, were carried 
out. 
3. The solutions were centrifuged for 25 minutes at 30,000 g and the supernatant was 
discarded. 
4. The red oily pellet was then washed twice with 100 μL of ultra pure H2O and finally 
redispersed in 60 μL of the same water. 
 
2.2.2.7.2 ICP analysis 
Samples of alloy AuAgNPs were sent to Rede de Química e Tecnologia (REQUIMTE/CQFB), 
Caparica, Portugal, for ICP analysis. The samples were prepared by dissolving 5 mL of NPs 
in 5 mL of freshly prepared aqua regia. The original solution of acqua regia was used as 
baseline. Seven standard solutions of Au and Ag, with concentrations ranging from 1.25 to 
100 mg/L, were used. Three independent measurements of each sample were registered 
with an Inductively Coupled Plasma-Atomic Emission Spectrophotometer equipped with a RF 
generator of 40.68 MHz and a type Czerny-Turner monochromator with 1.00 m (sequential). 
 
2.2.2.7.3 TEM analysis 
Samples of NPs were sent to Instituto de Ciência e Engenharia de Materiais e Superfícies 
(ICEMS/IST), Portugal, for TEM analysis. The samples were prepared by depositing 10 µL of 
the as-prepared colloidal suspensions in carbon copper grids, washing twice with 10 µL of 
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Milli-Q water, and air dried. TEM was performed with a HITACHI H-8100 microscope 
operated at 200 kV. Particle size and polydispersity were determined from the TEM pictures 
using the imaging software Carnoy 2.0, and by analyzing at least 100 NPs. 
 
2.2.2.7.4 DLS analysis 
The hydrodynamic diameter of the citrate capped AuNPs was determined by DLS using the 
Zetasizer Nano ZS system. A total volume of 500 uL of 2.5 nM AuNP was first stabilized for 
15 minutes at 25ºC and then a total of 15 measurements with 13 runs each were registered. 
DLS analysis was performed either at Instituto de Medicina Molecular (IMM), Lisboa, 
Portugal or Instituto de Tecnologia Química e Biológica (ITQB), Oeiras, Portugal. 
 
2.2.2.7.5 Zeta potential analysis 
The samples of Au-nanoprobes alone and with ssDNA were prepared as in the “Non-cross-
linking hybridization assay” protocol, except for replacing salt by 10 mM phosphate buffer 
(pH 8) and using an excess of target ssDNA (1 μM). The samples were let to stabilize for 15 
minutes at 25ºC and then a total of 25 zeta potential measurements with 65 runs each were 
registered by using a Zetasizer Nano ZS system. Zeta potential analysis was performed 
either at Instituto de Medicina Molecular (IMM/UL), Lisboa, Portugal or Instituto de 
Tecnologia Química e Biológica (ITQB/UNL), Oeiras, Portugal. 
 
2.2.2.7.6 Ferguson analysis 
1. The samples of Au-nanoprobes alone and with ssDNA were prepared as in the “Non-
cross-linking hybridization assay” protocol, except for substituting the salt with 10 mM 
phosphate buffer (pH 8) and using an excess of target ssDNA (1 μM). 
2. The samples were then submitted to agarose gel electrophoresis with varying 
agarose percentages (1–3% w/v) using glycol (final concentration 2.5% v/v) as loading 
buffer. 
3. Electrophoresis was performed for 2 hours at 4 V/cm in 0.5x TBE buffer, and the 
resulting electrophoretic pattern registered digitally using a white light transilluminator. 
4. The positions of the bands were measured with Discovery Quantity One v.4.5.2 
software using the center of the lane as reference and converted to an absolute mobility 
(M) velocity/field strength (cm2/V.s) and Ferguson analysis was performed as described 
by Park et al.[149] 
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3 CHAPTER 3. Nanoprobes characterization 
 
Characterization of the Au-nanoprobes stability against salt induced aggregation is a crucial 
step to develop the non-cross-linking method. In this chapter, the stability of the Au-
nanoprobes to different salts, pH values and in the presence of some common reagents in 
molecular biology was evaluated. Moreover, the stability of AuAg-nanoprobes was also 
assessed to further develop a multiplex non-cross-linking method. 
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3.1 Introduction 
The non-cross-linking method relies on the colorimetric changes of Au-nanoprobes, which is 
a consequence of differential stabilities in solution for increasing salt concentrations. 
Therefore, the characterization of Au-nanoprobe stability is a crucial step for the method’s 
development. In the present work several studies have been carried out to evaluate the Au-
nanoprobes stability in presence of different salts, at different pH values and in the presence 
of some common reagents used in DNA hybridization. Moreover, Au-nanoprobe stability has 
also been evaluated as function of functionalization protocol, i.e. the classical “salt-aging” 
protocol or by using ultrasounds. 
In this chapter, as well as in subsequent chapters, all the general aspects between different 
nanoprobes (i.e. bGlob, DOR1 or CYP1846 probes) will be discussed as a whole, in order to 
simplify the evaluation and discussion of results. Nonetheless, the particular aspects of a 
particular nanoprobe will be highlighted when justified (e.g. when a nanoprobe behaves 
significantly different from other nanoprobes). 
 
3.2 Results and Discussion 
The stability of noble metal NPs, such as AuNPs, can be easily monitored by following their 
visible absorbance spectra, since the inter-particle distance between NPs strongly affects 
their SPR absorbance band due to plasmon coupling.[68] The SPR absorbance band of 
dispersed AuNPs shifts towards longer wavelengths when the inter-particle distance 
decreases. A common accepted process to determine the level of AuNPs aggregation is to 
follow the integral of the absorption curve in the range of 600-800 nm.[150,151] Nonetheless, 
this approach requires the acquisition of a full spectrum for each sample in that range of 
wavelengths, which could increase the time for data acquisition if multiple samples are to be 
analyzed (e.g. in most recent microplate readers, the spectra between 600-800 nm of 384 
samples can take over 3 hours to acquire). Some authors have followed a single wavelength 
associated to the aggregated Au-nanoprobes to easily and quickly assess the level of 
aggregation[86] (e.g. a single wavelength absorbance of 384 samples takes just 1 minute to 
be registered by standard microplate readers). However, experimental error is associated to 
both approaches since the possible precipitation of Au-nanoprobes upon aggregation is not 
taken into consideration. Precipitation of Au-nanoprobes during data acquisition was 
frequently observed during the experimental procedures described in this Thesis, which can 
lower the absorbance of the aggregated Au-nanoprobes registered by the spectrophotometer, 
leading to a wrong interpretation of the observed aggregation. To overcome this problem, 
normalization was performed using absorbance of both single wavelengths that are 
characteristic of dispersed and aggregated nanoprobes - 526 nm and 600 nm for Au-
nanoprobes; 460 nm and 635 nm for AuAg-nanoprobes. This normalization consists of a 
ratio between Abs526nm or 460nm and Abs600nm or 635 nm, where higher and lower ratio values are 
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associated to dispersed and aggregated nanoprobes, respectively. Moreover, because the 
AuNPs plasmon coupling upon aggregation does not significantly affect the absorbance at 
400 nm (for Au-nanoprobes), or 340 nm (for AuAg-nanoprobes), it was used as an internal 
control to correct for absorbance shifts caused by phenomena that are not related to the 
nanoprobes SPR shift upon aggregation (e.g. precipitation, meniscus effect in the microplate 
reader, etc). 
 
3.2.1 Au-nanoprobe stability 
3.2.1.1 Salt effect 
The stability of the Au-nanoprobes against salt-induced aggregation was first assessed for 
increasing concentrations of NaCl through the acquisition of spectrophotometric data at each 
18 seconds for up to 30 minutes. Increasing NaCl concentrations had little or no effect on Au-
nanoprobes until the CCC of electrolyte was reached. It should be noted that the CCC 
sometimes varied for different batches of the same probe, which may be associated to 
different Au-nanoprobe functionalization despite following the same experimental protocol. 
After the CCC was reached, the salt induced aggregation of the Au-nanoprobes which could 
be followed by the red-shift in the SPR band from 526 nm to 600 nm, corresponding to a 
color change of the solution from red to blue (Figure 3.1). 
 
 
Figure 3.1 – Au-nanoprobe stability with increasing NaCl concentration. UV-visible spectra of Au-
nanoprobes at different NaCl concentrations registered 15 minutes after salt addition. Arrows indicate 
peaks trend for increasing NaCl concentration. Inset: Ratio of Abs526/Abs600 vs. NaCl concentration 
and the corresponding digital photos for increasing concentration of salt, from left to right. 
 
The transition of color for increasing salt concentration can be translated by the ratio 
Abs526/Abs600, where fully aggregated Au-nanoprobes present a ratio >1 as denoted by the 
stabilization of the ratio value above CCC. Aggregation also causes a decrease in the 
absorbance of Au-nanoprobes’ SPR band located in the UV region. As mentioned earlier, 
these spectrophotometric and colorimetric changes are a consequence of the plasmon 
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coupling between the AuNPs as the inter-particle distance diminishes and the Au-
nanoprobes aggregate.[68] 
 
The colorimetric changes resulting from Au-nanoprobe aggregation occur within the first 300 
seconds (5 minutes) upon salt addition (Figure 3.2 - A), after which the changes to the 
spectra are minimal. For higher NaCl concentrations, at which the Au-nanoprobes fully 
aggregate, the colorimetric changes occur slightly faster (i.e. within 3 min). 
 
 
Figure 3.2 – Kinetics of Au-nanoprobe stability with increasing concentration of (A) NaCl or (B) 
MgCl2 
 
As previously mentioned, the CCC of electrolyte can vary with each Au-nanoprobe. In the 
case of NaCl, 20% of all the Au-nanoprobes synthesized within the scope of this thesis (n=35) 
were stable at NaCl concentrations up to 3 M. For higher concentrations, the large volumes 
of salt needed were incompatible with the assays’ final volume. In other cases, the Au-
nanoprobes aggregated between 0.5 and 3 M of NaCl, but the majority fully aggregated 
between 0.5 and 1.0 M NaCl (see Figure 3.3 - A). The stability of Au-nanoprobes 
synthesized by the classic “salt-aging” method show a significant variation in the CCC value 
for each batch of Au-nanoprobes (Figure 3.3 - B). This variation is greatly reduced when the 
Au-nanoprobes are synthesized using ultrasounds (Figure 3.3 - C). 
Higher densities of thiol-modified oligonucleotides bound to the AuNPs surface have been 
associated with Au-nanoprobes with higher stability.[86] The observed variations in stability 
are, therefore, most likely associated to different Au-nanoprobe densities because the classic 
method is more prone to non-specific adsorptions that can lead to differences in 
functionalization.[85] 
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Figure 3.3 – Au-nanoprobes variability in stability with NaCl. Range of NaCl concentration that led 
to full aggregation of: (A) all Au-nanoprobes synthesized; or synthesized under the same conditions by 
(B) the classic “salt-aging” method; and (C) using ultrasounds. No agg. corresponds to the cases 
where no aggregation was observed with NaCl. 
 
The stability of the Au-nanoprobes was also tested for increasing concentrations of other 
monovalent salts, namely KCl, LiCl and NH4Cl. Aggregation patterns of the Au-nanoprobes 
are similar for any of these monovalent salts (Figure 3.4). 
 
 
Figure 3.4 – Au-nanoprobe stability against increasing concentrations of monovalent salts 
 
The stability of the Au-nanoprobes was also tested against increasing concentrations of 
divalent salts, namely MgCl2, MnCl2, ZnCl2, NiCl2 and CaCl2. The use of such electrolytes 
allows higher ionic strengths to be attained with smaller volumes and concentrations of 
electrolyte solutions than those made possible by monovalent salts, thus allowing 
aggregation of Au-nanoprobes that was not possible with NaCl. In presence of only 10 mM of 
MnCl2, ZnCl2, NiCl2 or CaCl2, Au-nanoprobes immediately flocculated and solutions became 
opaque, while retaining their initial red color (Figure 3.5). This flocculation may be due to the 
existence of a secondary minimum in the DLVO profile of the Au-nanoprobes colloidal 
system and/or due to the coordination of the divalent metal cations (Mn2+, Zn2+, Ni2+ and Ca2+) 
with the Au-nanoprobes’ ssDNA, which can lead to the formation of a cross-linked 
structure.[152] In the latter, it would be expected that the Au-nanoprobes also have changed 
color from red to blue, which did not occur even after several days. Nonetheless, since the 
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flocculation generated by these salts hampered the acquisition of spectrophotometric data, 
their use for subsequent studies and for the development of the non-cross-linking detection 
method was not further considered. 
 
 
Figure 3.5 - Influence of MgCl2, MnCl2, ZnCl2, NiCl2 or CaCl2 in Au-nanoprobe stability. Digital 
photography of Au-nanoprobes alone and in presence of 10 mM divalent salt (MgCl2, MnCl2, ZnCl2, 
NiCl2 and CaCl2, respectively). 
 
Interestingly, no flocculation was observed for MgCl2. This can be explained by the lower 
effectiveness of Mg2+ in coordinating a DNA structure when compared to the other divalent 
cations.[152] As observed for the monovalent salts, MgCl2 led to extensive Au-nanoprobe 
aggregation, and their SPR band shifted from 526 nm to 600 nm with concomitant change of 
color from red to blue (Figure 3.6). In this case, the color change was more intense than that 
observed with monovalent salts, as denoted by a slightly higher absorbance at 600 nm and, 
consequently, lower Abs526/Abs600 ratio (0.91 and 0.85 for 2 M NaCl and 30 mM MgCl2, 
respectively). 
 
 
Figure 3.6 – Au-nanoprobe stability with increasing MgCl2 concentration. UV-visible spectra of 
Au-nanoprobes at different MgCl2 concentrations registered 15 minutes after salt addition. Arrows 
indicate peaks trend for increasing MgCl2 concentration. Inset: ratio of Abs526/Abs600 vs. MgCl2 
concentration and the corresponding digital photos for increasing concentration of salt, from left to 
right. 
 
The majority of the Au-nanoprobes synthesized, that were tested with MgCl2 (n=27), 
aggregated between 10 ~ 20 mM (63%) of MgCl2, while other Au-nanoprobes aggregated 
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between 20 ~ 30 mM (26%) or 30 ~ 40 mM (11%) of MgCl2. These CCC values of MgCl2 are 
much lower than those observed for monovalent salts, even when compared in terms of their 
ionic strengths. Nonetheless, when comparing the CCC ratio value of monovalent and 
divalent salts obtained for the same Au-nanoprobes, the average of CCCmonovalent:CCCdivalent 
ratio is 1:0.0158 (STD=±1:0.0066), which is in good agreement with the ratio predicted by the 
Schulze-Hardy rule (i.e. 1:0.0156).[96] This indicates that, as predicted by the DLVO theory, 
the main forces involved in the dispersion stability of the Au-nanoprobes are both attractive 
van der Waals forces and repulsive double-layer electrostatic forces. 
 
3.2.1.2 pH effect 
All the previous salt stability tests were performed at pH 8. However, since the charge of 
DNA is strongly dependent on the pH, it was hypothesized that the stability of the Au-
nanoprobes could also change with pH. In fact, it has been recently demonstrated that Au-
nanoprobes are stable between pH 4 and pH 12 and aggregate outside this range.[153] 
Because DNA hybridization occurs only between a narrow range of pH values (6.5 - 8),[154] 
which is an important factor for the development of the non-cross-linking method, the effect 
of pH in Au-nanoprobe stability in salt-induced aggregation has not been thoroughly 
investigated outside this range. Within this range, the effect of pH in salt-induced (increasing 
concentrations of NaCl or MgCl2) aggregation of the Au-nanoprobes was assessed after 
washing and re-dispersing them in 10 mM phosphate buffer at different pH (6.5, 7, 7.5 and 8 
– actual values were determined using a pH potentiometer). Results show that the Au-
nanoprobes’ stability in relation to salt-induced aggregation remained unaltered between pH 
7.64 and pH 8.16 (Figure 3.7), and started to aggregate for lower pH values. This decrease 
in stability is most likely associated to the decrease of the negative charge of DNA molecules, 
as the solution pH approaches the isoelectric point of ssDNA (pI 4.0~4.5). 
 
 
Figure 3.7 – Effect of pH in Au-nanoprobe stability against salt-induced aggregation by (A) 
NaCl or (B) MgCl2 
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3.2.1.3 Au-nanoprobe concentration effect 
All the previous stability tests were performed with a final concentration of 2.5 nM Au-
nanoprobes, at which the associated color can be easily seen by the naked eye. 
Nonetheless, the salt-induced aggregation of Au-nanoprobes may be affected by their 
concentration in solution as this influences the probability of Au-nanoprobes’ self-interaction 
due to Brownian motion. To test this hypothesis, a set of different Au-nanoprobe 
concentrations (0.5 to 5 nM) was tested at the highest NaCl concentration (2 M NaCl) and 
the aggregation kinetics followed by UV-visible spectrophotometry. Results show that full 
aggregation only begins to occur for Au-nanoprobe concentrations above 2 nM, as the SPR 
spectra profile no longer changes above this concentration (Figure 3.8). Moreover, the 
changes in the SPR spectra of Au-nanoprobes stabilized within 5 minutes upon salt addition 
for all Au-nanoprobes concentrations. 
 
 
Figure 3.8 – Au-nanoprobe concentration effect in salt-induced aggregation. Spectra of Au-
nanoprobe taken 15 minutes upon the addition of 2 M NaCl at different Au-nanoprobe concentrations. 
 
These results seem to support the idea that Au-nanoprobe aggregation is hindered by lower 
concentrations that reduce interaction between Au-nanoprobes. Also, it indicates the 
existence of a minimum Au-nanoprobe concentration at which the Au-nanoprobes’ SPR band 
completely changes at 600 nm. Considering these results, all other assays where performed 
using a final concentration of 2.5 nM Au-nanoprobes. 
 
3.2.1.4 Effect of other reagents commonly used in molecular biology 
The stability of the Au-nanoprobes was also tested for reagents that are commonly used in 
molecular biology to facilitate DNA hybridization and increase stringency (e.g. betaine, 
DMSO, methanol and formamide). These reagents can also be present in the biological 
samples to be tested, such as a PCR product of GC-rich template (e.g. DOR1 gene), and 
therefore it is important to anticipate their effect in Au-nanoprobe stability. 
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The concentrations of the tested reagents were chosen according to what is normally used in 
molecular biology and as far as the added volumes allowed. Assays were performed only 
with MgCl2 in order to allow the larger volumes of other reagents. In the presence of DMSO, 
a polar aprotic solvent, the Au-nanoprobes stability decreased with a concentration of 0.5% 
DMSO (Figure 3.9 - A). This decrease in stability is most likely due to the changes in the 
dielectric constant of the medium surrounding the Au-nanoprobes, as DMSO has a lower 
dielectric constant than water. This leads to a decrease in the double-layer thickness that is 
responsible for the electrostatic repulsion between Au-nanoprobes (see Eq. 3 in Chapter 1, 
section 1.2.3.3). Moreover, the aprotic nature of DMSO should also favor the creation of 
dipole moments that can help facilitate the Au-nanoprobes aggregation. 
 
 
Figure 3.9 – Au-nanoprobe stability against salt-induced aggregation in presence of (A) DMSO, 
(B) Methanol, (C) Betaine or (D) Formamide. 
 
The stability of the Au-nanoprobes also decreased in the presence of methanol (Figure 3.9 – 
B), where the CCC of MgCl2 decreased by half for 10% methanol. Similarly to DMSO, 
methanol also has a lower dielectric constant than water, and, therefore, the increase in 
methanol concentration leads to a decrease in the repulsive electrostatic forces that prevent 
Au-nanoprobe aggregation. However, for higher concentrations of methanol, the Au-
nanoprobes de-stabilization started to reverse with increasing concentrations of MgCl2. This 
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strange effect can be due to a decrease in MgCl2 solubility with increasing methanol 
concentrations, decreasing the effective MgCl2 concentration in solution. 
Contrary to what has been observed for DMSO and methanol, both betaine and formamide 
increased the stability of Au-nanoprobes against salt-induced aggregation. In presence of 
betaine, Au-nanoprobe stability increased up to 2 M betaine. In the case of formamide, Au-
nanoprobe stability also increased in the presence of 30% formamide, but remained 
unaltered with a further increase to 40%. In both cases, the increased stability may be due to 
their adsorption to the AuNPs surface mediated by their amine group. 
 
3.2.1.5 Probe density effect 
To confirm the hypothesis that the variations in CCC values between Au-nanoprobes was 
due to different densities of thiolated oligonucleotide on the AuNP surface, a set of Au-
nanoprobes was synthesized using the ultrasound protocol with increasing ratios of 
oligos/AuNP at different final concentrations of the electrolyte during the salt aging step. 
Densities of thiolated oligonucleotides were determined by fluorescence measurements after 
displacement of the thiol-modified oligonucleotide with DTT (Table 4.1) – see Chapter 2, 
section 2.2.2.6.1. 
 
Table 3.1 – Au-nanoprobes density in pmol/cm
2
 according to the ratio of oligos/AuNP and NaCl 
concentration during synthesis (average±STD) 
 
Final NaCl concentration during salt aging 
0.1 M 0.3 M 0.7 M 
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25 Agg.a Agg.a -b 
50 5.3±1.6 8.2±1.5 -b 
100 11.0±1.7 24.0±1.3 -b 
200 11.6±1.5 25.1±3.0 -b 
400 -b -b 35.5±1.9 
600 -b -b 39.9±1.5 
a
Au-nanoprobes aggregated during synthesis; 
b
conditions where not tested 
 
Au-nanoprobes’ density increased considerably with the increase of electrolyte concentration 
during “salt-aging” process. This can be explained by the neutralization of non-specific 
binding.[85] The amount of thiol-modified oligonucleotides added during the synthesis also 
affected the final Au-nanoprobe density, although in a lesser extent than the electrolyte 
variation. The stability to NaCl and MgCl2 of Au-nanoprobes with different densities was then 
tested (Figure 3.10). 
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Figure 3.10 – Effect of Au-nanoprobe density in salt-induced aggregation by (A) NaCl or (B) 
MgCl2 
 
The Au-nanoprobes with lower oligonucleotide densities fully aggregated between 1 and 1.5 
M NaCl, while Au-nanoprobes with higher densities only started to fully aggregate at 2 M 
NaCl (Figure 3.10 - A). On the other hand, all Au-nanoprobes aggregated with 20 mM MgCl2, 
with exception of the Au-nanoprobe with the highest density, i.e. 40±2 pmol/cm2 (Figure 3.10 
– B). In this case, the Au-nanoprobe only fully aggregated with 30 mM MgCl2. These results 
indicate that the Au-nanoprobe density slightly influences the stability of Au-nanoprobes, and 
only more intensively at higher densities. This is partially corroborated by the previous work 
of Mirkin and co-workers, where evidence for Au-nanoprobe stability dependence on the 
derivatized oligonucleotide density was demonstrated.[86] 
 
3.2.2 AuAg-nanoprobes stability 
Taking benefit from the enhanced optical properties of silver NPs and the gold availability to 
thiol- quasi-covalent adsorption, ~40 nm Au/Ag (0.49/0.51 ratio) alloy NPs were synthesized 
and functionalized with thiol-modified DNA oligonucleotides (AuAg-nanoprobes) – see 
Appendix III for TEM and ICP analysis of AuAgNPs. The chosen oligonucleotide sequences 
to functionalize these NPs were the bGlob and DOR1C probe sequences. The 
characterization of AuAg-nanoprobes stability is crucial to evaluate their potential application 
in the non-cross-linking method and the development of a multiplex approach. Therefore, the 
stability of such NPs and nanoprobes against increasing concentrations of NaCl, or MgCl2, 
was assessed. Additional studies involving the synthesis and stability of AuAg-nanoprobes 
were the subject of the work of Jorge Dias (MSc thesis[155]), and, therefore, not addressed in 
the present thesis. 
 
3.2.2.1 Salt effect 
The AuAg-nanoprobes presented a higher stability against salt-induced aggregation than 
AuAgNPs alone. The AuAgNPs immediately aggregated with 50 mM NaCl whereas AuAg-
nanoprobes remained unaltered at the same concentration. This increase in stability is due to 
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the derivatized oligonucleotides that, similarly to the Au-nanoprobes, provide a higher 
electrostatic repulsion between NPs. The stability of AuAg-nanoprobes against salt-induced 
aggregation was further studied in the presence of NaCl and MgCl2 at pH 8. The resulting 
colorimetric changes were registered 15 minutes after salt addition so as to better compare 
results with the Au-nanoprobes. 
The AuAg-nanoprobes (0.05 nM concentration) remained unaltered for NaCl concentrations 
of up to 0.5 M (Figure 3.11). For higher concentrations of NaCl, the SPR band peak of the 
AuAg-nanoprobes, originally located at 460 nm, started to decrease and a wider band started 
to appear between 500 and 800 nm, with a broad peak at around 635 nm. To the naked eye, 
a color change from yellow to grey was observed as a consequence of AuAg-nanoprobe 
aggregation. 
 
 
Figure 3.11 – AuAg-nanoprobe stability with increasing NaCl concentration. UV-visible spectra of 
0.05 nM AuAg-nanoprobes at different NaCl concentrations registered 15 minutes after salt addition. 
Arrows indicate peaks trend for increasing NaCl concentration. Inset: Ratio of Abs460/Abs635 vs. NaCl 
concentration and the corresponding digital photos for increasing concentration of salt, from left to 
right. 
 
Full aggregation was attained for NaCl concentrations of 1.5 M and higher, as no further 
spectrophotometric changes in the SPR band were observed. The values of the 
Abs460/Abs635 ratio associated to full aggregation were all below 1, similar to what is observed 
for the Au-nanoprobes. Apart from the visible colorimetric changes, it was also possible to 
observe a slight decrease in the SPR band located in the UV region of the spectrum, as a 
consequence of AuAg-nanoprobes salt-induced aggregation. Nonetheless, this decrease 
was much less pronounced than that of the Au-nanoprobes. 
AuAg-nanoprobes were significantly stable up to 10 mM of MgCl2 (Figure 3.12) and full 
aggregation was reached between 20 ~ 30 mM of MgCl2. The SPR spectrum changes 
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induced by this divalent salt were similar to those observed for NaCl, although more 
pronounced with increasing salt concentration. 
 
 
Figure 3.12 – AuAg-nanoprobe stability with increasing MgCl2 concentration. UV-visible spectra 
of 0.05 nM AuAg-nanoprobes at different MgCl2 concentrations registered 15 minutes after salt 
addition. Arrows indicate peaks trend for increasing MgCl2 concentration. Inset: Ratio of Abs460/Abs635 
vs. MgCl2 concentration and the corresponding digital photos for increasing concentration of salt, from 
left to right. 
 
The ionic strength of NaCl needed to induce aggregation of AuAg-nanoprobes was much 
higher than the ionic strength of MgCl2 needed for the same effect, as it was observed for the 
Au-nanoprobes. However, the CCCmonovalent:CCCdivalent ratio obtained for the AuAg-
nanoprobes is 1:0.0133, which is near the ratio predicted by the Schulze-Hardy rule (i.e. 
1:0.0156).[96] The slight difference between the experimental ratio and the Schulze-Hardy 
ratio may be due to a coordination effect of Mg2+ cation with the functionalized AuAg-
nanoprobe DNA. Nonetheless, further studies with different batches of AuAg-nanoprobes are 
needed to determine a more exact experimental ratio and compare it with the Schulze-Hardy 
ratio. 
 
3.3 Conclusions 
It was possible to induce Au-nanoprobe aggregation with increasing concentrations of salt, 
which can be followed by naked eye (color change from red to blue); and/or by UV-visible 
spectrophotometry, due to the SPR red-shift (from 526 to 600 nm). The majority of the Au-
nanoprobes aggregated within 15 minutes in the presence of 1 M of any of the tested 
monovalent salts (i.e. NaCl, KCl, LiCl and NH4Cl) or in the presence of 20 mM MgCl2. In the 
presence of other divalent salts (i.e. MnCl2, ZnCl2, NiCl2 and CaCl2) the Au-nanoprobes 
flocculated and the solution turned opaque, impeding the assessment of the eventual 
colorimetric changes. Therefore, for the development of the non-cross-linking method, only 
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NaCl and MgCl2 were considered. MgCl2 showed an additional advantage due to the low 
concentrations needed and, hence, low volumes used to induce Au-nanoprobe aggregation. 
This can be extremely useful when testing diluted biological samples or when additional 
reagents are needed. However, MgCl2 should be used carefully since it may induce some 
cross-linking aggregation by coordination of the nanoprobes’ DNA. Results have shown that 
the Schulze-Hardy rule can be used to predict the CCC value of monovalent or divalent salt 
associated with a particular nanoprobe, provided that a salt-induced stability study is 
performed with at least one of the salts. 
The stability of the Au-nanoprobes also decreased for pH values below 7.5 and in the 
presence of increasing concentrations of DMSO or methanol. Conversely, stability increased 
with betaine or formamide. This should be taken into account when selecting the 
hybridization conditions, such as reagents for DNA hybridization or when already present in 
the biological sample to be tested. 
Full aggregation of Au-nanoprobes was also hindered by concentrations of Au-nanoprobe 
below 2 nM and for that reason a concentration of 2.5 nM was used herein. 
Au- and AuAg-nanoprobes presented similar stabilities against salt-induced aggregation, 
showing that both may be used for the development of non-cross-linking based 
methodologies for nucleic acid detection. 
The synthesis of Au-nanoprobe using ultrasounds allowed for better reproducibility between 
batches, when considering the variations of the CCC value associated to all Au-nanoprobes. 
This allows to better predict the CCC value of new batches and also synthesize the Au-
nanoprobes faster than when following the classical “salt-aging” method. Hence, the 
ultrasound method was elected as the preferred method for the synthesis of nanoprobes. 
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4 CHAPTER 4. Using the Non-cross-linking method for SNP detection 
 
The colorimetric properties of Au-nanoprobes have led to the development of a new class of 
nanobiosensors able to recognize and detect specific DNA and/or RNA sequences. A simple, 
easy-to-perform and inexpensive colorimetric assay for specific DNA sequence detection has 
been developed by our group based on the differential non-cross-linking aggregation of Au-
nanoprobes. This chapter describes further developments to this non-cross-linking method 
towards detection of single base mutations/SNPs. Preliminary work for the development of a 
multiplex non-cross-linking method has also been addressed via combination of Au- and 
AuAg-nanoprobes. 
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4.1 Introduction 
A simple non-cross-linking colorimetric method for specific DNA/RNA sequence detection 
has been being developed by our group.[91,103] The method is based on a non-cross-linking 
hybridization, where aggregation of the Au-nanoprobes is induced by an increasing salt 
concentration – the presence of complementary target prevents aggregation and the solution 
remains red, while non-complementary targets do not prevent Au-nanoprobe aggregation 
resulting in a visible change of color from red to blue. This approach has been successfully 
applied to detect eukaryotic gene expression from only 0.3 μg of unamplified total RNA 
without retro-transcription or PCR amplification[91] and in a fast and straightforward assay for 
Mycobacterium tuberculosis DNA detection in clinical samples at a final concentration of 36 
ng/μL of a first-round PCR amplicon.[103] 
Herein, the potential of this colorimetric method has been further explored in the detection of 
SNP/single-base mutations in DNA samples. As proof-of-concept, common point-mutations 
in the β-globin gene responsible for β-thalassemia were used. Afterwards, the method was 
further extended and optimized for the characterization of other SNPs targets: CYP2D6, 
associated to the level of xenobiotic metabolism, and DOR1, associated to obesity and Type 
2 diabetes. Following optimization of SNP characterization via Au-nanoprobes, specific DNA 
target detection was also achieved by means of AuAg-nanoprobes. Combining these two 
types of nanoprobes a multiplex (dual-color) non-cross-linking method has been developed. 
 
4.2 Results and Discussion 
4.2.1 Au-nanoprobes 
4.2.1.1 SNP/mutation detection: Proof-of-concept (work published in Doria G, et al.[156]) 
An Au-nanoprobe - bGlob - overlapping a region of the β-globin gene harboring three 
different single-point mutations causing β-thalassemia was used for the proof-of-concept of 
SNP/single point mutations detection via the non-cross-linking method (see Figure 2.1 in 
Chapter 2, section 2.1.5.5.2). To test the bGlob Au-nanoprobe, hybridization using a 396 bp 
fully complementary target or a 355 bp non-complementary target was performed. Three 
assay solutions were prepared: “Blank” – Au-nanoprobe alone; “Comp” – Au-nanoprobe in 
the presence of the complementary target; “Non-comp” – Au-nanoprobe in the presence of 
the non-complementary target. Additionally, a fourth solution (“No salt”) with the Au-
nanoprobe alone without salt (substituted by 10 mM phosphate buffer) was used. The assay 
was performed in triplicate, photographs taken and visible spectra recorded. 
After hybridization and upon salt addition, within 15 minutes, both “Blank” and “Non-comp” 
solutions changed color from red to blue (Figure 4.1). The color changes were corroborated 
by visible spectra, where an intense plasmon resonance band appears at 600–650 nm, with 
a concomitant decrease of the intensity of the original plasmon resonance at 526 nm. 
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Figure 4.1 – bGlob Au-nanoprobe aggregation profiles. UV-vis spectroscopy data and photos of 
samples after 15 minutes incubation with [NaCl]= 2 M (except “No Salt”). Final DNA concentration of 
36 ng/μL. Inset: Average Abs526/Abs600 ratio with corresponding standard deviation of three 
independent assays; dashed line indicates a ratio value of 1. 
 
In contrast, the “Comp” solution remained unaltered as confirmed by comparison with the 
“No salt” solution. These results were reproducible and concordant with those described 
earlier by the group for M. tuberculosis detection.[103] Similar results were obtained by using a 
plasmid (p158 plasmid) or a larger amplicon (1559 bp) as complementary targets. In this 
case, hybridization was also directly observed by AFM (see Chapter 5, section 5.2.1).[148] 
 
 
Figure 4.2 - Mutation/SNP detection. UV-Vis spectroscopy data of samples after 15 minutes 
incubation with [NaCl] = 2 M. Samples are Au-nanoprobe in presence of: a DNA from normal β-globin 
gene (“Comp”); a DNA harboring a single-point mutation IVS1, nt1 on the β-globin gene (“Mut1”); a 
DNA harboring a single-point mutation IVS1, nt2 on the β-globin gene (“Mut2”); and a DNA harboring 
a single-point mutation IVS1, nt6 on the β-globin gene (“Mut6”). The panel on the right shows the 
relative position of the mutation within the bGlob Au-nanoprobe sequence, marked by an inverted 
triangle. 
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Having confirmed the viability of the bGlob Au-nanoprobe to hybridize and detect a 
complementary target sequence, the assay was performed with three other 355 bp 
amplicons obtained by PCR amplification of genomic DNA samples previously screened for 
the presence of the β-thalassemia mutations. Figure 4.2 shows the spectrophotometric 
changes 15 min after increasing NaCl concentration to 2 M, in solutions containing bGlob Au-
nanoprobe in presence of fully complementary target (“Comp”) or in presence of targets 
harboring the mismatches at different positions within the region of overlap (“Mut1”, “Mut2” 
and “Mut6”). 
The bGlob Au-nanoprobe clearly distinguishes between fully complementary target 
sequences and the presence of any of the three single-base mutations. The mismatched 
targets did not prevent Au-nanoprobe aggregation and the solutions changed from red to 
blue, as it happens with non-complementary sequences. This assay was repeated at least 
four times. Even though most assays exhibited a clear color distinction between 
complementary and mismatched samples, best reproducibility of the assay was achieved 
with DNA concentrations between 18 and 36 ng/μl. Below that range, the difference in color 
between complementary and mismatched targets was not discriminating. 
As previously reported, nucleic acid sequences seem to protect AuNPs against salt induced 
aggregation, possibly through the electrostatic interactions between the negatively charged 
phosphate groups on the nucleic acid backbone.[91,103] This could explain the differences in 
aggregation observed for “Comp” against “Non-comp” and “Mismatched” samples. Although 
the presence of nucleic acid in solution may act as a “buffer” for increasing ionic strength, 
thus potentiating the stabilization of Au-nanoprobe in the non-aggregated form, it does not 
prevent aggregation at high ionic strengths when non-complementary targets are used. On 
the other hand, the increased stability observed for the complementary target can be 
explained by the fact that the full length of the Au-nanoprobe has hybridized with the 
complementary target DNA sequence. In the end, the resulting duplex is what actually 
prevents the salt induced aggregation. Destabilization of the duplex derived from the 
mismatch in the sequence, leads to Au-nanoprobe aggregation, and the level of such 
aggregation might be dependent on the position of the point mutation. In fact, this 
destabilization effect at room temperature was confirmed by fluorescence assays which 
indicate that a higher number of fully complementary targets hybridize to the Au-nanoprobe 
than mismatched targets, and that this difference is dependent on the mismatch position (see 
Chapter 5, section 5.2.2.2). 
In conclusion, these results prove that the non-cross-linking method is suitable to detect 
SNP/single point mutations in nucleic acid sequences, such as PCR amplicons. To further 
analyze the versatility of the non-cross-linking SNP/mutation detection, other SNP targets 
were assessed. 
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4.2.1.2 Extending the method to other targets (DOR1 and CYP1846 SNPs) 
As previously mentioned, a set of Au-nanoprobes were designed to detect SNPs within the 
CYP2D6 gene (i.e. CYP1846G and A probes) and the DOR1 gene (i.e. DOR1C and DOR1G 
probes). In each case, two Au-nanoprobes were designed to detect each possible allele, thus 
allowing characterization of homo- and heterozygous samples. In the case of CYP2D6, the 
CYP1846G and CYP1846A Au-nanoprobes are fully complementary to the CYP2D6*1 and 
CYP2D6*4 alleles, respectively. In the case of DOR1, the DOR1C and DOR1G Au-
nanoprobes are fully complementary to the DOR1C and DOR1G alleles, respectively. 
Following a similar approach to that used for the bGlob Au-nanoprobe, assays were 
performed with PCR amplified targets complementary, mismatched and non-complementary 
to each Au-nanoprobe, at a final DNA concentration of 36 ng/μL. Contrary to what it had 
been previously observed in the proof-of-concept upon the addition of increasing 
concentration of salt (NaCl or MgCl2), solutions changed color from red to blue, even in 
presence of complementary targets. However, an assay for the CYP1846G and CYP1846C 
Au-nanoprobes, complementary solutions were partially stable as indicated by a faint red 
solution and the Abs526/Abs600 value above 1 (Figure 4.3). The corresponding mismatched 
solutions were also stable, but less than solutions with the complementary targets. Taken 
together, these results indicate a low reproducibility that needs to be addressed in future 
optimizations. 
The difficulty in complementary target hybridization might be due to sub-optimal hybridization 
conditions (i.e. high stringency), such as low salt concentration and high pH during 
hybridization. Additionally, the targets’ %GC composition can also justify the discrimination 
observed for the bGlob and not for the DOR1 and CYP2D6 targets – 52%, 76% and 66%, 
respectively. DNA targets with high %GC contents are known to form stable secondary 
structures that are resistant to denaturation and, consequently, hamper probe 
hybridization.[157] 
To try circumventing these issues, the non-cross-linking hybridization was performed in less 
stringent conditions (i.e. higher salt concentrations and lower pH values) and/or in the 
presence of reagents that facilitate DNA hybridization (i.e. DMSO, formamide, methanol and 
betaine). The tested salt concentrations for hybridization varied from the initial 17 mM (added 
with the Au-nanoprobe volume) up to 500 mM of NaCl; pH varied between 7 and 8; DMSO 
concentrations up to 2.5% (v/v); betaine concentrations up to 2 M; formamide concentrations 
up to 40% (v/v); and methanol concentrations were tested up to 10% (v/v). Other conditions 
of salt and reagents were prohibited either due to Au-nanoprobe destabilization/aggregation, 
in high concentrations (see Chapter 3, section 3.2.1.4), or to volume limitations. Additionally, 
the hybridization period before salt addition was extended up to 16 hours. 
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Figure 4.3 – CYP1846G/A SNP detection. The Abs526/Abs600 ratio upon 15 minutes of NaCl adition 
(final concentration= 1 M) to Au-nanoprobes alone (“Blank”) or in presence of a non-complementary 
target (“Non-comp”); or the Probe CYP1846G in the presence of its complementary target 
(“CYP2D6*1 allele”) and mismatched target (“CYP2D6*4 allele”); or the Probe CYP1846C in the 
presence of its complementary target (“CYP2D6*4 allele”) and mismatched target (“CYP2D6*1 allele”). 
Schematics represent Au-nanoprobe alone or in presence of a target, where “X” represents a single 
base mismatch at the 3’-end of Au-nanoprobe. 
 
Unfortunately, none of the previous conditions allowed for reproducible colorimetric results 
with the DOR1 or CYP1846 Au-nanoprobes, as in all cases the assay solutions aggregated 
un-differentially upon salt addition. Moreover, the synthesis of CYP1846 Au-nanoprobes with 
a longer sequence (40 nt probes, CYP1846G_XL and A_XL) did not solve this hybridization 
issue. In some cases, the complementary, mismatched and non-complementary amplicon 
target samples provided stability to the Au-nanoprobes, even in very high salt concentration. 
It is worth mentioning that, after purification of such target samples, hybridization to Au-
nanoprobes no longer stabilized them and aggregation was observed. These observations 
indicate the presence of contaminations that stabilize Au-nanoprobes, most likely proteins 
present in DNA samples that could bind non-specifically to the AuNPs surface through 
electrostatic interaction or cysteine residues.[158,159] 
To confirm that Au-nanoprobes were actually viable to hybridize to a complementary target, 
the amplicon targets were substituted by synthetic ssDNA 40-mer oligonucleotides. In this 
case, the Au-nanoprobes retained their stability upon salt addition when in presence of a 
complementary target. However, it was not possible to observe a colorimetric differentiation 
between complementary and mismatched targets, as shown in the example of DOR1C and 
DOR1G Au-nanoprobes (Figure 4.4 – A). The Au-nanoprobe stability upon salt addition 
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decreased linearly with target concentration, showing complete aggregation at 0.025 pmol/μL 
(25 nM) (Figure 4.4 – B); above 0.075 pmol/μL (75 nM), the red color was retained. These 
results show that the method’s sensitivity is probably between those for the methods 
described by Mirkin’s and Sato’s groups.[101,82] The linear trend observed for the Au-
nanoprobe stability vs. target concentration has also been observed for a different target, i.e. 
mRNA.[160] 
 
 
Figure 4.4 – Hybridization assay with ssDNA oligonucleotides. (A) The average Abs526/Abs600 
ratio of the Au-nanoprobes alone (“Blank”) or in presence of a non-complementary target (“Non-
comp”); or for the DOR1C Au-nanoprobe in the presence of its complementary target (“DOR1C allele”) 
and mismatched target (“DOR1G allele”); or for the DOR1G Au-nanoprobe in the presence of its 
complementary target (“DOR1G allele”) and mismatched target (“DOR1C allele”). The final ssDNA 
concentration is 1pmol/μL. Schematics represent Au-nanoprobe alone or in presence of a target, 
where “X” represents a single base mismatch at the 3’-end of Au-nanoprobe. (B) The average 
Abs526/Abs600 ratio of the DOR1G Au-nanoprobe in presence of complementary target. Dashed line 
and equation represent the linear trendline for ratio obtained with target concentrations between 0.75 
and 0.5 pmol/μL. Error bars represent the standard deviation of three independent assays. 
 
In an attempt to attain colorimetric differentiation between complementary and mismatched 
ssDNA oligonucleotide targets, a salt titration was performed with increasing concentrations 
of NaCl and MgCl2. For both cases, it was not possible to discriminate between 
complementary and mismatched targets, while the “Blank” and “Non-comp” solutions 
aggregated at 1.5 M NaCl or 20 mM MgCl2 (Figure 4.5). 
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Figure 4.5 – Salt titration of Au-nanoprobe with ssDNA oligonucleotides. The average 
Abs526/Abs600 ratio of the DOR1G Au-nanoprobe alone (“Blank”); in the presence of a complementary 
target (“Comp”); a mismatched target (“Mis”); or a non-complementary target (“Non-comp”), 15minutes 
after addition of (A) NaCl or (B) MgCl2. Error bars represent the standard deviation of three 
independent assays. 
 
It was not possible to induce aggregation for the complementary/mismatched assays even 
with high concentrations of NaCl. On the other hand, the complementary/mismatched 
solutions both started to aggregated at 40 mM MgCl2 and aggregation stabilized at an 
Abs526/Abs600= 1.4 with >70 mM MgCl2 (Figure 4.5 – B). In this case, the absorbance ratio did 
not fall below 1, mainly due to the fact that the SPR band peak of these samples did not 
shifted further than 560 nm. This may be related to an increased inter-particle distance upon 
aggregation induction.[68] If that is the case, the inter-particle distance increase might be 
caused by a steric hindrance provided by the ssDNA oligonucleotides hybridized to the Au-
nanoprobes. This hypothesis is further supported by the measurements of the Au-
nanoprobes hydrodynamics radius, which increases with the hybridization of 
complementary/mismatched targets (see Chapter 5, section 5.2.3.2). 
Interestingly, when a second synthetic oligonucleotide, complementary to the target 
oligonucleotide, is added to the solution (thus generating a dsDNA synthetic target), the Au-
nanoprobes are no longer stabilized by their complementary/mismatched target and 
aggregate upon salt addition. This suggests existence of competition between hybridization 
and dsDNA renaturation, which could explain why the Au-nanoprobe hybridization to the 
dsDNA amplicon targets was hampered, as previously observed for DOR1 and CYP2D6 
targets (Figure 4.6). 
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Figure 4.6 – Scheme of dsDNA target hybridization competition. (A) A complementary ssDNA 
target hybridizes with the Au-nanoprobe after the denaturation/hybridization (ΔT/Hyb) step, (B) but 
when a second ssDNA with a sequence complementary to the ssDNA target sequence is added to 
solution, the hybridization between ssDNA strands overcomes the hybridization between the target 
and the Au-nanoprobe, forming a dsDNA instead. 
 
To confirm this, asymmetric PCR was used to yield both dsDNA and ssDNA amplicons. 
Double-stranded DNA and ssDNA were separated and purified by gel electrophoresis, and 
used in the non-cross-linking assay. Results clearly show that the complementary ssDNA 
amplicon easily hybridizes with the Au-nanoprobe, increasing protection against salt-induced 
aggregation, while hybridization to the dsDNA amplicon is hampered and the Au-nanoprobes 
aggregate (Figure 4.7). Moreover, ssDNA mismatched amplicon targets do not stabilize the 
Au-nanoprobe and they aggregate similarly to the Au-nanoprobes in presence of a non-
complementary target. 
A comparison between the results obtained for ssDNA synthetic oligonucleotides and for 
ssDNA produced by asymmetric PCR suggests that capability to detect SNP/mutations is 
influenced by the target length/complexity and, therefore, limited to more complex/longer 
targets. In summary, the use of asymmetric PCR overcomes the difficulties presented by 
GC-rich targets and allows the non-cross-linking method to the successfully detect 
SNP/mutations in virtually any DNA target, provided that asymmetric PCR is successful. 
Moreover, the use of two Au-nanoprobes, each fully complementary to each allele, should 
allow to fully characterize homo- and heterozygous samples (e.g. heterozygous samples 
stabilize both probes, while homozygous samples only stabilize one probe). 
 
81 
 
Figure 4.7 - ssDNA vs. dsDNA amplicon hybridization. The average Abs526/Abs600 ratio of the (A) 
DOR1G Au-nanoprobe in presence of its ssDNA/dsDNA complementary (“DOR1G allele”) and 
mismatched (“DOR1C allele”) target; and of the (B) DOR1C Au-nanoprobe in presence of its 
ssDNA/dsDNA complementary (“DOR1C allele”) and mismatched (“DOR1G allele”) target. Spectra 
were registered 15 minutes after addition of MgCl2 (final concentration= 25 mM and 45 mM MgCl2 for 
DOR1G and DOR1C Au-nanoprobes, respectively). Final target concentration is 30 ng/μL. Schematics 
represent Au-nanoprobe in presence of a target, where “X” represents a single base mismatch at the 
3’-end of Au-nanoprobe. Error bars represent the standard deviation of three independent assays. 
 
 
4.2.2 AuAg-nanoprobes 
The potential of AuAg-nanoprobes to specifically detect nucleic acids sequences based on 
the non-cross-linking method was tested. The stability of AuAg-nanoprobes against salt-
induced aggregation was tested following hybridization to a complementary and non-
complementary target (synthetic ssDNA oligonucleotides). The same procedure, as that for 
Au-nanoprobes, was followed and spectra taken 15 minutes upon salt addition. The SPR 
band of AuAg-nanoprobe alone (“Blank”) and in presence of a non-complementary target 
(“Non-comp”) shifted towards longer wavelengths, with a concomitant color change from 
yellow to blue (Figure 4.8). The presence of a complementary target significantly stabilized 
the nanoprobes and the solution retained its initial and non-aggregated yellow color. Similar 
results were obtained when using dsDNA amplicons as targets (396bp bGlob amplicon – see 
Chapter 2, section 2.2.1.5.1). Apart from the different initial SPR peak (460 nm and 526 nm 
for AuAg- and Au-nanoprobes, respectively) these results are in total agreement to those 
obtained for the Au-nanoprobes. 
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Figure 4.8 – AuAg-nanoprobe hybridization with ssDNA oligonucleotides. UV-vis spectrum of 
DOR1C AuAg-nanoprobe alone with no salt addition (“No salt”) and 15 minutes after MgCl2 addition 
(“Blank”); in presence of a complementary target (“Comp”); or a non-complementary target (“Non-
comp”). Final concentrations of 30 mM MgCl2 and 1 pmol/uL of ssDNA oligonucleotide. 
 
4.2.3 Multiplexing: proof-of-concept 
Making use of the different SPR band peak associated to the non-aggregated Au- and AuAg-
nanoprobes, and based on the fact that both nanoprobes present a similar behavior upon 
salt addition, a multiplex approach using the non-cross-linking method was evaluated. The 
proof-of-concept was made by using one Au-nanoprobe (CYP1846G probe) with one AuAg-
nanoprobe (DOR1C probe) at a final concentration of each nanoprobe of 2.5 and 0.05 nM, 
respectively. These concentrations were used to allow similar Abspeak value and, thus, to 
facilitate the visualization of both SPR band peaks. The nanoprobes were mixed together 
and tested for their stability against salt-induced aggregation. A total of six assay solutions 
were prepared: “No salt” - nanoprobes alone with no salt addition (salt was substituted by 
10mM phosphate buffer); “Blank” – nanoprobes alone; and “Au_Comp” – in presence of a 
complementary target to Au-nanoprobe; “AuAg_Comp” – in presence of the complementary 
target to AuAg-nanoprobe; “Au+AuAg_Comps” – in presence of complementary targets to 
each nanoprobe; “Non-comp” – in presence of a non-complementary target to either 
nanoprobe. All targets used were synthetic ssDNA oligonucleotides at a final concentration of 
1pmol/μL. Figure 4.9 shows the UV-visible spectra and digital photographs of the 
nanoprobes 15 minutes after salt addition (or phosphate buffer, in the case of “No salt”). 
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Figure 4.9 – Multiplex non-cross-linking assay. UV-visible spectra of Au-/AuAg-nanoprobes mix 15 
minutes after MgCl2 addition (final concentration 30 mM) and digital photographs of each solution. The 
nanoprobes alone – “No salt”, where the salt was substituted by phosphate buffer, and “Blank” – and 
in presence of: (A) a complementary target to Au-nanoprobe – “Au_Comp”; (B) a complementary 
target to AuAg-nanoprobe – “AuAg_Comp”; (C) complementary targets to each nanoprobe – 
“Au+AuAg_Comps”; (D) a non-complementary target to either nanoprobe – “Non-comp”. Schematics 
represent each nanoprobe and their complementary or non-complementary targets. 
 
The SPR band peaks – 460 and 526 nm – of the nanoprobes alone red-shifted to a single 
peak – 630 nm – after salt addition, with a concomitant change in color from the original dark 
orange to blue (“No Salt” vs. “Blank”). In the case of the “Au_comp” solution, the SPR band 
with double peaks located at 460 and 526 nm changed to a single peak at 526 nm, and this 
spectrophotometric change was translated by a change from dark orange to red, indicating 
that only the Au-nanoprobe remained stable in the presence of its complementary target 
(Figure 4.9 – A). In the “AuAg_comp” solution, the SPR band peaks shifted to a single peak 
at longer wavelengths but in a lesser extent than “Blank” solution, changing color from dark 
orange to blue, indicating that both nanoprobes aggregated (Figure 4.9 – B). Nonetheless, in 
this case, it is still possible to observe a slight band near the 460 nm, which may indicate that 
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not all AuAg-nanoprobes have aggregated due to the presence of their complementary target. 
In presence of both complementary targets – “Au+AuAg_comp” solution – both nanoprobes 
remained stable and the solution retained its initial color, despite the slight decrease in the 
SPR absorbance intensity (Figure 4.9 – C). In the case of the “Non-comp” solution, the initial 
SPR band peaks red-shifted in a similar way to the “Blank” solution, with a concomitant 
change in color from dark orange to blue (Figure 4.9 – D). 
 
Taken together, these results show that a multicolor/multiplex approach via the non-cross-
linking method is viable, provided that further optimization permits to avoid aggregation of the 
AuAg-nanoprobe in presence of its complementary target. The ultimate goal of this 
multiplexing approach is to detect SNP/single point mutations, allowing homo- and 
heterozygous characterization in a single reaction. 
 
4.3 Conclusions 
It was demonstrated that the non-cross-linking method can be used for detection of 
SNP/single point mutations at room temperature. In the case of the bGlob Au-nanoprobe, it 
was possible to successfully detect three different individual β-globin gene mutations in 
dsDNA amplicon targets with just one Au-nanoprobe. For GC-rich sequences (e.g. DOR1 
and CYP2D6 regions), the competing dsDNA renaturation hinders the target hybridization 
with Au-nanoprobe and hampers the detection of the respective complementary target, even 
in less stringent and optimal hybridization conditions. The use of less complex targets, such 
as ssDNA oligonucleotides or ssDNA amplicons produced by asymmetric PCR, allows 
overcoming this problem and enhances the reproducibility of the non-cross-linking method. 
Nonetheless, the discrimination of a single base mismatch is only possible with longer 
ssDNA targets (produced by asymmetric PCR), whereas 40-mer ssDNA oligonucleotides 
with a single base mismatch cannot be discriminated from fully complementary targets. The 
detection sensitivity of the non-cross-linking method was determined to be 73 and 75 nM for 
ssDNA/dsDNA amplicons and ssDNA oligonucleotide targets, respectively. This indicates 
that the sensitivity should be independent of target length/complexity. 
The detection of specific nucleic acids sequences via the non-cross-linking method is also 
possible through the use of AuAg-nanoprobes. Preliminary results indicate that a multiplex 
assay based on the conjugation of Au- and AuAg-nanoprobes is viable to detect multiple 
targets in a single reaction. 
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5 CHAPTER 5. Non-cross-linking Mechanism: Proposed model and 
optimization 
 
Unveiling the underlying mechanism of the non-cross-linking method may allow to better 
understand the single base resolution of Au-nanoprobes towards optimization. In this chapter, 
the use of AFM, fluorescent spectroscopy and electrophoretic mobility measurements 
(Ferguson analysis) allowed clarification of the nature of the forces involved in the differential 
colorimetric non-cross-linking aggregation and further optimize the Au-nanoprobe design to 
SNP/single point mutation discrimination at room temperature. 
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5.1 Introduction 
Since the development of the first Au-nanoprobes and the cross-linking method by Mirkin 
and co-workers,[80] several studies have been conducted to better understand the 
physicochemical properties of the Au-nanoprobes/DNA target conjugates.[81,161-172] The 
majority of these studies focused on the mechanisms of the cross-linked Au-nanoprobe/DNA 
aggregates, while few have actually focused on the thermodynamics and hybridization 
efficiency itself between an Au-nanoprobe and complementary DNA. 
 
To assess the hybridization efficiency between the Au-nanoprobes and DNA targets, Demers 
and co-workers developed a method using fluorescein-labeled ssDNA oligonucleotides as 
targets.[81] In their study, hybridization efficiency was shown to be linearly dependent of the 
Au-nanoprobe density (i.e. thiol-modified oligonucleotide coverage of the AuNPs’ surface), 
where higher densities (up to 20 pmol/cm2) allowed hybridization of more targets. Also, 
hybridization efficiency considerably increased (10-fold) with introduction of a poly(dA) or 
poly(dT) 20mer spacer between the propane-thiol group and the probe sequence. 
Introduction of such spacer leads to an enhanced binding strength between the Au-
nanoprobe and the DNA target, but an increase in the length of the recognition sequence (i.e. 
probe sequence) actually leads to a decrease in the added strength binding provided by 
these spacers.[165] The steric hindrance between DNA strands is believed to be alleviated by 
the introduction of such spacers, which move the DNA recognition sequence further away 
from the AuNPs’ surface. In the absence of the spacer, the DNA strands are closer to the 
particle surface and to each other, therefore reducing the ability of the target sequence to 
bind to the Au-nanoprobe. Additionally, the heteroduplexes formed on the surface of the Au-
nanoprobes were shown to become progressively less stable as the fraction of hybridized 
DNA on the surface increases.[164] This effect on the thermodynamics of hybridization is 
believed to be due to electrostatic interactions between near-neighbor DNA heteroduplexes, 
which difficult the binding of further DNA targets. The Au-nanoprobe sequence composition 
has also been shown to affect the hybridization efficiency, mainly due to non-specific 
adsorptions occurring between the nucleotides of the thiol-modified oligonucleotide and the 
AuNPs surface.[169] These non-specific adsorptions are greater for oligonucleotides with 
higher adenine and cytosine content, and lead to a decrease in hybridization efficiency. 
Moreover, the position of these high affinity sequences within the derivatized thiol-modified 
oligonucleotide affects the extent of hybridization, where high affinity nucleotides in the 
center affect hybridization in less extent than when located at the end. 
 
The specificity of the Au-nanoprobes for single base mismatches has also been studied, but 
always through the cross-linked approach. In this approach, the single base mismatch can 
be detected at a specific temperature that allows the dissociation of Au-nanoprobes/DNA 
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aggregates harboring the mismatch, while maintaining the complementary Au-
nanoprobes/DNA aggregates unaltered.[101] This is mainly due to the extraordinarily sharp 
melting profiles exhibited by the heteroduplex DNA cross-linked structures formed between 
DNA target strands and the Au-nanoprobes. This sharp melting is attributed to a cooperative 
mechanism that results from the presence of multiple DNA linkers between each pair of Au-
nanoprobes and a decrease in the melting temperature, as duplex DNA strands melt due to a 
concomitant reduction in local dielectric medium.[163,167] The sharp melting properties of the 
cross-linked Au-nanoprobes/DNA aggregates are affected by a number of factors, including 
DNA surface density, nanoparticle size and inter-particle distance.[162,163,171] 
 
Despite all these studies, the effect of a single base mismatch in the hybridization efficiency 
between a non-cross-linked conjugation of Au-nanoprobe and DNA targets has never been 
addressed. Also, the mechanism involved in the non-cross-linking hybridization method 
responsible for the colorimetric differentiation between complementary, mismatched and 
non-complementary targets has, so far, been elusive. 
 
Here, to better understand the mechanism of the non-cross-linking method, including its 
capability for single base resolution at room temperature, a combination of different 
techniques was used. The Au-nanoprobe capability to recognize a complementary target 
sequence by hybridization was directly observed by AFM.[148] Through the use of fluorescent 
spectroscopy, Au-nanoprobe specificity was further assessed by studying the effect of a 
single base mismatch in hybridization efficiency under different conditions (e.g. Au-
nanoprobe length, density, etc.).[173] The Au-nanoprobe/target DNA conjugates were also 
characterized through a Ferguson plot analysis to infer surface charge and hydrodynamic 
radius differences between conjugates. Based on the attained results, a model of the non-
cross-linking method mechanism is proposed, which sets up the optimal conditions for single 
base mismatch detection at room temperature. 
 
5.2 Results and Discussion 
5.2.1 Use of Atomic Force Microscopy to observe Au-nanoprobe hybridization (work 
published in Eaton P, Doria G, et al.[148]) 
AFM was used to directly observe the DNA recognition events that occur at the nanoscale 
involving hybridization of the target dsDNA and the Au-nanoprobes.[148] The bGlob Au-
nanoprobe was used together with a plasmid harboring a fragment of the -globin gene locus 
as target (see Chapter 2, section 2.2.1.5.1). At first, in order to evaluate hybridization of the 
Au-nanoprobe, the p158 plasmid was linearized by BamHI restriction enzyme and a fragment 
of 8668 bp was attained. At a second stage, PCR amplified 1559 bp fragment from the 
same plasmid was used. A 1565 bp PCR amplified fragment from the pCYP2D6*1 plasmid 
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was used as non-complementary target sequence. These different target molecules were 
manipulated so as to create a pool of targets of different lengths with the specific target 
region located towards one end of the molecule, thus allowing determination of relative 
position of the hybridization locus and evaluation of specificity. 
AFM images of these DNA targets alone and of the Au-nanoprobe alone were first made to 
assess their structure (Figure 5.1). The majority of the Au-nanoprobes appeared isolated with 
a more or less globular morphology and height measurements (diameter) of an average of 
~17 nm (Figure 5.1 - A). Although not visible in this image, a minority of the Au-nanoprobes 
were also observed as small aggregates (~2 to 8 Au-nanoprobes). All DNA targets could also 
be visualized as uniform and individual molecules with the expected length and height 
(Figure 5.1 - B, C and D), considering the theoretical value from crystallography of 3.2 Å per 
bp and the known errors associated to AFM measurements.[174] 
 
 
Figure 5.1 – AFM characterization of Au-nanoprobes and targets. AFM images of the (A) Au-
nanoprobe alone - inset shows TEM of bare gold clusters, scale bar= 100 nm; and DNA alone, namely 
(B) the 1559 bp complementary amplicon, (C) the 1565 bp non-complementary amplicon, and (D) the 
8668 bp linearized p158 plasmid. 
 
AFM samples of Au-nanoprobes in presence of a complementary target (plasmid or amplicon) 
or non-complementary target were prepared by following all the steps of the non-cross-
linking colorimetric assay, except for salt addition, followed by a washing step to remove the 
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non hybridized targets. A clear image of the Au-nanoprobes bound to the plasmid could be 
observed (Figure 5.2 - A). However, the plasmid DNA molecules appeared to have formed a 
complicated supramolecular structure that hampered a more thorough analysis. This way, it 
was unclear whether there is a single Au-nanoprobe bond per plasmid, as would be 
expected if the binding occurred by specific hybridization. Such super-structures made it 
impossible to ascertain where along the DNA molecule the Au-nanoprobe is bound to, and, 
hence, confirm specific hybridization. As mentioned earlier, the plasmid was linearized so as 
to localize the target sequence one third of the way along the length of the plasmid, allowing 
evaluation of specific binding of the Au-nanoprobe. Hybridization of Au-nanoprobes to the 
plasmid DNA was repeated several times and registered by AFM, but a ratio of 1:1 Au-
nanoprobe/DNA target conjugates was very rarely observed. These structures may arise as 
a consequence of AFM sample preparation and deposition or really occur from Au-
nanoprobe and target hybridization in solution. 
In order to better assess the binding position of the Au-nanoprobes within the target DNA 
sequence and to confirm whether this binding is due to specific hybridization, a smaller DNA 
target (amplicon) with the Au-nanoprobe recognition site located at the end of the sequence 
was used. Such shorter DNA fragments reduce the potential for DNA to wrap up into 
complex forms, thus simplifying analysis. Indeed, the AFM image obtained with these 
complementary PCR fragments showed some individual Au-nanoprobe/DNA target 
conjugates (Figure 5.2 - B). Nevertheless, individual (non-hybridized) Au-nanoprobes and 
targets, and more complex structures combining more than one target, and more than one 
Au-nanoprobe, were also observed. In the case of the individual Au-nanoprobe/DNA target 
(1:1) conjugates, some of the Au-nanoprobes were located in the middle of the DNA target 
molecule (gray arrows), but the majority (ca. 70%) were found to be located at the end of the 
DNA target molecule (white arrows) as expected. In the latter, the length of the “tails” of DNA 
extending from the Au-nanoprobe varied from 216 to 494 nm, with a mean value of 355 nm, 
which was coherent with a binding due to hybridization - the theoretical length of this 
complementary PCR fragment (1559 bp; 3.2 Å per bp) is 499 nm and the recognition site is 
located at 483 nm. For the cases where a smaller “tail” was observed, the DNA could also be 
bonded through a specific hybridization at the end of the target, where these overhanging 
fragments have considerable freedom of movement and that some of them can wind back on 
themselves or around the Au-nanoprobe, possibly stabilized by nonspecific interactions with 
the AuNP surface.[175] 
 
Further confirmation that Au-nanoprobe binding to DNA target is mediated through a 
hybridization mechanism was obtained through the negative control of this experiment, 
where a sample with a non-complementary PCR amplicon was prepared in an identical 
procedure as that of the complementary target. The AFM image of this non-complementary 
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sample only showed unbounded Au-nanoprobes (Figure 5.2 - C), as expected if binding 
would depend only of specific hybridization. 
 
Figure 5.2 – AFM study of target hybridization. AFM image of Au-nanoprobes in presence of: (A) a 
linearized p158 plasmid; (B) a 1559 bp complementary amplicon; and (C) a 1565 bp non-
complementary target. Arrows indicate 1:1 probe-target aggregates where the probe is at the end 
(white arrows), and in the middle (gray arrows) of the DNA molecule. 
 
In conclusion, these results strongly support the binding by complementary hybridization as 
the primary interaction occurring between the Au-nanoprobes and the DNA targets. 
Nevertheless, 30% of the interactions apparently occurred away from the end of the PCR 
fragment, which is a clear signal of the occurrence of nonspecific interactions. AFM images 
only depict a small fraction of the whole Au-nanoprobe/DNA target population present in 
solution, and therefore, further studies should be carried out to give a broader image of the 
hybridization specificity of the Au-nanoprobes. 
 
5.2.2 Optimizing Au-nanoprobes for specific sequence discrimination (part of this 
work has been published in Doria G, et al.[173]) 
To better evaluate the Au-nanoprobe specificity for sequence detection in solution, the 
hybridization efficiency between the Au-nanoprobe and a complementary, mismatched or 
non-complementary DNA target was determined through a fluorescein-labeled probe. A 
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similar approach to the fluorescence technique developed by Demers and co-workers[81] was 
used, where single stranded DNA oligonucleotides with half the sequence complementary to 
a fluorescent probe (FAM probe) were used as targets and the other half of their sequence 
was either complementary or non-complementary to the Au-nanoprobe, or produced a single 
base mismatch within the sequence of the Au-nanoprobe. The targets and fluorescent probe 
were mixed in equal amounts and in large excess to the Au-nanoprobes to avoid limiting the 
hybridization reaction. A blank solution was also prepared by mixing the Au-nanoprobe alone 
with the fluorescence probe, thus allowing evaluation of nonspecific binding between the 
fluorescent probe, and the Au-nanoprobe. Following the usual denaturation/hybridization 
protocol used in the colorimetric assay, the excess non-hybridized targets/fluorescent probes 
were washed out. Then, alkaline denaturation was used to free the hybridized 
targets/fluorescent probes, and, after centrifuge separation, the fluorescence of the 
supernatant was measured by fluorescent spectroscopy (Figure 5.3). The Au-nanoprobes’ 
final concentration was also confirmed and used to correct the eventual losses of Au-
nanoprobe during the washing steps. The residual contribution of fluorescein molecules in 
the absorption at 526 nm was neglected, since the extinction coefficient associated to the 
SPR absorption band of the Au-nanoprobes is several orders of magnitude higher than that 
of fluorescein (2.33x108 cm-1.M-1 and 78x103 cm-1.M-1, respectively). Special emphasis was 
given to the effect of a single base mismatch in the hybridization efficiency at room 
temperature. 
 
 
Figure 5.3 – Scheme of the fluorescence-based procedure for the determination of 
hybridization efficiency. The Au-nanoprobe is mixed with an excess of target and fluorescent probe 
and allowed to hybridize at room temperature, following the usual denaturation/hybridization protocol, 
to form a sandwich heteroduplex structure due to base pair complementarity. Afterwards, the excess 
DNA is washed-out and the bonded targets are drawn into solution by an alkaline denaturation, to be 
quantified by fluorescent spectroscopy. 
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The hybridization efficiency between the Au-nanoprobes and targets was determined under 
different conditions (e.g. pH, mismatch position, probe length, etc.) to evaluate the optimal 
conditions for Au-nanoprobe specificity and better understand what rules the non-cross-
linking hybridization between target and Au-nanoprobe. 
 
5.2.2.1 Effect of pH 
The effect of pH in the hybridization efficiency of a complementary, mismatched and non-
complementary target to the Au-nanoprobe was assessed, and the best pH condition for 
specific target hybridization determined. Four aliquots of the same Au-nanoprobe were 
washed and dispersed in phosphate buffer solutions with pH values ranging from 6.64 to 
8.13. This interval comprises the range of pH usually used in DNA recognition techniques, 
such as Southern and Northern blots, DNA chip technologies, etc.[154] 
 
Results show that the number of DNA targets bound to the Au-nanoprobe is higher for lower 
pH values (Figure 5.4). Nonetheless, for these pH values a significant nonspecific binding of 
the fluorescent probe is also observed. This nonspecific binding is most likely to happen 
through the exposed bases of the ssDNA fluorescent probe interacting with the AuNPs 
surface.[86] In the case of the non-complementary targets, a decrease in the number of 
bonded targets is observed most likely due to the fluorescent probe being fully hybridized to 
part of the non-complementary target sequence. In this case, half of the non-complementary 
target bases still remain exposed to bind nonspecifically to the Au-nanoprobes, but in a 
lesser extent. Considering these observations, the results for the complementary and 
mismatched target hybridization at pH 6.64 and 7.21 should be carefully considered when 
assessing the true hybridization efficiency and specificity. 
 
For higher pH values the nonspecific binding decreases considerably, especially in the case 
of pH 8.13. At this pH, it is also possible to observe that complementary targets hybridize to 
the Au-nanoprobe in slightly higher number than the targets harboring a single base 
mismatch (G•T) at the 3’-end of the Au-nanoprobe. Hence, we can conclude that the optimal 
pH for specific hybridization is set to be at pH 8. 
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Figure 5.4 – Effect of pH in hybridization efficiency and specificity. The Au-nanoprobe 
(CYP1846G) in presence of a fluorescent probe (FAM) – “Blank”; and a complementary target 
(CYP1846C) – “Comp”; and a target (CYP1846T) harboring a single base mismatch at the 3’-end of 
the Au-nanoprobe – “Mis”; and a non-complementary target (DOR1C) – “Non-comp”. Error bars 
represent standard deviation of three independent samples. 
 
5.2.2.2 Effect of mismatch position 
The effect of the position of a single base mismatch on hybridization efficiency was assessed 
by engendering a guanidine-guanidine (G•G) mismatch at several base positions along the 
sequence of the Au-nanoprobe (DOR1G) (Figure 5.5). Because the G•G mismatch is known 
to yield the strongest interaction among the non-Watson-Crick base paring,[176] it is most 
likely to allow the proper analysis of these phenomena at the molecular level. DOR1C was 
used as complementary target; targets DOR1GA, DOR1G_4, DOR1G16 and DOR1G_20 
where used so as to generate the single base mismatch at nucleotide 1, 4, 16 and 20 of the 
Au-nanoprobe, respectively (considering nucleotide 1 at the 3’-end of the Au-nanoprobe 
oligonucleotide); and target CYP1846C as non-complementary target. 
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Figure 5.5 – Scheme of mismatch position along Au-nanoprobe sequence. Different ssDNA 
targets were used as to generate a single guanidine-guanidine mismatch or full guanidine-cytosine 
complementarity (S= G or C) at different positions (nt# 1 to 20) along the sequence of the Au-
nanoprobe. 
 
The best mismatch discrimination was found to be at the 3’-end of the Au-nanoprobe (i.e. nt1) 
– see Table 5.1. As the mismatch position approaches the 5’-end of the Au-nanoprobes’ 
oligonucleotide sequence, discrimination between complementary and mismatched targets 
decreases. When the mismatch is located at the 5’-end (i.e. nt20), no discrimination is 
observed. This decrease of sequence specificity may be due to the decreased availability of 
the nucleotide bases close to the AuNP surface for base pairing interaction relative to the 
outer bases.[165] This way, the destabilizing effect of the mismatch in duplex stability and 
target hybridization efficiency is more evident when the mismatch is located at the 3’-end of 
the Au-nanoprobe. This effect also corroborates the previously observed results for SNP 
detection, in which the position of the mismatch seemed to affect Au-nanoprobe aggregation 
(see Chapter 4, section 4.2.1.1).[156] 
 
In conclusion, the Au-nanoprobe presents a higher level of specificity at the 3’-end of the 
thiol-modified oligonucleotide, where the discrimination of a single base mismatch is best 
achieved. 
 
Table 5.1 – Effect of mismatch position in hybridization efficiency 
Hybridized targets per Au-nanoprobe (Average±STD) 
Single base mismatch (G•G) position* 
Complementary 
Non-
complementary nt1 nt4 nt16 nt20 
8.42±0.83 
(2.44±0.24 
pmol/cm
2
) 
9.69±0.87 
(2.81±0.25 
pmol/cm
2
) 
15.61±0.21 
(4.53±0.06 
pmol/cm
2
) 
20.10±0.55 
(5.83±0.16 
pmol/cm
2
) 
19.15±0.39 
(5.56±0.11 
pmol/cm
2
) 
2.98±0.70 
(0.86±0.20 
pmol/cm
2
) 
* Considering nucleotide 1 (nt1) at the 3'-end base of the Au-nanoprobe oligonucleotide 
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5.2.2.3 Effect of base pair complementarity 
The effect of all possible base pair combinations at the 3’-end of the Au-nanoprobe was also 
assessed. For this purpose, a set of four different Au-nanoprobes with identical sequences, 
differing only at the 3’-end nucleotide (DOR1G, DOR1C, DOR1A and DOR1T, with G, C, A 
and T at 3’-end nucleotide, respectively) were hybridized to four different targets (DOR1CA, 
DOR1GA, DOR1TA and DOR1AA), each fully complementary to one of the Au-nanoprobes 
(Figure 5.6 – inset). The target CYP1846C was used as non-complementary target. 
Data show that all complementary targets hybridized in higher numbers than targets 
harboring a mismatch, whereas non-complementary targets showed negligible hybridization 
(Figure 5.6). The hybridization of mismatched base pair variants indicates that the type of the 
mismatched base pair has little or no effect in hybridization efficiency. Differences in 
mismatch discrimination between different Au-nanoprobes are most likely due to different Au-
nanoprobe densities, which have been previously reported to affect complementary target 
hybridization.[81] 
 
 
Figure 5.6 – Effect of base pairing at the 3’-end of the Au-nanoprobe on hybridization efficiency. 
The variable X translates for the Au-nanoprobe 3’-end base and the variable Z translates for the target 
base interacting with X, as shown in the inset scheme of the Au-nanoprobe and ssDNA target. Error 
bars represent standard deviation of three independent assays. 
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5.2.2.4 Effect of Au-nanoprobe density 
To confirm the previous hypothesis, the effect of Au-nanoprobe density in single base 
mismatch discrimination (G•G) was investigated. A set of Au-nanoprobes (DOR1G) with 
different densities of derivatized thiol-modified oligonucleotides at the surface was used. 
DOR1CA was used as a complementary target, while targets DOR1GA and CYP1846C were 
used as mismatched and non-complementary targets, respectively. 
 
The maximum efficiency of hybridization was observed for 83±4 oligos/AuNP, corresponding 
to a density of 24 pmol/cm2 (Figure 5.7). Bellow this value, hybridization efficiency has not 
yet reached the maximum, as fewer oligonucleotides are present to hybridize. For densities 
above the maximum, more oligonucleotides are present to hybridize but increasing 
electrostatic repulsion and steric hindrance possibly hamper hybridization.[165] These results 
are in good accordance with those published by Demers and co-workers, where a linear 
increase in hybridization efficiency was observed up to a density of 20 pmol/cm2 (higher 
densities where not evaluated).[81] 
 
 
Figure 5.7 – Effect of Au-nanoprobe density in hybridization efficiency. Au-nanoprobe in 
presence of: a complementary target – “Comp”; a target harboring a single base mismatch G•G at the 
3’-end of Au-nanoprobe – “Mis”; a non-complementary target – “Non-comp”. Error bars represent 
standard deviation of three independent experiments and dashed lines are guides for the eye. Inset: 
Difference between the number of complementary and mismatched targets hybridized to the Au-
nanoprobe in relation to its oligo density. 
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A similar effect is observed for discrimination between complementary and mismatched 
targets, i.e. the difference between the number of complementary targets and mismatched 
targets hybridized to the Au-nanoprobe (mismatch discrimination) increases gradually until 
reaching a plateau, beyond which the mismatch discrimination capability remains unaltered 
(Figure 5.7 – inset). This maximum discrimination level corresponds to an Au-nanoprobe 
density linked to the maximum hybridization efficiency. For lower densities, as the Au-
nanoprobes’ bases become more available to interact with their complementary target bases, 
the de-stabilizing effect of the mismatch in the duplex stability should become less 
pronounced. 
 
5.2.2.5 Effect of Au-nanoprobe length 
The effect of Au-nanoprobe length in hybridization efficiency and single base mismatch 
discrimination was also investigated by means of two Au-nanoprobes with 20 nt (CYP1846G) 
and 40 nt (CYP1846G_XL) sequences. The CYP1846G_XL Au-nanoprobe only differed from 
the CYP1846G Au-nanoprobe, in the first 20 nt starting from the 5’-end of the Au-nanoprobe. 
Nonetheless, the complementary (CYP1846C) and mismatched (CYP1846T) targets should 
only hybridize with the first 20 nt located at the 3’-end of both Au-nanoprobes (Figure 5.8). 
 
 
Figure 5.8 – Scheme of Au-nanoprobes with different lengths. Two Au-nanoprobes with (A) 20 nt 
or (B) 40 nt sequence were used to assess the effect of probe length in the hybridization efficiency 
with a fully complementary target or a target harboring a single base mismatch (G•T) at 3’-end of the 
Au-nanoprobes’ sequence (Y= C or T). 
 
The increase in the length of the Au-nanoprobe recognition sequence led to a decrease in 
hybridization efficiency to both complementary and mismatched targets (Table 5.2). This is 
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somehow consistent to what has been reported by Lytton-Jean and Mirkin, where an 
increase in the recognition sequence of their Au-nanoprobes led to a decrease in the 
enhancement of the binding strength provided by the spacer sequences used.[165] In our case, 
this decrease could also be due to the introduction of nucleotides with high-affinity to the 
AuNP surface (A and C) within the Au-nanoprobe sequence, which could difficult target 
hybridization.[169] Moreover, a decrease in density of the longer Au-nanoprobe could also be 
related to the decrease in hybridization efficiency. 
 
The increase of the Au-nanoprobe’s length also hampered discrimination between 
complementary and mismatched targets. This could be due to an increase in the Au-
nanoprobes’ bases availability to interact with their complementary target bases, which can 
in turn diminish the de-stabilizing effect of the mismatch within the duplex. This effect can be 
not only associated to an increase in the length of recognition sequence but also to the Au-
nanoprobe density, as previously demonstrated. Further studies with longer sequences and 
different Au-nanoprobe densities should be carried out to assess the actual effect of Au-
nanoprobe length in the single base mismatch discrimination at room temperature. 
 
Table 5.2 – Effect of Au-nanoprobe length in hybridization efficiency 
Hybridized targets per Au-nanoprobe (Average±STD) 
20 nt probe 40 nt probe 
Complementary Mismatch (G•T) Complementary Mismatch (G•T) 
15.18±0.73 
(4.40±0.21 pmol/cm
2
) 
13.88±1.09 
(4.02±0.32 pmol/cm
2
) 
5.42±0.32 
(1.57±0.09 pmol/cm
2
) 
5.31±0.65 
(1.54±0.19 pmol/cm
2
) 
 
 
5.2.2.6 Effect of target length/complexity 
The effect of target length/complexity in hybridization efficiency was also partially assessed 
by using a longer target that generated a dangling-end at the 5’-end of the Au-nanoprobe 
(DOR1G). To generate a 20 nt ssDNA dangling-end at the 5’-end of the Au-nanoprobe, two 
60 nt targets with a complementary sequence (DOR1C_XL) or a sequence (DOR1G_XL) 
harboring a single base mismatch at the 3’-end of the Au-nanoprobe, both located at the 
middle of the target, were used. As control, the usual 40 nt targets that generated a blunt-end 
at 5’-end of the Au-nanoprobe, namely DOR1CA (as complementary target) and DOR1GA 
(as mismatched target) were used (Figure 5.9). 
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Figure 5.9 – Scheme of ssDNA targets with different lengths. A set of (A) 40 nt and (B) 60 nt 
ssDNA oligonucleotides, fully complementary with the Au-nanoprobe or harboring a single base 
mismatch (G•G) at 3’-end of the Au-nanoprobes’ sequence (S= C or G) were used to assess the effect 
of target length/complexity in the hybridization efficiency. 
 
The number of hybridized complementary and mismatched targets considerably decreases 
with longer (60 nt) targets, when compared to shorter ones (40 nt) (Table 5.3). However, 
discrimination between complementary and mismatched targets is still possible, despite the 
fact that the differential between these two targets also decreased for longer targets. 
Although the target’s dangling-end at the 5’-end of the Au-nanoprobe is the most likely cause 
for the overall decrease in hybridization efficiency, the increase in target length can also 
generate secondary structures that may hamper hybridization to the Au-nanoprobe. Hence, 
further studies with longer targets, either generating a dangling-end at the 5’- or 3’-end of the 
Au-nanoprobe, should be carried out to confirm the real nature of the observed decrease in 
hybridization efficiency. 
 
Table 5.3 – Effect of a target length in hybridization efficiency 
Hybridized targets per Au-nanoprobe (Average±STD) 
40 nt targets 60 nt targets 
Complementary Mismatch (G•G) Complementary Mismatch (G•G) 
8.28±0.46 
(2.40±0.13 pmol/cm
2
) 
3.47±0.62 
(1.01±0.18 pmol/cm
2
) 
4.74±0.43 
(1.37±0.12 pmol/cm
2
) 
2.54±0.09 
(0.74±0.02 pmol/cm
2
) 
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In summary, hybridization efficiency and SNP discrimination at room temperature is 
maximized with a density of 83±4 thiol-oligonucleotides (20 nt) per 13.5 nm gold nanoparticle 
(24 pmol/cm2) at pH 8, and when the mismatch is localized at the 3’-end of the Au-
nanoprobe, i.e. away from the gold nanoparticle surface. Longer probe sequences (e.g. 40 nt) 
seem to decrease hybridization efficiency and hamper mismatch discrimination, while 
longer/more complex targets only lead to lower hybridization efficiencies, but allow mismatch 
discrimination. 
 
5.2.3 Characterization of the surface charge and hydrodynamic radius using 
Ferguson analysis 
The differential hybridization efficiency observed for fully complementary and mismatched 
targets considerably supports the colorimetric results obtained by the non-cross-linking 
method (see Chapter 4), when using longer/more complex ssDNA/dsDNA targets. 
Nonetheless, for shorter/less complex ssDNA oligonucleotide targets, the non-cross-linking 
method was unable to generate a differential colorimetric response between fully 
complementary and mismatched targets, despite the different hybridization efficiencies 
observed for these targets. Considering the negative charge associated to DNA due to the 
phosphate ions in its chemical backbone, it was expected that the number of targets 
hybridized to each Au-nanoprobe would determine a differential electrostatic repulsion 
between Au-nanoprobes dictating different stabilities against increasing ionic-strength and, 
hence, different aggregation profiles and colorimetric results between each target (i.e. fully 
complementary or mismatched target). On the other hand, the hybridized DNA targets may 
also provide the Au-nanoprobe with steric protection against aggregation, which can be less 
dependent on the number of targets hybridized and, therefore, explain the observed 
colorimetric results obtained with ssDNA oligonucleotides. 
 
To test these hypotheses, the surface charge and the hydrodynamic radius of the Au-
nanoprobe/DNA target conjugates were determined to evaluate the nature of the differential 
stability upon salt addition. For this study, the DOR1G Au-nanoprobe was used in 
conjunction with a complementary (DOR1CA), a mismatched target (DOR1GA, DOR1TA and 
DOR1AA) and a non-complementary (CYP1846C) target. 
 
5.2.3.1 Surface charge of Au-nanoprobe/target conjugates 
There is no satisfactory technique to determine surface charge of small particles in liquid, but 
a common approach relies on the measurement of zeta potential.[177] This is a function of the 
surface charge of the nanoparticle, the stationary layer at the interface and the nature and 
composition of the surrounding medium. Therefore, its value reflects the effective charge of 
the NPs and is closely related to the electrostatic repulsion between them, allowing 
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prediction of a coloidal solution’s stability - i.e. the higher the zeta potential, the higher the 
coloidal solutions’ electrostatic repulsion, thus, stability. 
 
The first approach to measure the zeta potential of the different Au-nanoprobe/targets 
conjugates was made using a device based in DLS. However, this approach yielded a set of 
irreproducible results (data not shown). Such non-reproducibility was also recently reported 
by Park and Hamad-Schifferli for AuNPs smaller than 20 nm in diameter,[149] as in our case. 
To circumvent this issue, a Ferguson analysis procedure was proposed by Park and Hamad-
Schifferli, where the surface charge and the hydrodynamic radius of AuNP/DNA conjugates 
can be determined through their differential migration in different agarose gel concentrations 
submitted to a constant electrical field (e.g. electrophoresis). 
 
Therefore, a Ferguson analysis was introduced to assess the surface charge and the 
hydrodynamic radius of the Au-nanoprobe/DNA target conjugates under study. The resulting 
gels clearly showed a different migration pattern for the Au-nanoprobe alone and in the 
presence of the complementary, mismatched or non-complementary targets (see Appendix 
V). The Au-nanoprobe alone and in presence of a non-complementary target migrated 
similarly and further than the Au-nanoprobe/mismatched target conjugates, while the Au-
nanoprobe/complementary target conjugates migrated less than the mismatched target 
conjugates. These results corroborate what had been previously observed in the 
fluorescence based approach (see Section 5.2.2), where complementary targets hybridized 
in higher number than mismatched targets, and the latter in higher number than non-
complementary targets. It should be noted that the differential migration can be either due to 
an increase in the hydrodynamic radius of the Au-nanoprobes or due to differential electrical 
potentials between Au-nanoprobe/target conjugates, or a conjugation of both. To sort each 
factor’s influence in the system, the mobility of each conjugate was plotted as function of 
agarose gel concentration. 
 
The mobility vs. gel concentration plots show similar vertical offsets between conjugates 
samples, indicating that the electric potential at the interfacial double layer of the Au-
nanoprobe does not change with hybridized targets, i.e., the superficial charge between 
samples is similar (Figure 5.10). This could help explain why the aggregation profiles of 
complementary and mismatched ssDNA oligonucleotide targets were also similar (see Figure 
4.5 in Chapter 4, section 4.2.1.2). However, based on these results alone, the Au-nanoprobe 
alone and in presence of a non-complementary target should also present a similar 
aggregation profile to those of Au-nanoprobe/complementary or mismatched targets, which 
was not observed. This suggests the influence of another factor ruling the Au-nanoprobe 
conjugates’ stability, such as steric hindrance. 
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Figure 5.10 – Ferguson analysis of Au-nanoprobe/target conjugates. Electrophoretic mobility of 
Au-nanoprobe/target conjugates as function of agarose gel concentration. Au-nanoprobe alone – 
“Blank”; in presence of a complementary target – “Comp”; in presence of a target harboring a 
mismatch G•G at 3’-end – “Mis (G•G)”; in presence of a target harboring a mismatch G•A at 3’-end – 
“Mis (G•A)”; in presence of a target harboring a mismatch G•T at 3’-end – “Mis (G•T)”; in presence of a 
non-complementary target – “Non-comp”. Linear fitting equations are presented with respective 
correlation coefficient. 
 
5.2.3.2 Hydrodynamic radius of Au-nanoprobe/target conjugates 
Steric hindrance can be related to different effective hydrodynamic radius of Au-
nanoprobe/target conjugates, and this radius can be determined through the analysis of the 
slopes given by the mobility vs. gel concentration plots (Figure 5.10).[149] The Au-nanoprobe 
alone or in presence of a non-complementary target present slopes ca. 15% smaller than 
those for Au-nanoprobe hybridized to mismatched or complementary targets. The increase of 
the slope in these cases indicates an increase of the effective hydrodynamic diameter of the 
Au-nanoprobes (Table 5.4). 
 
Table 5.4 – Effective hydrodynamic diameter of Au-nanoprobe/target conjugates 
Effective hydrodynamic diameter (nm)* 
Blank Comp Mis(G•G) Mis(G•A) Mis(G•T) Non-Comp 
20.27 23.49 23.06 22.55 22.53 20.23 
* determined by Ferguson analysis as described by Park and Hamad-Schifferli
[149]
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This increase in diameter can only be due to the presence of hybridized targets, as 
previously confirmed by fluorescence techniques, most probably in an extended double helix 
conformation with dangling unpaired bases at the 3’-end of the Au-nanoprobe.[164] These data 
are further corroborated by the colorimetric results obtained with MgCl2 induced aggregation, 
where the red-shift of SPR band for Au-nanoprobe/complementary or mismatched target 
conjugates was smaller to that of Au-nanoprobe alone or in presence of a non-
complementary target (see Figure 4.5 in Chapter 4, section 4.2.1.2). Since it is commonly 
accepted that the SPR band shift depends on the inter-particle distance between AuNPs,[178] 
these results indicate that steric hindrance of larger conjugates plays a crucial role in the 
colorimetric differentiation for the non-cross-linking method. The measurement of the 
hydrodynamic radius of the same conjugates using DLS could probably provide further 
evidence of such steric hindrance in solution and for different ionic strength conditions, and, 
therefore, should be considered for further studies. 
 
5.3 The non-cross-linking method: proposed mechanism model 
The work presented in this chapter has contributed to a better understanding of phenomena 
involved in Au-nanoprobe/target interactions, and helped determine the optimal conditions for 
single base mismatch discrimination at room temperature via the non-cross-linking method. 
In addition, the data generated by the different approaches allows to propose a model for the 
mechanism involved in the non-cross-linking differential colorimetric discrimination between 
complementary, mismatched and non-complementary targets. The colorimetric changes of 
the Au-nanoprobe solutions are a consequence of the AuNPs’ SPR coupling due to Au-
nanoprobe aggregation (i.e. dependent of inter-particle distance and aggregate size).[161,178] 
Previous reports have proposed that Au-nanoprobe stability with increasing ionic strength of 
the medium was due to an increase in the electrostatic repulsion between Au-nanoprobes 
associated with the negatively charged backbone of the hybridized nucleic acid 
targets.[91,103,156] However, based on the results presented in this chapter, it can be 
hypothesized that, in addition to that electrostatic effect, steric hindrance also plays an 
important role in the protective effect of hybridized targets against salt induced aggregation. 
This steric hindrance would then be responsible for keeping the inter-particle distance 
despite dipole coupling upon salt addition. Results obtained through Ferguson plot analysis 
indicate that the hybridization of the complementary/mismatched targets with the Au-
nanoprobe leads to an increase in the hydrodynamic radius of the Au-nanoprobes, while no 
changes to the surface charge of the Au-nanoprobes were detected. This indicates that a 
strong influence of steric hindrance rather than electrostatic repulsion is responsible for the 
Au-nanoprobe/target differential stability in the non-cross-linking method. Moreover, this 
steric hindrance can be considered to be relatively independent of the number of hybridized 
targets to the Au-nanoprobe, which may hamper the colorimetric discrimination of a single 
107 
base mismatch by the non-cross-linking method, considering that mismatched targets also 
hybridize to the Au-nanoprobe (as observed for the 40 nt oligonucleotide targets). 
Regardless of this, colorimetrical discrimination of single base mismatches through the non-
cross-linking method was still possible for longer/more complex DNA targets (see Figure 4.7 
in Chapter 4, section 4.2.1.2).[156] In this case, target length and/or the relative position of the 
Au-nanoprobe complementary sequence within the target may lead to a decreased 
hybridization efficiency, as shown by fluorescent assays (see Section 5.2.2.6). When dsDNA 
is used as target, the hybridization kinetics involving competition of Au-nanoprobe and 
dsDNA renaturation may also lead to a decrease in hybridization efficiency (see Figure 4.7 in 
Chapter 4, section 4.2.1.2). In these situations, the hybridization efficiency may decrease 
down to a point when just a few complementary targets hybridize with the Au-nanoprobe, 
and no hybridization occurs for the mismatched target. This hypothesis is further supported 
by AFM results, where hybridization of a single complementary target per Au-nanoprobe was 
predominantly observed (see Section 5.2.1). In the case of substantially longer targets 
(e.g. >8000 bp), the formation of complex structures involving several Au-nanoprobes and 
targets is very likely to occur, which may further stabilize the Au-nanoprobes/target 
complexes and avoid aggregation, through steric hindrance. All these hypotheses could be 
further corroborated by evaluating the hybridization efficiency, surface charge and 
hydrodynamic radius of longer and more complex DNA/Au-nanoprobe conjugates showing 
differential colorimetric results. Nonetheless, the error associated with these methods may 
hinder the evaluation of single target per Au-nanoprobe conjugates. The use of AFM to 
assess hybridization between Au-nanoprobes and longer/more complex mismatched targets 
may also provide confirmation of the “single target vs. no target hybridization” hypothesis, 
and, therefore, should be considered in future work. It should be noted that, although the 
eventual observation of Au-nanoprobe/mismatched DNA target conjugates compromises the 
proposed hypothesis for single base mismatch discrimination, its absence will never confirm 
it. 
The specificity of the Au-nanoprobe for single base mismatches seems to increase when the 
complementary fraction of the mismatched target is located in a region where stronger 
electrostatic interactions are most likely to occur (i.e. near the 5’-end of the Au-nanoprobe) 
and the mismatch is located further away from that zone (i.e. at the 3’-end of the Au-
nanoprobe). These differential electrostatic regions along the Au-nanoprobe oligonucleotide 
sequence are only possible due to the curvature of the spherical NPs surface. The 
electrostatic interactions should be mostly due to near-neighbor oligonucleotides of the Au-
nanoprobe and become much more pronounced with increasing Au-nanoprobe density (see 
Section 5.2.2.4), and should hamper hybridization of the complementary bases located near 
the 5’-end of the Au-nanoprobe. This effect in combination with the destabilization of the 
mismatch at the other end, should greatly affect the overall binding strength of the target. In 
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fully complementary targets, only the electrostatic destabilization near the 5’-end is present, 
and the overall binding strength of the target should be higher. Nevertheless, it should be 
noticed that electrostatic forces are not the only forces present in Au-nanoprobes/target 
conjugates and that other attractive/repulsive forces (e.g. hydrogen bond, steric hindrance, 
etc.) may intervene in target hybridization and single base mismatch discrimination. 
Based on all these data and hypotheses, a mechanism is proposed for the colorimetric 
discrimination of a single base mismatch by the non-cross-linking method – see figure 5.11. 
 
 
Figure 5.11 – Non-cross-linking method: proposed mechanism. The solutions containing the Au-
nanoprobe alone (“Blank”) or in presence of: a complementary target (“Comp”); a target harboring a 
single base mismatch at the 3’-end of the Au-nanoprobe sequence (“Mis”); or a non-complementary 
target (“Non-comp”) are heated, to denaturize dsDNA/secondary structures, and then cooled to room 
temperature, to allow hybridization between the Au-nanoprobes and targets (ΔT/Hyb). Only 
complementary and mismatched targets have complementary bases to the Au-nanoprobe sequence 
that allows them to significantly bind to the Au-nanoprobe. Nonetheless, the greater electrostatic 
repulsions generated by near-neighbor oligonucleotides at the 5’-end of the Au-nanoprobe sequence 
decrease the hybridization efficiency and, hence, the binding strength of Au-nanoprobe/target 
conjugates. Ultimately, this could lead to the hybridization of a single target per Au-nanoprobe. In the 
case of mismatched targets, the single base mismatch at the 3’-end of the Au-nanoprobe sequence 
further decreases the binding strength of Au-nanoprobe/target conjugates, which could lead to no 
target hybridizing with the Au-nanoprobes. Upon salt addition, the increased ionic strength attenuates 
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the electrostatic repulsion between Au-nanoprobes’ conjugates. Upon aggregation of the Au-
nanoprobes, the solution changes color from red to blue (due to SPR coupling), unless steric 
hindrance is provided by bounded/hybridized targets. In the later case, Au-nanoprobes remain 
dispersed and the solution retains its initial red color. 
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6 CHAPTER 6. Commercial application for Point-of-Care (STAB VIDA) 
 
The easy-of-use and low cost of the non-cross-linking method should allow its application at 
point-of-care. In this chapter, the technical issues for application at point-of-care are explored, 
together with the development of integrated optoelectronic/microfluidic technologies for 
automated sample handling and detection of colorimetric results. 
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6.1 STAB VIDA’s global market and strategy 
The main objective of this thesis was to develop a simple and cost-effective new portable 
method for nucleic acid detection at POC. This would meet the current demand for near-
patient nucleic acid testing and STAB VIDA’s commercial interests in POC molecular 
diagnosis. STAB VIDA (www.stabvida.com) is a Portuguese biotech company, pioneer in 
introducing genomics and related kits as well as products and services for the academic and 
clinical community. Thus far, STAB VIDA’s portfolio includes kits for the detection of 
Legionella and Dekkera/Brettanomyces, based on PCR or a differential growing medium, 
respectively. More recently, STAB VIDA started to expand its market to human genotyping 
by providing services for human disease diagnosis (e.g. celiac disease, lactose intolerance, 
etc.) and parental testing. These genotyping services are currently provided through DNA 
collection kits that can be used by patients at POC and later sent to STAB VIDA’s 
laboratories for further analysis. Genotyping is then performed by direct sequencing or Real-
time PCR by specialized and qualified personnel. By investing in the development of a new 
nucleic acid detection method based on Au-nanoprobes, STAB VIDA intends to provide 
simple, reliable, fast and inexpensive diagnostic tests for POC, allowing cost-cutting and 
entering a new diagnostic industry of healthcare systems. 
The non-cross-linking method developed in this thesis holds great potential and fits most of 
the desirable requirements for POC genetic testing, especially in areas of low economic 
resources. The simplicity of the method makes it user-friendly (only requiring mixing solutions 
and heat/cooling the samples) and the cost per assay is estimated at around €0.05/target, 
without the need for complex instrumentation to evaluate the final result. Nonetheless, the 
method, in its current format, still requires considerable optimization and scaling up before it 
can be applied at POC, but, in the meanwhile, can be used as a kit in standard molecular 
biology laboratories (including STAB VIDA’s laboratories), provided that validation and 
certification (e.g. CE mark) are successfully achieved. 
 
6.1.1 Medium-throughput assay kit 
The non-cross-linking method can be sold as a kit with intuitive labeled reagents (e.g. 
“Probe”, “Hybridization buffer”, “Developer” (salt), “Control POS” (complementary target) and 
“Control NEG” (non-complementary target)) and a simplified protocol booklet[179] to be used 
in standard molecular biology laboratories. The protocol includes mixing the sample DNA 
and Control solutions with Probe and Hybridization buffer solutions, heating/cooling the 
mixture and adding the Developer to reveal the colorimetric result, all within 45 minutes. 
Afterwards, the colorimetric result can be rapidly assessed using a UV/visible 
spectrophotometer or microplate reader. The latter would allow for up to 384 results to be 
registered within seconds, which is clearly suitable for the rapid analysis of multiple samples 
or targets – medium-throughput. 
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6.1.1.1 Storage stability 
Over the course of this thesis, most Au-nanoprobes proved to be stable and viable for at 
least 1 year when kept in a stock concentration of 15 nM at 4ºC or even at room temperature. 
Phosphate buffer and salt solutions are also very stable, provided that are kept sterile and in 
a dry environment. In the case of the salt solutions, a saturated solution should be used to 
avoid concentration variations that may affect the development of the colorimetric results 
along the time. Considering all this, the kit could be conveniently stored at room temperature, 
with exception for the control solutions that should be stored at 4ºC or -20ºC, with a 1 year 
validity (minimum). Nevertheless, a more thorough evaluation of the kit stability and viability 
should be performed, including for more extreme conditions (e.g. high/low temperatures, 
high/low humidity, etc.). The stability and viability of the Au-nanoprobe and reagents at these 
conditions is relevant mainly to third-world countries’ laboratories, which usually lack the 
controlled conditions of a more advanced research/clinical laboratory. 
 
6.1.2 Point-of-care (POC) testing 
Point-of-care testing is a rapidly growing segment of the healthcare industry, with an estimate 
market value of around 5 Mrd. US$ (~3.5 Mrd. Euros) and a growth rate of 10.5% per 
year.[180] POC assays bring the resources of clinical laboratory closer to both patient and 
doctor. The main benefits of POC testing lies in the immediate result assessment where it is 
most needed (i.e. at patient’s side), allowing for a decreased turnaround time and more 
efficient therapy management. Common sites for POC testing are patient’s daily routine 
environments (e.g. home, work place, etc.) and clinical environments (e.g. hospital’s bedside, 
physician’s office, etc.). POC systems may also constitute an alternative for third-world 
countries, which lack the health care infrastructures available in more developed 
countries.[181] 
POC assays are usually accomplished through the use of portable handheld instruments (e.g. 
blood glucose meter) and test kits (e.g. pregnancy test). The majority of the currently 
available POC assays rely on targeting proteins (e.g. antibodies and/or antigens) or 
hormones, or enzymatic assays that yield a direct result or via a redox/acid-base reaction. 
Genetic testing at point-of-care (nucleic acid POC assays) is a very attractive market, as it 
can be used for the molecular identification of pathogens sequences with increased 
specificity, test for mutations/polymorphisms associated with genetic disorders, or used in 
personalized therapeutics (i.e. pharmacogenetics and pharmacogenomics). A list of current 
POC systems for nucleic acid analysis, approved for in vitro diagnosis in clinical environment, 
can be found in Table 6.1. 
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Table 6.1 – Currently commercialized POC systems for nucleic acid detection 
System 
Integrated 
sample 
preparation 
Integrated 
PCR 
Sample 
maximum 
capacity 
Assay 
time 
Platform Format 
GeneXpert 
(Cepheid) 
Yes Yes 
16 samples 
(6 targets/each) 
60 min 
Real-time 
PCR 
Benchtop 
Liat™ Analyzer 
(IQuum Inc.) 
Yes Yes 
1 sample 
(4 targets) 
60 min 
Real-time 
PCR 
Handheld 
eSensor® 
(Osmetech) 
No No 
48 samples 
(36 targets/each) 
4h* Microarray Benchtop 
Verigene system 
(Nanosphere Inc.) 
No Not required 4 samples 90 min Microarray Benchtop 
NanoChip® NC400 
(Nanogen) 
No No 
2 samples 
(400 targets/each) 
4h Microarray Benchtop 
GeneChip® 
System 3000Dx 
(Affymetrix) 
No No 
48 samples 
(510,000 
targets/each) 
n.s. Microarray Benchtop 
R.A.P.I.D.® 
System 
(Idaho Technology 
Inc.) 
No Yes 
32 samples 
(3 targets/each) 
30 min* 
Real-time 
PCR 
Suitcase 
Prove-it™ 
Lab-on-a-chip 
(Mobidiag) 
No Yes 5 samples 3h Microarray Benchtop 
* does not include sample preparation and/or PCR amplification time. n.s. – not specified 
 
Among these POC systems, only two (GeneXpert and Lyat™ Analyzer) include sample 
preparation - DNA extraction and PCR amplification, mainly through the use of microfluidics: 
which are the only fully autonomous POC genetic assays allowing a “sample in-answer out” 
response. These POC systems still rely on either fluorescent based real-time PCR or 
microarray platforms (electrical or fluorescent based), which are expensive technologies and 
not truly portable. 
The non-cross-linking method allows for a cost-effective diagnosis, but in its current format 
still relies on purified DNA samples and PCR amplification, which hampers its true 
application at POC. Also, the colorimetric changes may sometimes be difficult to assess by 
the naked eye and should be quantitatively measured through the use of spectrophotometric 
platforms to prevent user-error and ensure a correct result interpretation. Hence, to transform 
the developed non-cross-linking sequence detection method in a “sample in-answer out” 
POC assay, these issues still need to be tackled. 
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6.1.2.1 Portability and colorimetric reading 
The issue of portability and colorimetric reading, has been addressed via a light sensitive 
amorphous/nanocrystalline silicon pi’ii’’n photovoltaic sensor to develop a simple and 
inexpensive system that allows to quantitatively assess the colorimetric results.[182] The 
different layers of this photovoltaic sensor and their thicknesses allows to tailor its spectral 
response band to an optimal response peak that fits the non-aggregated Au-nanoprobes 
SPR absorption band. Moreover, the substrate of the sensor is glass, which allows a direct 
application of the Au-nanoprobes sample on the back side of the sensor ensuring maximum 
photon capture. When a green laser light (530 nm) passes through the Au-nanoprobes 
sample and focuses on the photovoltaic sensor, an electrical signal will be generated 
accordingly to the Au-nanoprobe SPR band absorption. When the Au-nanoprobes are 
dispersed, the SPR band peak is located at 526 nm and most of the light from the laser is 
absorbed. Consequently, less light will reach the photovoltaic sensor and a decrease in the 
electrical signal is observed. Conversely, when the Au-nanoprobes aggregate, the SPR band 
peak shifts to longer wavelengths and the light from the laser is less absorbed, being able to 
reach the sensor with higher intensity and generate a higher electric signal (see Figure 6.1). 
 
 
Figure 6.1 – Scheme of optoelectronic detector for Au-nanoprobe colorimetric changes
[183]
 
 
Through this approach, it was possible to quantitatively assess the level of Au-nanoprobe 
aggregation, which has been here shown to be relevant for target quantification and SNP 
detection. Moreover, it was also possible to use ten times less sample volumes than what is 
used in colorimetric tests assessed by the naked eye. 
Nevertheless, the application of the non-cross-linking method to POC is still dependent of 
miniaturization of the developed biosensor prototype, and requires sample preparation and 
PCR amplification. These issues may be solved via microfluidics for DNA extraction and 
PCR amplification with the photovoltaic sensor being inserted in the microchip platform.[184-186] 
A cost-effective portable handheld device integrating the microfluidic controls, the heating 
system for PCR and/or sample denaturation/hybridization and the photovoltaic sensor could 
be developed along with disposable microfluidic chips to mix samples and reagents, allowing 
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to conduct the assay in a “sample in-answer out” configuration. This way, no specialized 
experience would be required by the end-user, cross-contamination between samples is 
avoided (i.e. the chips that handle the samples are disposable), multiple targets could be 
assessed simultaneously (i.e. multiple Au-nanoprobes for multiple targets within amplicon 
can be analyzed by multiple photodetectors) and the overall costs per assay could be 
reduced (i.e. less reagents are needed and the most expensive low-cost components are 
within the portable device). Optimization and miniaturization of the photodetector is currently 
being pursued.[183,187,188] 
 
6.2 Conclusions 
In summary, the non-cross-linking method should be suitable to be commercialized as a kit, 
provided that validation and certification (e.g. CE mark) are successfully achieved. The kit 
can be used for medium-throughput nucleic acid target detection by specialized personnel at 
any standard molecular biology research/clinical laboratory, as an alternative to more 
expensive methodologies currently used (e.g. Real-Time PCR, RFLP, low-density DNA 
microarrays, etc.). In the future, integration of the non-cross-linking method in a microfluidic 
disposable low-cost chip could allow its application at POC by un-specialized personnel. 
These chips could then be processed by a portable device with a low-cost detection system, 
such as the light sensitive amorphous/nanocrystalline silicon pi’ii’’n photovoltaic sensor 
presented in this chapter. This will allow a faster result assessment where it is most needed 
(i.e. at patient’s side), allowing for a decreased turnaround time and more efficient therapy 
management. 
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7 CHAPTER 7. General Discussions and Future Perspectives 
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In the post-genomic era, the demand for improved molecular diagnostic methods for use at 
the point-of-care allowing for the rapid, sensitive and accurate identification of pathogens and 
biothreat agents, early detection of cancer and genetic diseases, or for genotyping patients in 
personalized medicine, has steadily increased.[180] Currently available methods for the 
detection of specific nucleic acid sequences are still cumbersome and expensive, requiring 
specialized personnel and equipment. Nanobiotechnology approaches promise to offer 
solutions with higher sensitivity and selectivity at low costs, by exploring the peculiar physico-
chemical properties of nanoscaled materials. Within these nanoscaled materials, AuNPs are 
one of the most promising and explored nanomaterials for molecular diagnostic 
applications.[62,100] Due to its simplicity, rapidness and low cost, the non-cross-linking Au-
nanoprobe nucleic acid detection method presented here, holds great potential for POC 
diagnostic. The method has already been successfully applied to eukaryotic gene expression 
studies without retro-transcription or PCR amplification,[91] in a fast assay for Mycobacterium 
tuberculosis DNA detection in clinical samples,[103,104] and for SNP/mutation detection.[156] 
 
Throughout the work presented in this thesis, several data were obtained regarding the noble 
metal nanoprobes’ properties and their application for nucleic acid detection. From all the 
attained data, some constitute clear landmarks for the understanding of the non-cross-linking 
based detection and for the development of a commercial kit: 
 
- The functionalization method of AuNPs based on ultrasounds allows for a faster synthesis 
of Au-nanoprobes with increased reproducibility between batches, when compared to the 
classic “salt-aging” method. This increased reproducibility grants a greater control over 
nanoprobe salt-induced aggregation which can be relevant to multiplexing using Au- and 
AuAg-nanoprobes, since it is convenient that both nanoprobes present similar stability (see 
Chapter 3); 
 
- Monovalent salts and MgCl2 quickly induce aggregation of nanoprobes, but MgCl2 presents 
greater benefits for the non-cross-linking method, such as lower salt volumes needed and 
greater contrast in colorimetric changes. The presence of other reagents in solution (e.g. 
DMSO, formamide, etc.) can also further de-/stabilize the nanoprobes and, therefore, should 
be taken into account when performing the non-cross-linking method. Ultimately, the DLVO 
theory and the Schulze-Hardy rule can be used to predict the CCC value of salts to achieve 
nanoprobe aggregation (see Chapter 3); 
 
- The non-cross-linking method allows to colorimetrically detect SNPs/mutations in most 
nucleic acids at room temperature, i.e. without the need for a controlled temperature, which 
is one of the main advantages over other molecular diagnostic methods. The detection can 
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be easily and quickly evaluated by naked eye or registered using standard 
spectrophotometric devices, with a sensitivity of ~70 nM target DNA (see Chapter 4); 
 
- Both Au- and AuAg-nanoprobes can be used in the non-cross-linking method, and the 
simultaneous use of these nanoprobes may allow the detection of multiple targets in a single 
reaction, i.e. multiplexing (see Chapter 4); 
 
- Maximum hybridization efficiency and SNP discrimination is achieved at pH8 with Au-
nanoprobes holding a density of 24 pmol/cm2 thiol-modified oligonucleotides, and when the 
mismatch is localized at the 3’-end of Au-nanoprobe (see Chapter 5); 
 
- Electrostatic repulsion and steric hindrance proved to have an active role in Au-nanoprobe 
aggregation and, consequently, in the colorimetric changes observed for the non-cross-
linking method. Between these two repulsive forces, steric hindrance proved to be the most 
relevant in nucleic acid and SNP/mutation detection (Chapter 5). 
 
 
Through the extensive study of conditions and parameters influencing the non-cross-linking 
Au-nanoprobe nucleic acid detection method performance, several issues have been raised, 
paving the way for improvement and optimization towards use in clinical diagnostic. One of 
the problems that could be easily solved is the hybridization efficiency of Au-nanoprobes to 
dsDNA samples that affects the sensitivity and reproducibility of the method, especially for 
targets with a high GC-content. In some situations, this issue can be overcome by re-
designing the Au-nanoprobe sequence to bind with a more accessible sequence. However, 
in the case of SNP/mutations this approach is not viable, and little can be done in the design 
of the Au-nanoprobe sequence other than varying its length (see Chapter 5, section 5.2.2.5). 
For 20 nt Au-nanoprobes, the density of thiol-oligonucleotide functionalized at the AuNPs 
surface has been shown to influence hybridization efficiency and mismatch discrimination, 
and, therefore, the hybridization efficiency of the 40 nt Au-nanoprobes should also be 
evaluated for different Au-nanoprobes density. The use of spacer d(T) sequences between 
the thiol- moiety and the probe sequences have also been reported to significantly improve 
the hybridization efficiency of Au-nanoprobes[81] and, therefore, should also be considered in 
future optimizations of the non-cross-linking method. Nonetheless, based on the results 
shown in Chapter 5, the use of longer sequences or spacers to decrease the steric 
congestion around the Au-nanoprobe’s recognition sequence, may compromise the non-
cross-linking method’s capability of discriminating a mismatch at room temperature. 
Moreover, the longer oligonucleotides at the NP’s surface may increase the stability of such 
Au-nanoprobes that no longer aggregate with the addition of an electrolyte in solution, 
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hampering their use in the non-cross-linking method. Therefore, a balance must be sought 
between sequence/spacer length, mismatch discrimination and Au-nanoprobe stability. Also, 
the use of ultrasounds to fragment long/complex targets into shorter and more accessible 
fragments[189] may improve hybridization efficiency with the Au-nanoprobes, and should be 
considered in future works. 
Another approach that can increase the hybridization efficiency and mismatch discrimination 
without changing the Au-nanoprobe sequence length or using spacer sequences, is to use 
thiol-modified LNA (locked nucleic acids) or PNA (protein nucleic acids) sequences to 
functionalize the AuNPs. These DNA analogs molecules have been shown to possess a 
higher affinity and specificity to complementary DNA/RNA sequences than ssDNA 
oligonucleotides.[190,191] Functionalization of AuNPs with PNA has been described by 
Chakrabarti and co-workers, where a cysteine residue was added to either the N- or C-
terminus of PNAs to provide the thiol necessary for immobilization to AuNPs.[192] These PNA-
AuNPs conjugates were successfully used to colorimetrically detect a mismatch in ssDNA 
oligonucleotides targets by following the same non-cross-linking approach described in this 
thesis. Nonetheless, the application of such approach to the detection of real biological 
dsDNA samples has not been addressed and remains unexplored. Functionalization of 
AuNPs with alkanethiol-modified LNA/DNA chimeras, and their use in the detection of nucleic 
acid sequences following the cross-linking method, has been recently reported by McKenzie 
and co-workers.[193,194] These LNA-AuNPs conjugates have demonstrated to have greater 
sequence specificity and better binding affinity to ssDNA, or even to specifically bind to 
dsDNA when targeting a polypurine duplex region. Therefore, the use of such LNA-AuNPs 
conjugates in the non-cross-linking method could avoid the need for DNA denaturation and 
the problems related to rich GC-sequences. It should be pointed out that the main 
disadvantage of using LNA and PNA is their current high synthesis costs, which can 
considerably raise the costs of the proposed method. 
As it frequently happens with other approaches, the direct detection of SNP/mutations in 
genomic DNA with Au-nanoprobes may not be possible due to highly homologous 
sequences present in pseudogenes, where problems with false-positive polymorphism 
genotyping in genes with high homology to other gene family members or pseudogenes have 
been reported,[195] including with the CYP2D6 and associated pseudogenes.[196] In such 
cases, the non-cross-linking method needs to be associated to a method that allows to 
specifically amplifying the sequence of interest (i.e. the target locus) in detriment of 
homologous sequences (e.g. pseudogene), since the Au-nanoprobe sequence may not be 
able to be designed in a non-homologous region. The use of conventional and asymmetric 
PCR has so far allowed flanking and specifically amplifying that sequence of interest 
overcoming this problem. Additionally, asymmetric PCR also improves target hybridization to 
the Au-nanoprobes. 
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Another option would be to use isothermal amplification techniques near room temperature 
that could circumvent the need for a thermocycler (a heated bath or a helicase could be used 
for DNA denaturation). A good candidate would be the helicase-dependent amplification 
(HDA), which is a simple method that allows the amplification of a primer-flanked region at 
room temperature without the need for template denaturation, and that can achieve a million-
fold amplification under 1h.[197] This method could be further adapted to yield ssDNA targets 
for direct hybridization with Au-nanoprobes, by using different primer concentrations as in the 
case of asymmetric PCR. Nevertheless, HDA relies on the presence of two DNA binding 
proteins, namely SSB proteins and helicase accessory proteins, which may interfere with the 
non-cross-linking method by non-specific adsorption to the Au-nanoprobes (i.e. they may not 
aggregate at all with the adsorption of such proteins). Therefore, a stability test of the Au-
nanoprobes against increasing concentrations of salt should be performed in the presence of 
such proteins to assess the viability of this method. Even so, if these proteins actually 
interfere with the non-cross-linking method, simple sample purification could be included. 
For most applications, however, it is safe to admit that further improvements of Au-
nanoprobe hybridization efficiency will allow to increase sensitivity and to directly detect 
SNP/mutations in genomic DNA. This would discard the need for PCR amplification, reduce 
false positives/negatives due to the possibility of mutation insertion by Taq polymerase,[198] 
while making the non-cross-linking a better candidate for point-of-care diagnostic. 
The current sensitivity of the non-cross-linking method could be further enhanced by using 
bigger (e.g. 40~50 nm) AuNPs or alloy AuAgNPs, which have higher absorption coefficients 
and much stronger scattering properties.[66,78] By using such NPs it would be possible to 
explore the more sensitive properties of light scattering, which also change with AuNPs 
aggregation.[199] In the case of alloy AuAgNPs, it has been here demonstrated that they can 
be used for the detection of specific nucleic acids sequences following the non-cross-linking 
method. Preliminary results for the multiplexing approach have shown that the combination 
of Au-nanoprobes with AuAg-nanoprobes hold great potential for multiplexing, and, ultimately, 
for homo/heterozygous characterization in a single reaction. Still, one of the biggest 
challenges for this multiplexing approach is to gather two nanoprobes with similar stability 
against salt-induced aggregation. Nonetheless, as previously described, the functionalization 
of the AuNPs and AuAgNPs following the ultrasound approach has allowed to better control 
and reproduce the resulting nanoprobes, and this is reflected in a more constant and 
reproducible stability. 
The application of non-cross-linking method to other type of mutations, such as deletions, 
insertions, gene duplications, chromosomal translocations or inversions, should also be 
addressed in future studies. In principle, the single nucleotide resolution of the Au-
nanoprobes should allow to detect these other mutations, except, maybe, for gene 
duplications. In this latter case, the multiplex non-cross-linking method could be used to 
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relatively quantify the target gene by using a second nanoprobe as an internal control. The 
overall ratio between aggregated/dispersed Au-nanoprobes has been shown to linearly 
depend on increasing complementary target concentration (see Figure 4.4 – B in Chapter 4, 
section 4.2.1.2). Therefore, the presence of gene duplications could be inferred by the non-
cross-linking method through the quantification of serial dilutions of the sample. 
Finally, the non-cross-linking method as it is, when compared to other currently developed 
methods, presents both advantages and disadvantages. The main advantage is its overall 
cost, which is estimated to be ~€0.05 per test. Even though it looks promising when 
compared to other platforms, its use is more suitable for few targets in routine diagnostics 
and not as a high-throughput method for the analysis of a larger numbers of biomarkers. 
Considering this issue, the non-cross-linking method would be better suited for the 
assessment of few loci at point-of-care (medium throughput). In a laboratory setting, this 
method should be effective for the molecular diagnosis of pathogenic diseases, where the 
capability of the method to detect SNP/mutations can be used for multi-drug resistance 
characterization (e.g. multi-drug resistant tuberculosis[200]). Indeed, the inexpensive 
experimental set-up, the short developing time without the need of signal amplification or 
temperature control and the fact that color change can be assessed visually are of great 
advantage for the application of the non-cross-linking in the field, and application to other 
clinical relevant situations have already been shown.[104] 
In summary, this thesis has successfully achieved its objectives by providing a new low-cost 
and fast colorimetric method to detect SNP/mutations in biological samples. The method and 
its application as a kit has already been protected by a pending national and international 
patent.[179] Therefore, the method can now be further validated and certified for commercial 
application as a kit and further integrated into new nano/microfluidics autonomous platforms 
for POC application. Based on all the information gathered within this thesis, the application 
of the method to other targets should now be easily achieved. 
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APPENDICES 
Appendix I – AuNPs based methods for nucleic acids detection 
Category 
Detection 
technique 
Detection 
limit 
Target(s) 
Application to 
biological samples 
Refs 
Catalyser Chemiluminescence 0.1nM ssDNA n/a [201] 
Colorimetric 
Naked-eye (Dry-
reagent dipstick) 
2fmol; 
0.16nM 
dsDNA, 
cDNA, 
SNP 
Prostate specific 
antigen; hepatitis C 
virus; GMO (35S 
promoter and nopaline 
synthase (NOS) 
terminator); mannose-
binding lectin gene 
(MBL2) 
[98,105-
107,202] 
Colorimetric 
Naked-eye 
(Electrostatic 
interactions with 
unmodified AuNPs) 
<100fmol 
- 10nM 
ssDNA, 
dsDNA, 
SNP 
SNPs associated with 
a fatal arrhythmia 
known as 
long QT syndrome 
(KCNE1 gene) 
[97,203, 
204] 
Colorimetric 
Naked-eye or CCD 
camera (sandwich 
hybridization) 
0.4fmol miRNA 
miRNA from leaf and 
root of rice 
(OryzasativaL.ssp.indi
ca) seedlings 
[205] 
Colorimetric 
Naked-eye or optical 
monitoring system 
(cross-linking 
aggregation) 
50pM - 
10nM; 
33fM 
(using 
scattered 
light) 
ssDNA, 
dsDNA, 
SNP 
methicillin-resistant 
Staphylococcus 
aureus mecA gene 
[101,199, 
206-210] 
Colorimetric 
UV-vis spectroscopy 
(aggregation induced 
by 
polymerase/nicking 
machine) 
1pM ssDNA M13 phage [211] 
Colorimetric 
Naked-eye or UV-vis 
spectroscopy (non-
cross-linking 
aggregation) 
1nM – 
100nM 
ssDNA, 
dsDNA, 
RNA, 
SNP 
K-ras oncogene; 
cytochrome p450 
CYP2D6*4 haplotype; 
beta-thalassemia 
mutations; M. 
tuberculosis; FSY1 
gene expression (S. 
bayanus) 
[91,102, 
103,156, 
212] 
148 
Category 
(cont.) 
Detection 
technique 
Detection 
limit 
Target(s) 
Application to 
biological samples 
Refs 
Spectroscopy 
Light scattering 
imaging (sandwich 
hybridization) 
50fM – 
20fM 
ssDNA, 
dsDNA, 
RNA, 
SNP 
High-, medium-, low- 
and non-expressed 
genes in human brain 
tissue; methicillin-
resistant 
Staphylococcus 
aureus mecA gene; 
Coagulation genes 
associated with 
thrombotic (factor V, 
factor II and MTHFR) 
[99,108, 
213,214] 
Electrochemical 
Electrochemical 
impedance 
spectroscopy 
0.24nM 
ssDNA, 
SNP 
n/a [215] 
Electrochemical 
Electrogenerated 
chemiluminescence 
5pM ssDNA n/a [216] 
Electrochemical 
Microchip gel 
electrophoresis with 
microelectrode 
detector 
5.7amol dsDNA n/a [217] 
Electrochemical 
Conducting atomic 
force microscopy 
(AFM) 
- ssDNA n/a [218] 
Electrochemical 
Differential pulse 
voltammetry 
0.78fmol 
ssDNA, 
dsDNA, 
SNP 
Factor V Leiden 
mutation (MTHFR 
gene) 
[219] 
Electrochemical 
Potentiometric 
stripping analysis 
32pM - 
1.5nM 
ssDNA, 
SNP 
n/a [220,221] 
Electrochemical 
Conductivity across 
two electrodes 
10pM ssDNA n/a [222] 
Electrochemical 
Cyclic voltammetry 
and 
chronocoulometry 
10fM ssDNA n/a [223] 
Electrochemical 
Magnetically induced 
direct 
electrochemical 
detection 
660nM 
ssDNA, 
SNP 
n/a [224] 
Microscopy 
Atomic force 
microscopy 
2.5pM ssDNA n/a [225] 
149 
Category 
(cont.) 
Detection 
technique 
Detection 
limit 
Target(s) 
Application to 
biological samples 
Refs 
Spectroscopy 
Hyper-Rayleigh 
scattering 
(Electrostatic 
interactions with 
unmodified AuNPs) 
10nM ssDNA n/a [83] 
Spectroscopy 
Surface-enhanced 
Raman scattering 
20fM 
DNA, 
RNA, 
SNP 
n/a [109] 
Spectroscopy 
Microarray SPR 
imaging (sandwich 
hybridization) 
1.38 fM –
10pM 
ssDNA, 
dsDNA, 
cDNA, 
SNP 
familiar breast and 
ovarian cancer 
(BRCA1 gene); p53 
gene expression 
[226-228] 
Spectroscopy 
Surface plasmon 
resonance (SPR) 
imaging (non-cross-
linking aggregation) 
32nM ssDNA n/a [229] 
Spectroscopy 
Fluorescence 
spectroscopy 
(quenching by 
AuNPs) 
2nM ssDNA n/a [230] 
Spectroscopy 
Infrared 
thermography 
10pM – 
100pM 
ssDNA n/a [231] 
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Appendix II – AuNPs characterization 
 
 
Figure A.1 – Gold nanoparticles. (A) TEM image and (B) size histogram corresponding to the 
measurements of 52 NPs. AuNPs size (nm): 13.5±1.3 (Average±STD) 
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Appendix III – AuAgNPs characterization 
 
 
Figure A.2 – Gold-silver alloy nanoparticles. (A) TEM image and (B) size histogram corresponding 
to the measurements of 54 NPs with an average Au:Ag ratio of 0.49:0.51, as determined by ICP – 
element concentration: Ag= 0.0046 g/L and Au= 0.0082 g/L. AuAgNPs size (nm): 45.8±11.2 
(Average±STD). 
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Appendix IV – Reference Materials (maps and sequences) 
HBB material 
Plasmid p158 
 
 
     1 GTTAACCTCC TATTTGACAC CACTGATTAC CCCATTGATA GTCACACTTT 
    51 GGGTTGTAAG TGACTTTTTA TTTATTTGTA TTTTTGACTG CATTAAGAGG 
   101 TCTCTAGTTT TTTATCTCTT GTTTCCCAAA ACCTAATAAG TAACTAATGC 
   151 ACAGAGCACA TTGATTTGTA TTTATTCTAT TTTTAGACAT AATTTATTAG 
   201 CATGCATGAG CAAATTAAGA AAAACAACAA CAAATGAATG CATATATATG 
   251 TATATGTATG TGTGTATATA TACACACATA TATATATATA TTTTTTCTTT 
   301 TCTTACCAGA AGGTTTTAAT CCAAATAAGG AGAAGATATG CTTAGAACCG 
   351 AGGTAGAGTT TTCATCCATT CTGTCCTGTA AGTATTTTGC ATATTCTGGA 
   401 GACGCAGGAA GAGATCCATC TACATATCCC AAAGCTGAAT TATGGTAGAC 
   451 AAAACTCTTC CACTTTTAGT GCATCAACTT CTTATTTGTG TAATAAGAAA 
   501 ATTGGGAAAA CGATCTTCAA TATGCTTACC AAGCTGTGAT TCCAAATATT 
   551 ACGTAAATAC ACTTGCAAAG GAGGATGTTT TTAGTAGCAA TTTGTACTGA 
   601 TGGTATGGGG CCAAGAGATA TATCTTAGAG GGAGGGCTGA GGGTTTGAAG 
   651 TCCAACTCCT AAGCCAGTGC CAGAAGAGCC AAGGACAGGT ACGGCTGTCA 
   701 TCACTTAGAC CTCACCCTGT GGAGCCACAC CCTAGGGTTG GCCAATCTAC 
   751 TCCCAGGAGC AGGGAGGGCA GGAGCCAGGG CTGGGCATAA AAGTCAGGGC 
   801 AGAGCCATCT ATTGCTTACA TTTGCTTCTG ACACAACTGT GTTCACTAGC 
   851 AACCTCAAAC AGACACCATG GTGCATCTGA CTCCTGAGGA GAAGTCTGCC 
   901 GTTACTGCCC TGTGGGGCAA GGTGAACGTG GATGAAGTTG GTGGTGAGGC 
   951 CCTGGGCAGG TTGGTATCAA GGTTACAAGA CAGGTTTAAG GAGACCAATA 
156 
  1001 GAAACTGGGC ATGTGGAGAC AGAGAAGACT CTTGGGTTTC TGATAGGCAC 
  1051 TGACTCTCTC TGCCTATTGG TCTATTTTCC CACCCTTAGG CTGCTGGTGG 
  1101 TCTACCCTTG GACCCAGAGG TTCTTTGAGT CCTTTGGGGA TCTGTCCACT 
  1151 CCTGATGCTG TTATGGGCAA CCCTAAGGTG AAGGCTCATG GCAAGAAAGT 
  1201 GCTCGGTGCC TTTAGTGATG GCCTGGCTCA CCTGGACAAC CTCAAGGGCA 
  1251 CCTTTGCCAC ACTGAGTGAG CTGCACTGTG ACAAGCTGCA CGTGGATCCT 
  1301 GAGAACTTCA GGGTGAGTCT ATGGGACGCT TGATGTTTTC TTTCCCCTTC 
  1351 TTTTCTATGG TTAAGTTCAT GTCATAGGAA GGGGATAAGT AACAGGGTAC 
  1401 AGTTTAGAAT GGGAAACAGA CGAATGATTG CATCAGTGTG GAAGTCTCAG 
  1451 GATCGTTTTA GTTTCTTTTA TTTGCTGTTC ATAACAATTG TTTTCTTTTG 
  1501 TTTAATTCTT GCTTTCTTTT TTTTTCTTCT CCGCAATTTT TACTATTATA 
  1551 CTTAATGCCT TAACATTGTG TATAACAAAA GGAAATATCT CTGAGATACA 
  1601 TTAAGTAACT TAAAAAAAAA CTTTACACAG TCTGCCTAGT ACATTACTAT 
  1651 TTGGAATATA TGTGTGCTTA TTTGCATATT CATAATCTCC CTACTTTATT 
  1701 TTCTTTTATT TTTAATTGAT ACATAATCAT TATACATATT TATGGGTTAA 
  1751 AGTGTAATGT TTTAATATGT GTACACATAT TGACCAAATC AGGGTAATTT 
  1801 TGCATTTGTA ATTTTAAAAA ATGCTTTCTT CTTTTAATAT ACTTTTTTGT 
  1851 TTATCTTATT TCTAATACTT TCCCTAATCT CTTTCTTTCA GGGCAATAAT 
  1901 GATACAATGT ATCATGCCTC TTTGCACCAT TCTAAAGAAT AACAGTGATA 
  1951 ATTTCTGGGT TAAGGCAATA GCAATATCTC TGCATATAAA TATTTCTGCA 
  2001 TATAAATTGT AACTGATGTA AGAGGTTTCA TATTGCTAAT AGCAGCTACA 
  2051 ATCCAGCTAC CATTCTGCTT TTATTTTATG GTTGGGATAA GGCTGGATTA 
  2101 TTCTGAGTCC AAGCTAGGCC CTTTTGCTAA TCATGTTCAT ACCTCTTATC 
  2151 TTCCTCCCAC AGCTCCTGGG CAACGTGCTG GTCTGTGTGC TGGCCCATCA 
  2201 CTTTGGCAAA GAATTCACCC CACCAGTGCA GGCTGCCTAT CAGAAAGTGG 
  2251 TGGCTGGTGT GGCTAATGCC CTGGCCCACA AGTATCACTA AGCTCGCTTT 
  2301 CTTGCTGTCC AATTTCTATT AAAGGTTCCT TTGTTCCCTA AGTCCAACTA 
  2351 CTAAACTGGG GGATATTATG AAGGGCCTTG AGCATCTGGA TTCTGCCTAA 
  2401 TAAAAAACAT TTATTTTCAT TGCAATGATG TATTTAAATT ATTTCTGAAT 
  2451 ATTTTACTAA AAAGGGAATG TGGGAGGTCA GTGCATTTAA AACATAAAGA 
  2501 AATGAAGAGC TAGTTCAAAC CTTGGGAAAA TACACTATAT CTTAAACTCC 
  2551 ATGAAAGAAG GTGAGGCTGC AAACAGCTAA TGCACATTGG CAACAGCCCC 
  2601 TGATGCATAT GCCTTATTCA TCCCTCAGAA AAGGATTCAA GTAGAGGCTT 
  2651 GATTTGGAGG TTAAAGTTTT GCTATGCTGT ATTTTACATT ACTTATTGTT 
  2701 TTAGCTGTCC TCATGAATGT CTTTTCACTA CCCATTTGCT TATCCTGCAT 
  2751 CTCTCAGCCT TGACTCCACT CAGTTCTCTT GCTTAGAGAT ACCACCTTTC 
  2801 CCCTGAAGTG TTCCTTCCAT GTTTTACGGC GAGATGGTTT CTCCTCGCCT 
  2851 GGCCACTCAG CCTTAGTTGT CTCTGTTGTC TTATAGAGGT CTACTTGAAG 
  2901 AAGGAAAAAC AGGGGTCATG GTTTGACTGT CCTGTGAGCC CTTCTTCCCT 
  2951 GCCTCCCCCA CTCACAGTGA CCCGGAATCT GCAGTGCTAG TCTCCCGGAA 
  3001 CTATCACTCT TTCACAGTCT GCTTTGGAAG GACTGGGCTT AGTATGAAAA 
  3051 GTTAGGACTG AGAAGAATTT GAAAGGCGGC TTTTTGTAGC TTGATATTCA 
  3101 CTACTGTCTT ATTACCCTGT CATAGGCCCA CCCCAAATGG AAGTCCCATT 
  3151 CTTCCTCAGG ATGTTTAAGA TTAGCATTCA GGAAGAGATC AGAGGTCTGC 
157 
  3201 TGGCTCCCTT ATCATGTCCC TTATGGTGCT TCTGGCTCTG CAGTTATTAG 
  3251 CATAGTGTTA CCATCAACCA CCTTAACTTC ATTTTTCTTA TTCAATACCT 
  3301 AGGTAGGTAG ATGCTAGATT CTGGAAATAA AATATGAGTC TCAAGTGGTC 
  3351 CTTGTCCTCT CTCCCAGTCA AATTCTGAAT CTAGTTGGCA AGATTCTGAA 
  3401 ATCAAGGCAT ATAATCAGTA ATAAGTGATG ATAGAAGGGT ATATAGAAGA 
  3451 ATTTTATTAT ATGAGAGGGT GAAACCCTCA AAATGAAATG AAATCAGACC 
  3501 CTTGTCTTAC ACCATAAACA AAAATAAATT TGAATGGGTT AAAGAATTAA 
  3551 ACTAAGACCT AAAACCATAA AAATTTTTAA AGAAATCAAA AGAAGAAAAT 
  3601 TCTAATATTC ACGTTGCAGC CGTTTTTGAA TTTGATATGA GAAGCAAAGG 
  3651 CAACAAAAGG AAAAATAAAG AAGTGAGGCT ACATCAAACT AAAAAATTTC 
  3701 CACACAAAAA AGAAAACAAT GAACAAATGA AAGGTGAACC ATGAAATGGC 
  3751 ATATTTGCAA ACCAAATATT TCTTAAATAT TTTGGTTAAT ATCCAAAATA 
  3801 TATAAGAAAC ACAGATGATT CAATAACAAA CAAAAAATTA AAAATAGGAA 
  3851 AATAAAAAAA TTAAAAAGAA GAAAATCCTG CCATTTATGC GAGAATTGAT 
  3901 GAACCTGGAG GATGTAAAAC TAAGAAAAAT AAGCCTGACA CAAAAAGACA 
  3951 AATACTACAC AACCTTGCTC ATATGTGAAA CATAAAAAAG TCACTCTCAT 
  4001 GGAAACAGAC AGTAGAGGTA TGGTTTCCAG GGGTTGGGGG TGGGAGAATC 
  4051 AGGAAACTAT TACTCAAAGG GTATAAAATT TCAGTTATGT GGGATGAATA 
  4101 AATTCTAGAG TCGACCTGCA GGCATGCAAG CTTGGCGTAA TCATGGTCAT 
  4151 AGCTGTTTCC TGTGTGAAAT TGTTATCCGC TCACAATTCC ACACAACATA 
  4201 CGAGCCGGAA GCATAAAGTG TAAAGCCTGG GGTGCCTAAT GAGTGAGCTA 
  4251 ACTCACATTA ATTGCGTTGC GCTCACTGCC CGCTTTCCAG TCGGGAAACC 
  4301 TGTCGTGCCA GCTGCATTAA TGAATCGGCC AACGCGCGGG GAGAGGCGGT 
  4351 TTGCGTATTG GGCGCTCTTC CGCTTCCTCG CTCACTGACT CGCTGCGCTC 
  4401 GGTCGTTCGG CTGCGGCGAG CGGTATCAGC TCACTCAAAG GCGGTAATAC 
  4451 GGTTATCCAC AGAATCAGGG GATAACGCAG GAAAGAACAT GTGAGCAAAA 
  4501 GGCCAGCAAA AGGCCAGGAA CCGTAAAAAG GCCGCGTTGC TGGCGTTTTT 
  4551 CCATAGGCTC CGCCCCCCTG ACGAGCATCA CAAAAATCGA CGCTCAAGTC 
  4601 AGAGGTGGCG AAACCCGACA GGACTATAAA GATACCAGGC GTTTCCCCCT 
  4651 GGAAGCTCCC TCGTGCGCTC TCCTGTTCCG ACCCTGCCGC TTACCGGATA 
  4701 CCTGTCCGCC TTTCTCCCTT CGGGAAGCGT GGCGCTTTCT CATAGCTCAC 
  4751 GCTGTAGGTA TCTCAGTTCG GTGTAGGTCG TTCGCTCCAA GCTGGGCTGT 
  4801 GTGCACGAAC CCCCCGTTCA GCCCGACCGC TGCGCCTTAT CCGGTAACTA 
  4851 TCGTCTTGAG TCCAACCCGG TAAGACACGA CTTATCGCCA CTGGCAGCAG 
  4901 CCACTGGTAA CAGGATTAGC AGAGCGAGGT ATGTAGGCGG TGCTACAGAG 
  4951 TTCTTGAAGT GGTGGCCTAA CTACGGCTAC ACTAGAAGGA CAGTATTTGG 
  5001 TATCTGCGCT CTGCTGAAGC CAGTTACCTT CGGAAAAAGA GTTGGTAGCT 
  5051 CTTGATCCGG CAAACAAACC ACCGCTGGTA GCGGTGGTTT TTTTGTTTGC 
  5101 AAGCAGCAGA TTACGCGCAG AAAAAAAGGA TCTCAAGAAG ATCCTTTGAT 
  5151 CTTTTCTACG GGGTCTGACG CTCAGTGGAA CGAAAACTCA CGTTAAGGGA 
  5201 TTTTGGTCAT GAGATTATCA AAAAGGATCT TCACCTAGAT CCTTTTAAAT 
  5251 TAAAAATGAA GTTTTAAATC AATCTAAAGT ATATATGAGT AAACTTGGTC 
  5301 TGACAGTTAC CAATGCTTAA TCAGTGAGGC ACCTATCTCA GCGATCTGTC 
  5351 TATTTCGTTC ATCCATAGTT GCCTGACTCC CCGTCGTGTA GATAACTACG 
158 
  5401 ATACGGGAGG GCTTACCATC TGGCCCCAGT GCTGCAATGA TACCGCGAGA 
  5451 CCCACGCTCA CCGGCTCCAG ATTTATCAGC AATAAACCAG CCAGCCGGAA 
  5501 GGGCCGAGCG CAGAAGTGGT CCTGCAACTT TATCCGCCTC CATCCAGTCT 
  5551 ATTAATTGTT GCCGGGAAGC TAGAGTAAGT AGTTCGCCAG TTAATAGTTT 
  5601 GCGCAACGTT GTTGCCATTG CTACAGGCAT CGTGGTGTCA CGCTCGTCGT 
  5651 TTGGTATGGC TTCATTCAGC TCCGGTTCCC AACGATCAAG GCGAGTTACA 
  5701 TGATCCCCCA TGTTGTGCAA AAAAGCGGTT AGCTCCTTCG GTCCTCCGAT 
  5751 CGTTGTCAGA AGTAAGTTGG CCGCAGTGTT ATCACTCATG GTTATGGCAG 
  5801 CACTGCATAA TTCTCTTACT GTCATGCCAT CCGTAAGATG CTTTTCTGTG 
  5851 ACTGGTGAGT ACTCAACCAA GTCATTCTGA GAATAGTGTA TGCGGCGACC 
  5901 GAGTTGCTCT TGCCCGGCGT CAATACGGGA TAATACCGCG CCACATAGCA 
  5951 GAACTTTAAA AGTGCTCATC ATTGGAAAAC GTTCTTCGGG GCGAAAACTC 
  6001 TCAAGGATCT TACCGCTGTT GAGATCCAGT TCGATGTAAC CCACTCGTGC 
  6051 ACCCAACTGA TCTTCAGCAT CTTTTACTTT CACCAGCGTT TCTGGGTGAG 
  6101 CAAAAACAGG AAGGCAAAAT GCCGCAAAAA AGGGAATAAG GGCGACACGG 
  6151 AAATGTTGAA TACTCATACT CTTCCTTTTT CAATATTATT GAAGCATTTA 
  6201 TCAGGGTTAT TGTCTCATGA GCGGATACAT ATTTGAATGT ATTTAGAAAA 
  6251 ATAAACAAAT AGGGGTTCCG CGCACATTTC CCCGAAAAGT GCCACCTGAC 
  6301 GTCTAAGAAA CCATTATTAT CATGACATTA ACCTATAAAA ATAGGCGTAT 
  6351 CACGAGGCCC TTTCGTCTCG CGCGTTTCGG TGATGACGGT GAAAACCTCT 
  6401 GACACATGCA GCTCCCGGAG ACGGTCACAG CTTGTCTGTA AGCGGATGCC 
  6451 GGGAGCAGAC AAGCCCGTCA GGGCGCGTCA GCGGGTGTTG GCGGGTGTCG 
  6501 GGGCTGGCTT AACTATGCGG CATCAGAGCA GATTGTACTG AGAGTGCACC 
  6551 ATATGCGGTG TGAAATACCG CACAGATGCG TAAGGAGAAA ATACCGCATC 
  6601 AGGCGCCATT CGCCATTCAG GCTGCGCAAC TGTTGGGAAG GGCGATCGGT 
  6651 GCGGGCCTCT TCGCTATTAC GCCAGCTGGC GAAAGGGGGA TGTGCTGCAA 
  6701 GGCGATTAAG TTGGGTAACG CCAGGGTTTT CCCAGTCACG ACGTTGTAAA 
  6751 ACGACGGCCA GTGAATTCGA GCTCGGTACG GTACCAGTGG GGCCTCTAAG 
  6801 ACTAAGTCAC TCTGTCTCAC TGTGTCTTAG CCAGTTCCTT ACAGCTTGCC 
  6851 CTGATGGGAG ATAGAGAATG GGTATCCTCC AACAAAAAAA TAAATTTTCA 
  6901 TTTCTCAAGG TCCAACTTAT GTTTTCTTAA TTTTTAAAAA AATCTTGACC 
  6951 ATTCTCCACT CTCTAAAATA ATCCACAGTG AGAGAAACAT TCTTTTCCCC 
  7001 CATCCCATAA ATACCTCTAT TAAATATGGA AAATCTGGGC ATGGTGTCTC 
  7051 ACACCTGTAA TCCCAGCACT TTGGGAGGCT GAGGTGGGTG GACTGCTTGG 
  7101 AGCTCAGGAG TTCAAGACCA TCTTGGACAA CATGGTGATA CCCTGCCTCT 
  7151 ACAAAAAGTA CAAAAATTAG CCTGGCATGG TGGTGTGCAC CTGTAATCCC 
  7201 AGCTATTAGG GTGGCTGAGG CAGGAGAATT GCTTGAACCC GGGAGGCGGA 
  7251 GGTTGCAGTG AGCTGAGATC GTGCCACTGC ACTCCAGCCT GGGGGACAGA 
  7301 GCACATTATA ATTAACTGTT ATTTTTTACT TGGACTCTTG TGGGGAATAA 
  7351 GATACATGTT TTATTCTTAT TTATGATTCA AGCACTGAAA ATAGTGTTTA 
  7401 GCATCCAGCA GGTGCTTCAA AACCATTTGC TGAATGATTA CTATACTTTT 
  7451 TACAAGCTCA GCTCCCTCTA TCCCTTCCAG CATCCTCATC TCTGATTAAA 
  7501 TAAGCTTCAG TTTTTCCTTA GTTCCTGTTA CATTTCTGTG TGTCTCCATT 
  7551 AGTGACCTCC CATAGTCCAA GCATGAGCAG TTCTGGCCAG GCCCCTGTCG 
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  7601 GGGTCAGTGC CCCACCCCCG CCTTCTGGTT CTGTGTAACC TTCTAAGCAA 
  7651 ACCTTCTGGC TCAAGCACAG CAATGCTGAG TCATGATGAG TCATGCTGAG 
  7701 GCTTAGGGTG TGTGCCCAGA TGTTCTCAGC CTAGAGTGAT GACTCCTATC 
  7751 TGGGTCCCCA GCAGGATGCT TACAGGGCAG ATGGCAAAAA AAAGGAGAAG 
  7801 CTGACCACCT GACTAAAACT CCACCTCAAA CGGCATCATA AAGAAAATGG 
  7851 ATGCCTGAGA CAGAATGTGA CATATTCTAG AATATATTAT TTCCTGAATA 
  7901 TATATATATA TATACACATA TACGTATATA TATATATATA TATATATTTG 
  7951 TTGTTATCAA TTGCCATAGA ATGATTAGTT ATTGTGAATC AAATATTTAT 
  8001 CTTGCAGGTG GCCTCTATAC CTAGAAGCGG CAGAATCAGG CTTTATTAAT 
  8051 ACATGTGTAT AGATTTTTAG GATCTATACA CATGTATTAA TATGAAACAA 
  8101 GGATATGGAA GAGGAAGGCA TGAAAACAGG AAAAGAAAAC AAACCTTGTT 
  8151 TGCCATTTTA AGGCACCCCT GGACAGCTAG GTGGCAAAAG GCCTGTGCTG 
  8201 TTAGAGGACA CATGCTCACA TACGGGGTCA GATCTGACTT GGGGTGCTAC 
  8251 TGGGAAGCTC TCATCTTAAG GATACATCTC AGGCCAGTCT TGGTGCATTA 
  8301 GGAAGATGTA GGCAACTCTG ATCCTGAGAG GAAAGAAACA TTCCTCCAGG 
  8351 AGAGCTAAAA GGGTTCACCT GTGTGGGTAA CTGTGAAGGA CTACAAGAGG 
  8401 ATGAAAAACA ATGACAGACA GACATAATGC TTGTGGGAGA AAAAACAGGA 
  8451 GGTCAAGGGG ATAGAGAAGG CTTCCAGAAG AATGGCTTTG AAGCTGGCTT 
  8501 CTGTAGGAGT TCACAGTGGC AAAGATGTTT CAGAAATGTG ACATGACTTA 
  8551 AGGAACTATA CAAAAAGGAA CAAATTTAAG GAGAGGCAGA TAAATTAGTT 
  8601 CAACAGACAT GCAAGGAATT TTCAGATGAA TGTTATGTCT CCACTGAGCT 
  8651 TCTTGAGGTT AGCAGCTG 
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DOR1 material 
DOR1 amplicons 
 
 
Figure A.3 – Electrophoresis analysis of DOR1 amplicons (A) digested by DdeI restriction 
enzyme or (B) produced by asymmetric PCR. Conditions: (A) 1.5% agarose, 80V for 1 h in 1x TBE; 
(B) 2% agarose, 80V for 1h30min in 1x TBE. Lanes: “1”- DOR1G amplicon; “2”- digested DOR1G 
amplicon; “3”- digested DOR1C amplicon; “4”- DOR1C amplicon; “L”- GeneRuler™ DNA Ladder Mix; 
“5”- DOR1C amplified by conventional PCR; “6”- DOR1C amplified by asymmetric PCR. 
 
Plasmid pDOR1G 
 
     1 GGGCGAATTG GGCCCGACGT CGCATGCTCC CGGCCGCCAT GGCGGCCGCG 
    51 GGAATTCGAT TCGCCGGCGG AGACAGACAA AGGCCCGGGC GCGGGGGGCG 
   101 CAGGGCGTGT CCGTGGCAGG GGAGCCCCCA GGCCCACCCG GGTCGGGACT 
   151 CACCTGGGGG CGGGAGGGGG GCGGCACGGC GTTGAGGTAG TTGTGCGGCG 
   201 GGGCGTCCCA GGGTCGCCGG CCGCTCACAG GCCGGGCCGC ATCGCCGGGA 
161 
   251 CTCGCGGGGG AGGCGGCGGG GCCGCGGTCG CTCCGGGCTG CTGAGCTCGC 
   301 CCGCGGGGCT TTGAGTCTGT GCGGCCGCTG CGGCGGGGCT CACGGCACAA 
   351 ATTGGAACGT TCAAACAGCT GATTGTGACG TCACAAAGGG GCCCGCCCGC 
   401 CTCGCGTCAC CGGCTGGCGG GGCGGCGGCC AATCCCGGGC TGCGGATCCC 
   451 CCCCTGCCCC TCCCCTCCCC TCCCCTCCCG GTTTGCGGGC CGGGCGCTCG 
   501 GGCCGGGAAA CGTTCTCGGA ACCGGGAGGG TGAGTGTTCG GGGAGGCAGC 
   551 TGCGGGGAGC TGGGAGCCCT GCGCCGCGGC GAGCTCTCCG CGAGGAGGAT 
   601 CTCCACTCCC TCCTACCGGC TCCTAATCAC TAGTGAATTC GCGGCCGCCT 
   651 GCAGGTCGAC CATATGGGAG AGCTCCCAAC GCGTTGGATG CATAGCTTGA 
   701 GTATTCTATA GTGTCACCTA AATAGCTTGG CGTAATCATG GTCATAGCTG 
   751 TTTCCTGTGT GAAATTGTTA TCCGCTCACA ATTCCACACA ACATACGAGC 
   801 CGGAAGCATA AAGTGTAAAG CCTGGGGTGC CTAATGAGTG AGCTAACTCA 
   851 CATTAATTGC GTTGCGCTCA CTGCCCGCTT TCCAGTCGGG AAACCTGTCG 
   901 TGCCAGCTGC ATTAATGAAT CGGCCAACGC GCGGGGAGAG GCGGTTTGCG 
   951 TATTGGGCGC TCTTCCGCTT CCTCGCTCAC TGACTCGCTG CGCTCGGTCG 
  1001 TTCGGCTGCG GCGAGCGGTA TCAGCTCACT CAAAGGCGGT AATACGGTTA 
  1051 TCCACAGAAT CAGGGGATAA CGCAGGAAAG AACATGTGAG CAAAAGGCCA 
  1101 GCAAAAGGCC AGGAACCGTA AAAAGGCCGC GTTGCTGGCG TTTTTCCATA 
  1151 GGCTCCGCCC CCCTGACGAG CATCACAAAA ATCGACGCTC AAGTCAGAGG 
  1201 TGGCGAAACC CGACAGGACT ATAAAGATAC CAGGCGTTTC CCCCTGGAAG 
  1251 CTCCCTCGTG CGCTCTCCTG TTCCGACCCT GCCGCTTACC GGATACCTGT 
  1301 CCGCCTTTCT CCCTTCGGGA AGCGTGGCGC TTTCTCATAG CTCACGCTGT 
  1351 AGGTATCTCA GTTCGGTGTA GGTCGTTCGC TCCAAGCTGG GCTGTGTGCA 
  1401 CGAACCCCCC GTTCAGCCCG ACCGCTGCGC CTTATCCGGT AACTATCGTC 
  1451 TTGAGTCCAA CCCGGTAAGA CACGACTTAT CGCCACTGGC AGCAGCCACT 
  1501 GGTAACAGGA TTAGCAGAGC GAGGTATGTA GGCGGTGCTA CAGAGTTCTT 
  1551 GAAGTGGTGG CCTAACTACG GCTACACTAG AAGAACAGTA TTTGGTATCT 
  1601 GCGCTCTGCT GAAGCCAGTT ACCTTCGGAA AAAGAGTTGG TAGCTCTTGA 
  1651 TCCGGCAAAC AAACCACCGC TGGTAGCGGT GGTTTTTTTG TTTGCAAGCA 
  1701 GCAGATTACG CGCAGAAAAA AAGGATCTCA AGAAGATCCT TTGATCTTTT 
  1751 CTACGGGGTC TGACGCTCAG TGGAACGAAA ACTCACGTTA AGGGATTTTG 
  1801 GTCATGAGAT TATCAAAAAG GATCTTCACC TAGATCCTTT TAAATTAAAA 
  1851 ATGAAGTTTT AAATCAATCT AAAGTATATA TGAGTAAACT TGGTCTGACA 
  1901 GTTACCAATG CTTAATCAGT GAGGCACCTA TCTCAGCGAT CTGTCTATTT 
  1951 CGTTCATCCA TAGTTGCCTG ACTCCCCGTC GTGTAGATAA CTACGATACG 
  2001 GGAGGGCTTA CCATCTGGCC CCAGTGCTGC AATGATACCG CGAGACCCAC 
  2051 GCTCACCGGC TCCAGATTTA TCAGCAATAA ACCAGCCAGC CGGAAGGGCC 
  2101 GAGCGCAGAA GTGGTCCTGC AACTTTATCC GCCTCCATCC AGTCTATTAA 
  2151 TTGTTGCCGG GAAGCTAGAG TAAGTAGTTC GCCAGTTAAT AGTTTGCGCA 
  2201 ACGTTGTTGC CATTGCTACA GGCATCGTGG TGTCACGCTC GTCGTTTGGT 
  2251 ATGGCTTCAT TCAGCTCCGG TTCCCAACGA TCAAGGCGAG TTACATGATC 
  2301 CCCCATGTTG TGCAAAAAAG CGGTTAGCTC CTTCGGTCCT CCGATCGTTG 
  2351 TCAGAAGTAA GTTGGCCGCA GTGTTATCAC TCATGGTTAT GGCAGCACTG 
  2401 CATAATTCTC TTACTGTCAT GCCATCCGTA AGATGCTTTT CTGTGACTGG 
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  2451 TGAGTACTCA ACCAAGTCAT TCTGAGAATA GTGTATGCGG CGACCGAGTT 
  2501 GCTCTTGCCC GGCGTCAATA CGGGATAATA CCGCGCCACA TAGCAGAACT 
  2551 TTAAAAGTGC TCATCATTGG AAAACGTTCT TCGGGGCGAA AACTCTCAAG 
  2601 GATCTTACCG CTGTTGAGAT CCAGTTCGAT GTAACCCACT CGTGCACCCA 
  2651 ACTGATCTTC AGCATCTTTT ACTTTCACCA GCGTTTCTGG GTGAGCAAAA 
  2701 ACAGGAAGGC AAAATGCCGC AAAAAAGGGA ATAAGGGCGA CACGGAAATG 
  2751 TTGAATACTC ATACTCTTCC TTTTTCAATA TTATTGAAGC ATTTATCAGG 
  2801 GTTATTGTCT CATGAGCGGA TACATATTTG AATGTATTTA GAAAAATAAA 
  2851 CAAATAGGGG TTCCGCGCAC ATTTCCCCGA AAAGTGCCAC CTGATGCGGT 
  2901 GTGAAATACC GCACAGATGC GTAAGGAGAA AATACCGCAT CAGGAAATTG 
  2951 TAAGCGTTAA TATTTTGTTA AAATTCGCGT TAAATTTTTG TTAAATCAGC 
  3001 TCATTTTTTA ACCAATAGGC CGAAATCGGC AAAATCCCTT ATAAATCAAA 
  3051 AGAATAGACC GAGATAGGGT TGAGTGTTGT TCCAGTTTGG AACAAGAGTC 
  3101 CACTATTAAA GAACGTGGAC TCCAACGTCA AAGGGCGAAA AACCGTCTAT 
  3151 CAGGGCGATG GCCCACTACG TGAACCATCA CCCTAATCAA GTTTTTTGGG 
  3201 GTCGAGGTGC CGTAAAGCAC TAAATCGGAA CCCTAAAGGG AGCCCCCGAT 
  3251 TTAGAGCTTG ACGGGGAAAG CCGGCGAACG TGGCGAGAAA GGAAGGGAAG 
  3301 AAAGCGAAAG GAGCGGGCGC TAGGGCGCTG GCAAGTGTAG CGGTCACGCT 
  3351 GCGCGTAACC ACCACACCCG CCGCGCTTAA TGCGCCGCTA CAGGGCGCGT 
  3401 CCATTCGCCA TTCAGGCTGC GCAACTGTTG GGAAGGGCGA TCGGTGCGGG 
  3451 CCTCTTCGCT ATTACGCCAG CTGGCGAAAG GGGGATGTGC TGCAAGGCGA 
  3501 TTAAGTTGGG TAACGCCAGG GTTTTCCCAG TCACGACGTT GTAAAACGAC 
  3551 GGCCAGTGAA TTGTAATACG ACTCACTATA 
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Plasmid pDOR1C 
 
     1 GGGCGAATTG GGCCCGACGT CGCATGCTCC CGGCCGCCAT GGCGGCCGCG 
    51 GGAATTCGAT TCGCCGGCGG AGACAGACAA AGGCCCGGGC GCGGGGGGCG 
   101 CAGGGCGTGT CCGTGGCAGG GGAGCCCCCA GGCCCACCCG GGTCGGGACT 
   151 CACCTGGGGG CGGGAGGGGG GCGGCACGGC GTTGAGGTAG TTGTGCGGCG 
   201 GGGCGTCCCA GGGTCGCCGG CCGCTCACAG GCCGGGCCGC ATCGCCGGGA 
   251 CTCGCGGGGG AGGCGGCGGG GCCGCGGTCG CTCCGGGCTG CTGAGCTCGC 
   301 CCGCGGGGCT TTGAGTCTGT GCGGCCGCTG CGGCGGGGCT CAGGGCACAA 
   351 ATTGGAACGT TCAAACAGCT GATTGTGACG TCACAAAGGG GCCCGCCCGC 
   401 CTCGCGTCAC CGGCTGGCGG GGCGGCGGCC AATCCCGGGC TGCGGATCCC 
   451 CCCCTGCCCC TCCCCTCCCC TCCCCTCCCG GTTTGCGGGC CGGGCGCTCG 
   501 GGCCGGGAAA CGTTCTCGGA ACCGGGAGGG TGAGTGTTCG GGGAGGCAGC 
   551 TGCGGGGAGC TGGGAGCCCT GCGCCGCGGC GAGCTCTCCG CGAGGAGGAT 
   601 CTCCACTCCC TCCTACCGGC TCCTAATCAC TAGTGAATTC GCGGCCGCCT 
   651 GCAGGTCGAC CATATGGGAG AGCTCCCAAC GCGTTGGATG CATAGCTTGA 
   701 GTATTCTATA GTGTCACCTA AATAGCTTGG CGTAATCATG GTCATAGCTG 
   751 TTTCCTGTGT GAAATTGTTA TCCGCTCACA ATTCCACACA ACATACGAGC 
   801 CGGAAGCATA AAGTGTAAAG CCTGGGGTGC CTAATGAGTG AGCTAACTCA 
   851 CATTAATTGC GTTGCGCTCA CTGCCCGCTT TCCAGTCGGG AAACCTGTCG 
   901 TGCCAGCTGC ATTAATGAAT CGGCCAACGC GCGGGGAGAG GCGGTTTGCG 
   951 TATTGGGCGC TCTTCCGCTT CCTCGCTCAC TGACTCGCTG CGCTCGGTCG 
  1001 TTCGGCTGCG GCGAGCGGTA TCAGCTCACT CAAAGGCGGT AATACGGTTA 
  1051 TCCACAGAAT CAGGGGATAA CGCAGGAAAG AACATGTGAG CAAAAGGCCA 
  1101 GCAAAAGGCC AGGAACCGTA AAAAGGCCGC GTTGCTGGCG TTTTTCCATA 
  1151 GGCTCCGCCC CCCTGACGAG CATCACAAAA ATCGACGCTC AAGTCAGAGG 
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  1201 TGGCGAAACC CGACAGGACT ATAAAGATAC CAGGCGTTTC CCCCTGGAAG 
  1251 CTCCCTCGTG CGCTCTCCTG TTCCGACCCT GCCGCTTACC GGATACCTGT 
  1301 CCGCCTTTCT CCCTTCGGGA AGCGTGGCGC TTTCTCATAG CTCACGCTGT 
  1351 AGGTATCTCA GTTCGGTGTA GGTCGTTCGC TCCAAGCTGG GCTGTGTGCA 
  1401 CGAACCCCCC GTTCAGCCCG ACCGCTGCGC CTTATCCGGT AACTATCGTC 
  1451 TTGAGTCCAA CCCGGTAAGA CACGACTTAT CGCCACTGGC AGCAGCCACT 
  1501 GGTAACAGGA TTAGCAGAGC GAGGTATGTA GGCGGTGCTA CAGAGTTCTT 
  1551 GAAGTGGTGG CCTAACTACG GCTACACTAG AAGAACAGTA TTTGGTATCT 
  1601 GCGCTCTGCT GAAGCCAGTT ACCTTCGGAA AAAGAGTTGG TAGCTCTTGA 
  1651 TCCGGCAAAC AAACCACCGC TGGTAGCGGT GGTTTTTTTG TTTGCAAGCA 
  1701 GCAGATTACG CGCAGAAAAA AAGGATCTCA AGAAGATCCT TTGATCTTTT 
  1751 CTACGGGGTC TGACGCTCAG TGGAACGAAA ACTCACGTTA AGGGATTTTG 
  1801 GTCATGAGAT TATCAAAAAG GATCTTCACC TAGATCCTTT TAAATTAAAA 
  1851 ATGAAGTTTT AAATCAATCT AAAGTATATA TGAGTAAACT TGGTCTGACA 
  1901 GTTACCAATG CTTAATCAGT GAGGCACCTA TCTCAGCGAT CTGTCTATTT 
  1951 CGTTCATCCA TAGTTGCCTG ACTCCCCGTC GTGTAGATAA CTACGATACG 
  2001 GGAGGGCTTA CCATCTGGCC CCAGTGCTGC AATGATACCG CGAGACCCAC 
  2051 GCTCACCGGC TCCAGATTTA TCAGCAATAA ACCAGCCAGC CGGAAGGGCC 
  2101 GAGCGCAGAA GTGGTCCTGC AACTTTATCC GCCTCCATCC AGTCTATTAA 
  2151 TTGTTGCCGG GAAGCTAGAG TAAGTAGTTC GCCAGTTAAT AGTTTGCGCA 
  2201 ACGTTGTTGC CATTGCTACA GGCATCGTGG TGTCACGCTC GTCGTTTGGT 
  2251 ATGGCTTCAT TCAGCTCCGG TTCCCAACGA TCAAGGCGAG TTACATGATC 
  2301 CCCCATGTTG TGCAAAAAAG CGGTTAGCTC CTTCGGTCCT CCGATCGTTG 
  2351 TCAGAAGTAA GTTGGCCGCA GTGTTATCAC TCATGGTTAT GGCAGCACTG 
  2401 CATAATTCTC TTACTGTCAT GCCATCCGTA AGATGCTTTT CTGTGACTGG 
  2451 TGAGTACTCA ACCAAGTCAT TCTGAGAATA GTGTATGCGG CGACCGAGTT 
  2501 GCTCTTGCCC GGCGTCAATA CGGGATAATA CCGCGCCACA TAGCAGAACT 
  2551 TTAAAAGTGC TCATCATTGG AAAACGTTCT TCGGGGCGAA AACTCTCAAG 
  2601 GATCTTACCG CTGTTGAGAT CCAGTTCGAT GTAACCCACT CGTGCACCCA 
  2651 ACTGATCTTC AGCATCTTTT ACTTTCACCA GCGTTTCTGG GTGAGCAAAA 
  2701 ACAGGAAGGC AAAATGCCGC AAAAAAGGGA ATAAGGGCGA CACGGAAATG 
  2751 TTGAATACTC ATACTCTTCC TTTTTCAATA TTATTGAAGC ATTTATCAGG 
  2801 GTTATTGTCT CATGAGCGGA TACATATTTG AATGTATTTA GAAAAATAAA 
  2851 CAAATAGGGG TTCCGCGCAC ATTTCCCCGA AAAGTGCCAC CTGATGCGGT 
  2901 GTGAAATACC GCACAGATGC GTAAGGAGAA AATACCGCAT CAGGAAATTG 
  2951 TAAGCGTTAA TATTTTGTTA AAATTCGCGT TAAATTTTTG TTAAATCAGC 
  3001 TCATTTTTTA ACCAATAGGC CGAAATCGGC AAAATCCCTT ATAAATCAAA 
  3051 AGAATAGACC GAGATAGGGT TGAGTGTTGT TCCAGTTTGG AACAAGAGTC 
  3101 CACTATTAAA GAACGTGGAC TCCAACGTCA AAGGGCGAAA AACCGTCTAT 
  3151 CAGGGCGATG GCCCACTACG TGAACCATCA CCCTAATCAA GTTTTTTGGG 
  3201 GTCGAGGTGC CGTAAAGCAC TAAATCGGAA CCCTAAAGGG AGCCCCCGAT 
  3251 TTAGAGCTTG ACGGGGAAAG CCGGCGAACG TGGCGAGAAA GGAAGGGAAG 
  3301 AAAGCGAAAG GAGCGGGCGC TAGGGCGCTG GCAAGTGTAG CGGTCACGCT 
  3351 GCGCGTAACC ACCACACCCG CCGCGCTTAA TGCGCCGCTA CAGGGCGCGT 
165 
  3401 CCATTCGCCA TTCAGGCTGC GCAACTGTTG GGAAGGGCGA TCGGTGCGGG 
  3451 CCTCTTCGCT ATTACGCCAG CTGGCGAAAG GGGGATGTGC TGCAAGGCGA 
  3501 TTAAGTTGGG TAACGCCAGG GTTTTCCCAG TCACGACGTT GTAAAACGAC 
  3551 GGCCAGTGAA TTGTAATACG ACTCACTATA 
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CYP2D6 material 
CYP2D6 amplicons 
 
 
Figure A.4 – Electrophoresis analysis of CYP2D6 amplicons (A) produced by Long PCR or (B) 
by PCR and digested with MvaI restriction enzyme. Conditions: (A) 1% agarose, 80V for 1 h in 1x 
TBE; (B) 2% agarose, 60V for 1h30 in 1x TBE. Lanes: “1”- CYP2D6*1/*1 Long PCR amplicon; “2”- 
CYP2D6*4/*4 Long PCR amplicon; “3”- CYP2D6*4 amplicon; “4”- CYP2D6*4 amplicon digested by 
MvaI; “5”- CYP2D6*1 amplicon digested by MvaI; “6”- CYP2D6*1 amplicon; “L”- GeneRuler™ DNA 
Ladder Mix. 
 
Plasmid pCYP2D6*1 
 
 
    1 GACGAAAGGG CCTCGTGATA CGCCTATTTT TATAGGTTAA TGTCATGATA 
   51 ATAATGGTTT CTTAGACGTC AGGTGGCACT TTTCGGGGAA ATGTGCGCGG 
  101 AACCCCTATT TGTTTATTTT TCTAAATACA TTCAAATATG TATCCGCTCA 
  151 TGAGACAATA ACCCTGATAA ATGCTTCAAT AATATTGAAA AAGGAAGAGT 
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  201 ATGAGTATTC AACATTTCCG TGTCGCCCTT ATTCCCTTTT TTGCGGCATT 
  251 TTGCCTTCCT GTTTTTGCTC ACCCAGAAAC GCTGGTGAAA GTAAAAGATG 
  301 CTGAAGATCA GTTGGGTGCA CGAGTGGGTT ACATCGAACT GGATCTCAAC 
  351 AGCGGTAAGA TCCTTGAGAG TTTTCGCCCC GAAGAACGTT TTCCAATGAT 
  401 GAGCACTTTT AAAGTTCTGC TATGTGGCGC GGTATTATCC CGTATTGACG 
  451 CCGGGCAAGA GCAACTCGGT CGCCGCATAC ACTATTCTCA GAATGACTTG 
  501 GTTGAGTACT CACCAGTCAC AGAAAAGCAT CTTACGGATG GCATGACAGT 
  551 AAGAGAATTA TGCAGTGCTG CCATAACCAT GAGTGATAAC ACTGCGGCCA 
  601 ACTTACTTCT GACAACGATC GGAGGACCGA AGGAGCTAAC CGCTTTTTTG 
  651 CACAACATGG GGGATCATGT AACTCGCCTT GATCGTTGGG AACCGGAGCT 
  701 GAATGAAGCC ATACCAAACG ACGAGCGTGA CACCACGATG CCTGTAGCAA 
  751 TGGCAACAAC GTTGCGCAAA CTATTAACTG GCGAACTACT TACTCTAGCT 
  801 TCCCGGCAAC AATTAATAGA CTGGATGGAG GCGGATAAAG TTGCAGGACC 
  851 ACTTCTGCGC TCGGCCCTTC CGGCTGGCTG GTTTATTGCT GATAAATCTG 
  901 GAGCCGGTGA GCGTGGGTCT CGCGGTATCA TTGCAGCACT GGGGCCAGAT 
  951 GGTAAGCCCT CCCGTATCGT AGTTATCTAC ACGACGGGGA GTCAGGCAAC 
 1001 TATGGATGAA CGAAATAGAC AGATCGCTGA GATAGGTGCC TCACTGATTA 
 1051 AGCATTGGTA ACTGTCAGAC CAAGTTTACT CATATATACT TTAGATTGAT 
 1101 TTAAAACTTC ATTTTTAATT TAAAAGGATC TAGGTGAAGA TCCTTTTTGA 
 1151 TAATCTCATG ACCAAAATCC CTTAACGTGA GTTTTCGTTC CACTGAGCGT 
 1201 CAGACCCCGT AGAAAAGATC AAAGGATCTT CTTGAGATCC TTTTTTTCTG 
 1251 CGCGTAATCT GCTGCTTGCA AACAAAAAAA CCACCGCTAC CAGCGGTGGT 
 1301 TTGTTTGCCG GATCAAGAGC TACCAACTCT TTTTCCGAAG GTAACTGGCT 
 1351 TCAGCAGAGC GCAGATACCA AATACTGTCC TTCTAGTGTA GCCGTAGTTA 
 1401 GGCCACCACT TCAAGAACTC TGTAGCACCG CCTACATACC TCGCTCTGCT 
 1451 AATCCTGTTA CCAGTGGCTG CTGCCAGTGG CGATAAGTCG TGTCTTACCG 
 1501 GGTTGGACTC AAGACGATAG TTACCGGATA AGGCGCAGCG GTCGGGCTGA 
 1551 ACGGGGGGTT CGTGCACACA GCCCAGCTTG GAGCGAACGA CCTACACCGA 
 1601 ACTGAGATAC CTACAGCGTG AGCTATGAGA AAGCGCCACG CTTCCCGAAG 
 1651 GGAGAAAGGC GGACAGGTAT CCGGTAAGCG GCAGGGTCGG AACAGGAGAG 
 1701 CGCACGAGGG AGCTTCCAGG GGGAAACGCC TGGTATCTTT ATAGTCCTGT 
 1751 CGGGTTTCGC CACCTCTGAC TTGAGCGTCG ATTTTTGTGA TGCTCGTCAG 
 1801 GGGGGCGGAG CCTATGGAAA AACGCCAGCA ACGCGGCCTT TTTACGGTTC 
 1851 CTGGCCTTTT GCTGGCCTTT TGCTCACATG TTCTTTCCTG CGTTATCCCC 
 1901 TGATTCTGTG GATAACCGTA TTACCGCCTT TGAGTGAGCT GATACCGCTC 
 1951 GCCGCAGCCG AACGACCGAG CGCAGCGAGT CAGTGAGCGA GGAAGCGGAA 
 2001 GAGCGCCCAA TACGCAAACC GCCTCTCCCC GCGCGTTGGC CGATTCATTA 
 2051 ATGCAGCTGG CACGACAGGT TTCCCGACTG GAAAGCGCTG CAGGGGCCCG 
 2101 GGATCCAATT GGCAGTGAGC GCAACGCAAT TAATGTGAGT TAGCTCACTC 
 2151 ATTAGGCACC CCAGGCTTTA CACTTTATGC TTCCGGCTCG TATAATGTGT 
 2201 GGAATTGTGA GCGGATAACA ATTTCACACA GGAGGTTTAA ACTTTAAACA 
 2251 TGTCAAAAGA GACGTCTTTT GTTAAGAATG CTGAGGAACT TGCAAAGCAA 
 2301 AAAATGGATG CTATTAACCC TGAACTTTCT TCAAAATTTA AATTTTTAAT 
 2351 AAAATTCCTG TCTCAGTTTC CTGAAGCTTG CTCTAAACCT CGTTCAAAAA 
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 2401 AAATGCAGAA TAAAGTTGGT CAAGAGGAAC ATATTGAATA TTTAGCTCGT 
 2451 AGTTTTCATG AGAGTCGATT GCCAAGAAAA CCCACGCCAC CTACAACGGT 
 2501 TCCTGATGAG GTGGTTAGCA TAGTTCTTAA TATAAGTTTT AATATACAGC 
 2551 CTGAAAATCT TGAGAGAATA AAAGAAGAAC ATCGATTTTC CATGGCAGCT 
 2601 GAGAATATTG TAGGAGATCT TCTAGAAAGA TTATCCCAGA AGGCTTTGCA 
 2651 GGCTTCAGGA GCTTGGAGTG GGGAGAGGGG GTGACTTCTC CGACCAGGCC 
 2701 CCTCCACCGG CCTACCCTGG GTAAGGGCCT GGAGCAGGAA GCAGGGGCAA 
 2751 GAACCTCTGG AGCAGCCCAT ACCCGCCCTG GCCTGACTCT GCCACTGGCA 
 2801 GCACAGTCAA CACAGCAGGT TCACTCACAG CAGAGGGCAA AGGCCATCAT 
 2851 CAGCTCCCTT TATAAGGGAA GGGTCACGCG CTCGGTGTGC TGAGAGTGTC 
 2901 CTGCCTGGTC CTCTGTGCCT GGTGGGGTGG GGGTGCCAGG TGTGTCCAGA 
 2951 GGAGCCCATT TGGTAGTGAG GCAGGTATGG GGCTAGCAGC ACTGGTGCCC 
 3001 CTGGCCGTGA TAGTGGCCAT CTTCCTGCTC CTGGTGGACC TGATGCACCG 
 3051 GCGCCAACGC TGGGCTGCAC GCTACCCACC AGGCCCCCTG CCACCGCCCG 
 3101 GGCTGGGCAA CCTGCTGCAT GTGGACTTCC AGAACACACC ATACTGCTTC 
 3151 GACCAGGTGA GGGAGGAGGT CCTGGAGGGC GGCAGAGGTG CTGAGGCTCC 
 3201 CCTACCAGAA GCAAACATGG ATGGTGGGTG AAACCACAGG CTGGACCAGA 
 3251 AGCCAGGCTG AGAAGGGGAA GCAGGTTTGG GGGACGTCCT GGAGAAGGGC 
 3301 ATTTATACAT GGCATGAAGG ACTGGATTTT CCAAAGGCCA AGGAAGAGTA 
 3351 GGGCAAGGGC CTGGAGGTGG AGCTGGACTT GGCAGTGGGC ATGCAAGCCC 
 3401 ATTGGGCAAC ATATGTTATG GAGTACAAAG TCCCTTCTGC TGACACCAGA 
 3451 AGGAAAGGCC TTGGGAATGG AAGATGAGTT AGTCCTGAGT GCCGTTTAAA 
 3501 TCACGAAATC GAGGATGAAG GGGGTGCAGT GACCCGGTTC AAACCTTTTG 
 3551 CACTGTGGGT CCTCGGGCCT CACTGCTCAC CGGCATGGAC CATCATCTGG 
 3601 GAATGGGATG CTAACTGGGG CCTCTCGGCA ATTTTGGTGA CTCTTGCAAG 
 3651 GTCATACCTG GGTGACGCAT CCAAACTGAG TTCCTCCATC ACAGAAGGTG 
 3701 TGACCCCCAC CCCCGCCCCA CGATCAGGAG GCTGGGTCTC CTCCTTCCAC 
 3751 CTGCTCACTC CTGGTAGCCC CGGGGGTCGT CCAAGGTTCA AATAGGACTA 
 3801 GGACCAGTAG TCTGGGGTGA TCCTGGCTTG ACAAGAGGCC CTGACCCTCC 
 3851 CTCTGCAGTT GCGGCGCCGC TTCGGGGACG TGTTCAGCCT GCAGCTGGCC 
 3901 TGGACGCCGG TGGTCGTGCT CAATGGGCTG GCGGCCGTGC GCGAGGCGCT 
 3951 GGTGACCCAC GGCGAGGACA CCGCCGACCG CCCGCCTGTG CCCATCACCC 
 4001 AGATCCTGGG TTTCGGGCCG CGTTCCCAAG GCAAGCAGCG GTGGGGACAG 
 4051 AGACAGATTT CCGTGGGACC CGGGTGGGTG ATGACCGTAG TCCGAGCTGG 
 4101 GCAGAGAGGG CGCGGGGTCG TGGACATGAA ACAGGCCAGC GAGTGGGGAC 
 4151 AGCGGGCCAA GAAACCACCT GCACTAGGGA GGTGKGAGCA TGGGGACGAG 
 4201 GGCGGGGCTT GTGACGAGTG GGCGGGGCCA CTGCCGAGAC CTGGCAGGAG 
 4251 CCCAATGGGT GAGGCTGGCG CATTTCCCAG CTGGAATCCG GTGTCGAAGT 
 4301 GGGGGGCGGG GACCGCACCT GTGCTGTAAG CTCAGTGTGG GTGGCGCGGG 
 4351 GCCCGCGGGG TCTTCCCTGA GTGCAAAGGC GGTCAGGGTG GGCAGAGACG 
 4401 AGGTGGGGCA AAGCCCTGCC CCAGCCAAGG GAGCAAGGTG GATGCACAAA 
 4451 GAGTGGGCCC TGTGACCAGC TGGACAGAGC CAGGGACTGC GGGAGACCAG 
 4501 GGGGAGCATA GGGTTGGAGT GGGTGGTGGA TGGTGGGGCT AATGCCTTCA 
 4551 TGGCCACGCG CACGTGCCCG TCCCACCCCC AGGGGTGTTC CTGGCGCGCT 
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 4601 ATGGGCCCGC GTGGCGCGAG CAGAGGCGCT TCTCCGTGTC CACCTTGCGC 
 4651 AACTTGGGCC TGGGCAAGAA GTCGCTGGAG CAGTGGGTGA CCGAGGAGGC 
 4701 CGCCTGCCTT TGTGCCGCCT TCGCCAACCA CTCCGGTGGG TGATGGGCAG 
 4751 AAGGGCACAA AGCGGGAACT GGGAAGGCGG GGGACGGGGA AGGCGACCCC 
 4801 TTACCCGCAT CTCCCACCCC CAGGACGCCC CTTTCGCCCC AACGGTCTCT 
 4851 TGGACAAAGC CGTGAGCAAC GTGATCGCCT CCCTCACCTG CGGGCGCCGC 
 4901 TTCGAGTACG ACGACCCTCG CTTCCTCAGG CTGCTGGACC TAGCTCAGGA 
 4951 GGGACTGAAG GAGGAGTCGG GCTTTCTGCG CGAGGTGCGG AGCGAGAGAC 
 5001 CGAGGAGTCT CCGCAGGGCG AGCTCCCGAG AGGTGCCGGG GCTGGACTGG 
 5051 GGCCTCGGAA GAGCAGGATT TGCATAGATG GGTTTGGGAA AGGACATTCC 
 5101 AGGAGACCCC ACTGTAAGAA GGGCCTGGAG GAGGAGGGGA CATCTCAGAC 
 5151 ATGGTCGTGG GAGAGGTGTG CCCGGGTCAG GGGGCACCAG GAGAGGCCAA 
 5201 GGACTCTGTA CCTCCTATCC ACGTCAGAGA TTTCGATTTT AGGTTTCTCC 
 5251 TCTGGGCAAG GAGAGAGGGT GGAGGCTGGC ACTTGGGGAG GGACTTGGTG 
 5301 AGGTCAGGGG TAAGGACAGG CAGGCCCTGG GTCTACCTGG AGATGGCTGG 
 5351 GGCCTGAGAC TTGTCCAGGT GAACGCAGAG CACAGGAGGG ATTGAGACCC 
 5401 CGTTCTGTCT GGTGTAGGTG CTGAATGCTG TCCCCGTCCT CCTGCATATC 
 5451 CCAACGCTGG CTGGCAAGGT CCTACGCTTC CAAAAGGCTT TCCTGACCCA 
 5501 GCTGGATGAG CTGCTAACTG AGCACAGGAT GACCTGGGAC CCAGCCCAGC 
 5551 CCCCCCGAGA CCTGACTGAG GCCTTCCTGG CAGAGATGGA GAAGGTGAGA 
 5601 GTGGCTGCCA CGGTGGGGGG CAAGGGTGGT GGGTTGAGCG TCCCAGGAGG 
 5651 AATGAGGGGA GGCTGGGCAA AAGGTTGGAC CAGTGCATCA CCCGGCGAGC 
 5701 CGCATCTGGG CTGACAGGTG CAGAATTGGA GGTCATTTGG GGGCTACCCC 
 5751 GTTCTGTCCC GAGTATGCTC TCGGCCCTGC TCAGGCCAAG GGGAACCCTG 
 5801 AGAGCAGCTT CAATGATGAG AACCTGCGCA TAGTGGTGGC TGACCTGTTC 
 5851 TCTGCCGGGA TGGTGACCAC CTCGACCACG CTGGCCTGGG GCCTCCTGCT 
 5901 CATGACCCTA CATCCGGATG TGCAGCGTGA GCCCATCTGG GAAACAGTGC 
 5951 AGGGGCCGAG GGAGGAAGGG TACAGGCGGG GGCCCATGAA CTTTGCTGGG 
 6001 ACACCCGGGG CTCCAAGCAC AGGCTTGACG AGGATCCTGT AAGCCTGACC 
 6051 TCCTCCAACA TAGGAGGCAA GAAGGAGTGT CAGGGCCGGA CCCCCTGGGT 
 6101 GCTGACCCAT TGTGGGGACG CATGTCTGTC CAGGCCGTGT CCAACAGGAG 
 6151 ATCAACGACG TGATAGGGCA GGTGCGGCGA CCAGAGATGG GTGACCAGGC 
 6201 TCACATGCCC TACACCACTG CCGTGATTCA TGAGGTGCAG CGCTTTGGGG 
 6251 ACATCGTCCC CCTGGGTGTG ACCCATATGA CATCCCGTGA CATCGAAGTA 
 6301 CAGGGCTTCC GCATCCCTAA GGTAGGCCTG GCGCCCTCCT CACCCCAGCT 
 6351 CAGCACCAGC ACCTGGTGAT AGCCCCAGCA TGGCTACTGC CAGGTGGGCC 
 6401 CACTCTAGGA ACCCTGGCCA CCTAGTCCTC AATGCCGCCA CACTGACTGT 
 6451 CCCCACTTGG GTGGGGGGTC CAGAGTATAG GCAGGGCTGG CCTGTCCATC 
 6501 CAGAGCCCCT GTCTAGTGGG GAGACAAACC AGGACCTGCC AGAATGTTGG 
 6551 AGGACCCAAC GCCTGCAGGG AGAGGGGGCA GTGTGGGTGC CTCTGAGAGG 
 6601 TGTGACTGCG CCCTGCTGTG GGGTCGGAGG GGGTACTGTG GAGCTTCTCG 
 6651 GGCGCAGGAC TAGTTGACAG AGTCCAGCTG TGTGCCAGGC AGTGTGTGTC 
 6701 CCCCGTGTGT TTGGTGGCAG GGGTCCCAGC ATCCTAGAGT CCAGTCCCCA 
 6751 CTCTCACCCT GCATCTCCTG CCCAGGGAAC GACACTCATC ACCAACCTGT 
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 6801 CATCGGTGCT GAAGGATGAG GCCGTCTGGG AGAAGCCCTT CCGCTTCCAC 
 6851 CCCGAACACT TCCTGGATGC CCAGGGCCAC TTTGTGAAGC CGGAGGCCTT 
 6901 CCTGCCTTTC TCAGCAGGTG CCTGTGGGGA GCCCGGCTCC CTGTCCCCCT 
 6951 CCGTGGAGTC TTGCAGGGGT ATCACCCAGG AGCCAGGCTC ACTGACGCCC 
 7001 CTCCCCTCCC CACAGGCCGC CGTGCATGCC TCGGGGAGCC CCTGGCCCGC 
 7051 ATGGAGCTCT TCCTCTTCTT CACCTCCCTG CTGCAGCACT TCAGCTTCTC 
 7101 GGTGCCCACT GGACAGCCCC GGCCCAGCCA CCATGGTGTC TTTGCTTTCC 
 7151 TGGTGAGCCC ATCCCCCTAT GAGCTTTGTG CTGTGCCCCG CTAGAATGGG 
 7201 GTACCTAGTC CCCAGCCTGC TCCCTAGCCA GAGGCTCTAA TGTACAATAA 
 7251 AGCAATGTGG TAGTTCCAAC TCGGGTCCCC TGCTCACGCC CTCGTTGGGA 
 7301 TCATCCTCCT CAGGGCAACC CCACCCCTGC CTCATTCCTG CTTACCCCAC 
 7351 CGCCTGGCCG CATTTGAGAC AGGGGTACGT TGAGGCTGAG CAGATGTCAG 
 7401 TTACCCTTGC CCATAATCCC ATGTCCCCCA CTGACCCAAC TCTGACTGCC 
 7451 CAGATTGGTG ACAAGGACTA CATTGTCCTG GCATGTGGGG AAGGGGCCAG 
 7501 AATGGGCTGA CTAGAGGTGT CAGTCAGCCC TGGATGTGGT GGAGAGGGCA 
 7551 GGACTCAGCC TGGAGGCCCA TATTTCAGGC CTAACTCAGC CCACCCCACA 
 7601 TCAGGGACAG CAGTCCTGCC AGCACCATCA CAACAGTCAC CTCCCTTCAT 
 7651 ATATGACACC CCAAAACGGA AGACAAATCA TGGCGTCAGG GAGCTATATG 
 7701 CCAGGGCTAC CTACCTCCCA GGGCTCAGTC GGCATCTTGC TGAAAAACTC 
 7751 GAGCCATCCG GATGGATATG GTGTTCAGGC ACAAGTGTTA AAGCAGTTGA 
 7801 TTTTATTCAC TATGATGAAA AAAACAATGA ATGGAACCTG CTCCAAGTTA 
 7851 AAAATAGAGA TAATACCGAA AACTCATCGA GTAGTAAGAT TAGAGATAAT 
 7901 ACAACAATAA AAAAATGGTT TAGAACTTAC TCACAGCGTG ATGCTACTAA 
 7951 TTGGGACAAT TTTCCAGATG AAGTATCATC TAAGAATTTA AATGAAGAAG 
 8001 ACTTCAGAGC TTTTGTTAAA AATTATTTGG CAAAAATAAT ATAATTCGAA 
 8051 TTCACGTGTC GACGAGCTCG CGGCCGCATG CTAGCTTAAG CCAGCCCCGA 
 8101 CACCCGCCAA CACCCGCTGA CGCGCCCTGA CGGGCTTGTC TGCTCCCGGC 
 8151 ATCCGCTTAC AGACAAGCTG TGACCGTCTC CGGGAGCTGC ATGTGTCAGA 
 8201 GGTTTTCACC GTCATCACCG AAACGCGCGA 
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Plasmid pCYP2D6*4 
 
 
    1 GACGAAAGGG CCTCGTGATA CGCCTATTTT TATAGGTTAA TGTCATGATA 
   51 ATAATGGTTT CTTAGACGTC AGGTGGCACT TTTCGGGGAA ATGTGCGCGG 
  101 AACCCCTATT TGTTTATTTT TCTAAATACA TTCAAATATG TATCCGCTCA 
  151 TGAGACAATA ACCCTGATAA ATGCTTCAAT AATATTGAAA AAGGAAGAGT 
  201 ATGAGTATTC AACATTTCCG TGTCGCCCTT ATTCCCTTTT TTGCGGCATT 
  251 TTGCCTTCCT GTTTTTGCTC ACCCAGAAAC GCTGGTGAAA GTAAAAGATG 
  301 CTGAAGATCA GTTGGGTGCA CGAGTGGGTT ACATCGAACT GGATCTCAAC 
  351 AGCGGTAAGA TCCTTGAGAG TTTTCGCCCC GAAGAACGTT TTCCAATGAT 
  401 GAGCACTTTT AAAGTTCTGC TATGTGGCGC GGTATTATCC CGTATTGACG 
  451 CCGGGCAAGA GCAACTCGGT CGCCGCATAC ACTATTCTCA GAATGACTTG 
  501 GTTGAGTACT CACCAGTCAC AGAAAAGCAT CTTACGGATG GCATGACAGT 
  551 AAGAGAATTA TGCAGTGCTG CCATAACCAT GAGTGATAAC ACTGCGGCCA 
  601 ACTTACTTCT GACAACGATC GGAGGACCGA AGGAGCTAAC CGCTTTTTTG 
  651 CACAACATGG GGGATCATGT AACTCGCCTT GATCGTTGGG AACCGGAGCT 
  701 GAATGAAGCC ATACCAAACG ACGAGCGTGA CACCACGATG CCTGTAGCAA 
  751 TGGCAACAAC GTTGCGCAAA CTATTAACTG GCGAACTACT TACTCTAGCT 
  801 TCCCGGCAAC AATTAATAGA CTGGATGGAG GCGGATAAAG TTGCAGGACC 
  851 ACTTCTGCGC TCGGCCCTTC CGGCTGGCTG GTTTATTGCT GATAAATCTG 
  901 GAGCCGGTGA GCGTGGGTCT CGCGGTATCA TTGCAGCACT GGGGCCAGAT 
  951 GGTAAGCCCT CCCGTATCGT AGTTATCTAC ACGACGGGGA GTCAGGCAAC 
 1001 TATGGATGAA CGAAATAGAC AGATCGCTGA GATAGGTGCC TCACTGATTA 
 1051 AGCATTGGTA ACTGTCAGAC CAAGTTTACT CATATATACT TTAGATTGAT 
 1101 TTAAAACTTC ATTTTTAATT TAAAAGGATC TAGGTGAAGA TCCTTTTTGA 
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 1151 TAATCTCATG ACCAAAATCC CTTAACGTGA GTTTTCGTTC CACTGAGCGT 
 1201 CAGACCCCGT AGAAAAGATC AAAGGATCTT CTTGAGATCC TTTTTTTCTG 
 1251 CGCGTAATCT GCTGCTTGCA AACAAAAAAA CCACCGCTAC CAGCGGTGGT 
 1301 TTGTTTGCCG GATCAAGAGC TACCAACTCT TTTTCCGAAG GTAACTGGCT 
 1351 TCAGCAGAGC GCAGATACCA AATACTGTCC TTCTAGTGTA GCCGTAGTTA 
 1401 GGCCACCACT TCAAGAACTC TGTAGCACCG CCTACATACC TCGCTCTGCT 
 1451 AATCCTGTTA CCAGTGGCTG CTGCCAGTGG CGATAAGTCG TGTCTTACCG 
 1501 GGTTGGACTC AAGACGATAG TTACCGGATA AGGCGCAGCG GTCGGGCTGA 
 1551 ACGGGGGGTT CGTGCACACA GCCCAGCTTG GAGCGAACGA CCTACACCGA 
 1601 ACTGAGATAC CTACAGCGTG AGCTATGAGA AAGCGCCACG CTTCCCGAAG 
 1651 GGAGAAAGGC GGACAGGTAT CCGGTAAGCG GCAGGGTCGG AACAGGAGAG 
 1701 CGCACGAGGG AGCTTCCAGG GGGAAACGCC TGGTATCTTT ATAGTCCTGT 
 1751 CGGGTTTCGC CACCTCTGAC TTGAGCGTCG ATTTTTGTGA TGCTCGTCAG 
 1801 GGGGGCGGAG CCTATGGAAA AACGCCAGCA ACGCGGCCTT TTTACGGTTC 
 1851 CTGGCCTTTT GCTGGCCTTT TGCTCACATG TTCTTTCCTG CGTTATCCCC 
 1901 TGATTCTGTG GATAACCGTA TTACCGCCTT TGAGTGAGCT GATACCGCTC 
 1951 GCCGCAGCCG AACGACCGAG CGCAGCGAGT CAGTGAGCGA GGAAGCGGAA 
 2001 GAGCGCCCAA TACGCAAACC GCCTCTCCCC GCGCGTTGGC CGATTCATTA 
 2051 ATGCAGCTGG CACGACAGGT TTCCCGACTG GAAAGCGCTG CAGGGGCCCG 
 2101 GGATCCAATT GGCAGTGAGC GCAACGCAAT TAATGTGAGT TAGCTCACTC 
 2151 ATTAGGCACC CCAGGCTTTA CACTTTATGC TTCCGGCTCG TATAATGTGT 
 2201 GGAATTGTGA GCGGATAACA ATTTCACACA GGAGGTTTAA ACTTTAAACA 
 2251 TGTCAAAAGA GACGTCTTTT GTTAAGAATG CTGAGGAACT TGCAAAGCAA 
 2301 AAAATGGATG CTATTAACCC TGAACTTTCT TCAAAATTTA AATTTTTAAT 
 2351 AAAATTCCTG TCTCAGTTTC CTGAAGCTTG CTCTAAACCT CGTTCAAAAA 
 2401 AAATGCAGAA TAAAGTTGGT CAAGAGGAAC ATATTGAATA TTTAGCTCGT 
 2451 AGTTTTCATG AGAGTCGATT GCCAAGAAAA CCCACGCCAC CTACAACGGT 
 2501 TCCTGATGAG GTGGTTAGCA TAGTTCTTAA TATAAGTTTT AATATACAGC 
 2551 CTGAAAATCT TGAGAGAATA AAAGAAGAAC ATCGATTTTC CATGGCAGCT 
 2601 GAGAATATTG TAGGAGATCT TCTAGAAAGA TGTTATCCCA GAAGGCTTTG 
 2651 CAGGCTTCAG GAGCTTGGAG TGGGGAGAGG GGGTGACTTC TCCGACCAGG 
 2701 CCCCTCCACC GGCCTACCCT GGGTAAGGGC CTGGAGCAGG AAGCAGGGGC 
 2751 AAGAACCTCT GGAGCAGCCC ATACCCGCCC TGGCCTGACT CTGCCACTGG 
 2801 CAGCACAGTC AACACAGCAG GTTCGCTCAC AGCAGAGGGC AAAGGCCATC 
 2851 ATCAGCTCCC TTTATAAGGG AAGGGTCACG CGCTCGGTGT GCTGAGAGTG 
 2901 TCCTGCCTGG TCCTCTGTGC CTGGTGGGGT GGGGGTGCCA GGTGTGTCCA 
 2951 GAGGAGCCCA TTTGGTAGTG AGGCAGGTAT GGGGCTAGAA GCACTGGTGC 
 3001 CCCTGGCCGT GATAGTGGCC ATCTTCCTGC TCCTGGTGGA CCTGATGCAC 
 3051 CGGCGCCAAC GCTGGGCTGC ACGCTACTCA CCAGGCCCCC TGCCACTGCC 
 3101 CGGGCTGGGC AACCTGCTGC ATGTGGACTT CCAGAACACA CCATACTGCT 
 3151 TCGACCAGGT GAGGGAGGAG GTCCTGGAGG GCGGCAGAGG TGCTGAGGCT 
 3201 CCCCTACCAG AAGCAAACAT GGATGGTGGG TGAAACCACA GGCTGGACCA 
 3251 GAAGCCAGGC TGAGAAGGGG AAGCAGGTTT GGGGGACTTC CTGGAGAAGG 
 3301 GCATTTATAC ATGGCATGAA GGACTGGATT TTCCAAAGGC CAAGGAAGAG 
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 3351 TAGGGCAAGG GCCTGGAGGT GGAGCTGGAC TTGGCAGTGG GCATGCAAGC 
 3401 CCATTGGGCA ACATATGTTA TGGAGTACAA AGTCCCTTCT GCTGACACCA 
 3451 GAAGGAAGGC CTTGGGAATG GAAGATGAGT TAGTCCTGAG TGCCGTTTAA 
 3501 ATCACGAAAT CGAGGATGAA GGGGGTGCAG TGACCCGGTT CAAACCTTTT 
 3551 GCACTGTGGG TCCTCGGGCC TCACTGCTCA CCGGCATGGA CCATCATCTG 
 3601 GGAATGGGAT GCTAACTGGG GCCTCTCGGC AATTTTGGTG ACTCTTGCAA 
 3651 GGTCATACCT GGGTGACGCA TCCAAACTGA GTTCCTCCAT CACAGAAGGT 
 3701 GTGACTCCCA CCCCCGCCCC AGGATCAGGA GGCTGGGTCT CCTCCTTCCA 
 3751 CCTGCTCACT CCTGGTAGCC CCGGGGGGTC GTCCAAGGTT CAAATAGGAC 
 3801 TAGGACCTGT AGTCTGGGGG GATCCTGGCT TGACAAGAGG CCCTGACCCT 
 3851 CCCTCTGCAG TTGCGGCGCC GCTTCGGGGA CGTGTTCAGC CTGCAGCTGG 
 3901 CCTGGACGCC GGTGGTCGTG CTCAATGGGC TGGCGGCCGT GCGCGAGGCG 
 3951 ATGGTGACCC GCGGCGAGGA CACGGCCGAC CGCCCGCCTG TGCCCATCAC 
 4001 CCAGATCCTG GGTTTCGGGC CGCGTTCCCA AGGCAAGCAG CGGTGGGGAC 
 4051 AGAGACAGAT TTCCGTGGGA CCCGGGTGGG TGATGACCGT AGTCCGAGCT 
 4101 GGGCAGAGAG GGCGCGGGGT CGTGGACATG AAACAGGCCA GCGAGTGGGG 
 4151 ACAGCGGGCC AAGAAACCAC CTGCACTAGG GAGGTGTGAG CATGGGGACG 
 4201 AGGGCGGGGC TTGTGACGAG TGGGCGGGGC CACTGCCGAG ACCTGGCAGG 
 4251 AGCCCAATGG GTGAGGCTGG CGCATTTCCC AGCTGGAATC CGGTGTCGAA 
 4301 GTGGGGGGCG GGGACCGCAC CTGTGCTGTA AGCTCAGTGT GGGTGGCGCG 
 4351 GGGCCCGCGG GGTCTTCCCT GAGTGCAAAG GCGGTCAGGG TGGGCAGAGA 
 4401 CGAGGTGGGG CAAAGCCCTG CCCCAGCCAA GGGAGCAAGG TGGATGCACA 
 4451 AAGAGTGGGC CCTGTGACCA GCTGGACAGA GCCAGGGACT GCGGGAGACC 
 4501 AGGGGGAGCA TAGGGTTGGA GTGGGTGGTG GATGGTGGGG CTAATGCCTT 
 4551 CATGGCCACG CGCACGTGCC CGTCCCACCC CCAGGGGTGT TCCTGGCGCG 
 4601 CTATGGGCCC GCGTGGCGCG AGCAGAGGCG CTTCTCCGTC TCCACCTTGC 
 4651 GCAACTTGGG CCTGGGCAAG AAGTCGCTGG AGCAGTGGGT GACCGAGGAG 
 4701 GCCGCCTGCC TTTGTGCCGC CTTCGCCAAC CACTCCGGTG GGTGATGGGC 
 4751 AGAAGGGCAC AAAGCGGGAA CTGGGAAGGC GGGGGACGGG GAAGGCGACC 
 4801 CCTTACCCGC ATCTCCCACC CCCAAGACGC CCCTTTCGCC CCAACGGTCT 
 4851 CTTGGACAAA GCCGTGAGCA ACGTGATCGC CTCCCTCACC TGCGGGCGCC 
 4901 GCTTCGAGTA CGACGACCCT CGCTTCCTCA GGCTGCTGGA CCTAGCTCAG 
 4951 GAGGGACTGA AGGAGGAGTC GGGCTTTCTG CGCGAGGTGC GGGGCGAGAG 
 5001 ACCGAGGAGT CTCTGCAGGG CGAGCTCCCG AGAGGTGCCG GGGCTGGACT 
 5051 GGGGCCTCGG AAGAGCAGGA TTTGCGTAGA TGGGTTTGGG AAAGGACATT 
 5101 CCAGGAGACC CCACTGTAAG AAGGGCCTGG AGGAGGAGGG GACATCTCAG 
 5151 ACATGGTCGT GGGAGAGGTG TGCCCGGGTC AGGGGGCACC AGGAGAGGCC 
 5201 AAGGACTCTG TACCTCCTAT CCACGTCAGA GATTTCGATT TTAGGTTTCT 
 5251 CCTCTGGGCA AGGAGAGAGG GTGGAGGCTG GCACTTGGGG AGGGACTTGG 
 5301 TGAGGTCAGT GGTAAGGACA GGCAGGCCCT GGGTCTACCT GGAGATGGCT 
 5351 GGGGCCTGAG ACTTGTCCAG GTGAACGCAG AGCACAGGAG GGATTGAGAC 
 5401 CCCGTTCTGT CTGGTGTAGG TGCTGAATGC TGTCCCCGTC CTCCTGCATA 
 5451 TCCCAGCGCT GGCTGGCAAG GTCCTACGCT TCCAAAAGGC TTTCCTGACC 
 5501 CAGCTGGATG AGCTGCTAAC TGAGCACAGG ATGACCTGGG ACCCAGCCCA 
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 5551 GCCCCCCCGA GACCTGACTG AGGCCTTCCT GGCAGAGATG GAGAAGGTGA 
 5601 GAGTGGCTGC CACGGTGGGG GGCAAGGGTG GTGGGTTGAG CGTCCCAGGA 
 5651 GGAATGAGGG GAGGCTGGGC AAAAGGTTGG ACCAGTGCAT CACCCGGCGA 
 5701 GCCGCATCTG GGCTGACAGG TGCAGAATTG GAGGTCATTT GGGGGCTACC 
 5751 CCGTTCTGTC CCGAGTATGC TCTCGGCCCT GCTCAGGCCA AGGGGAACCC 
 5801 TGAGAGCAGC TTCAATGATG AGAACCTGCG CATAGTGGTG GCTGACCTGT 
 5851 TCTCTGCCGG GATGGTGACC ACCTCGACCA CGCTGGCCTG GGGCCTCCTG 
 5901 CTCATGATCC TACATCCGGA TGTGCAGCGT GAGCCCATCT GGGAAACAGT 
 5951 GCAGGGGCCG AGGGAGGAAG GGTACAGGCG GGGGCCCATG AACTTTGCTG 
 6001 GGACACCCGG GGCTCCAAGC ACAGGCTTGA CCAGGATCCT GTAAGCCTGA 
 6051 CCTCCTCCAA CATAGGAGGC AAGAAGGAGT GTCAGGGCCG GACCCCCTGG 
 6101 GTGCTGACCC ATTGTGGGGA CGCATGTCTG TCCAGGCCGT GTCCAACAGG 
 6151 AGATCGACGA CGTGATAGGG CAGGTGCGGC GACCAGAGAT GGGTGACCAG 
 6201 GCTCACATGC CCTACACCAC TGCCGTGATT CATGAGGTGC AGCGCTTTGG 
 6251 GGACATCGTC CCCCTGGGTG TGACCCATAT GACATCCCGT GACATCGAAG 
 6301 TACAGGGCTC CCGCATCCCT AAGGTAGGCC TGGCGCCCTC CTCACCCCAG 
 6351 CTCAGCACCA GCCCCTGGTG ATAGCCCCAG CATGGCTACT GCCAGGTGGG 
 6401 CCCACTCTAG GAAACCTGGC CACCTAGTCC TCAATGCCAC CACACTGACT 
 6451 GTCCCCACTT GGGTGGGGGG TCCAGAGTAT AGGCAGGGCT GGCCTGTCCA 
 6501 TCCAGAGCCC CCGTCTAGTG GGGAGACAAA CCAGGACCTG CCAGAATGTT 
 6551 GGAGGACCCA GCGCCTGCAG GGAGAGGGGG CAGTGTGGGT GCCTCTGAGA 
 6601 GGTGTGACTG CGCCCTGCTG TAGGGTCGGA GAGAGTACTG TGGAGCTTCT 
 6651 CGGGCGCAGG ACTAGTTGAC AGAGTCCAGC TGTGTGCCAG GCAGTGTGTG 
 6701 TCCCCCGTGT GTTTGGTGGC AGGGGTCCCA GCATCCTAGA GTCCAGTCCC 
 6751 CACTCTCACC CTGCATCTCC TGCCCAGGGA ACGACACTCA TCACCAACCT 
 6801 GTCATCGGTG CTGAAGGATG AGGCCGTCTG GGAGAAGCCC TTCCGCTTCC 
 6851 ACCCCGAACA CTTCCTGGAT GCCCAGGGCC ACTTTGTGAA GCCGGAGGCC 
 6901 TTCCTGCCTT TCTCAGCAGG TGCCTGTGGG GAGCCCGGCT CCCTGTCCCC 
 6951 TTCCGTGGAG TCTTGCAGGG GTATCACCCA GGAGCCAGGC TCACTGACGC 
 7001 CCCTCCCCTC CCCACAGGCC GCCGTGCATG CCTCGGGGAG CCCCTGGCCC 
 7051 GCATGGAGCT CTTCCTCTTC TTCACCTCCC TGCTGCAGCA CTTCAGCTTC 
 7101 TCGGTGCCCA CTGGACAGCC CCGGCCCAGC CACCATGGTG TCTTTGCTTT 
 7151 CCTGGTGACC CCATCCCCCT ATGAGCTTTG TGCTGTGCCC CGCTAGAATG 
 7201 GGGTACCTAG TCCCCAGCCT GCTCCCTAGC CAGAGGCTCT AATGTACAAT 
 7251 AAAGCAATGA GGTAGTTCCA ACTCGGGTCC CCTGCTCACG CCCTCGTTGG 
 7301 GATCATCCTC CTCAGGGCAA CCCCACCCCT GCCTCATTCC TGCTTACCCC 
 7351 ACCGCCTGGC CGCATTTGAG ACAGGGGTAT GTTGAGGCTG AGCAGATGTC 
 7401 AGTTACCCTT GCCCATAATC CCATGTCCCC CACTGACCCA ACTCTGACTG 
 7451 CCCAGATTGG TGACAAGGAC TACATTGTCC TGGCATGTGG GGAAGGGGCC 
 7501 AGAATGGGCT GACTAGAGGT GTCAGTCAGC CCTGGATGTG GTGGAGAGGG 
 7551 CAGGACTCAG CCTGGAGGCC CATATTTCAG GCCTAACCCA GCCCACCCCA 
 7601 CATCAGGGAC AGCAGTCCTG CCAGCACCAT CACAACAGTC ACCTCCCTTC 
 7651 ATATATGACA CCCCAAAACG GAAGACAAAT CATGGCGTCA GGGAGCTATA 
 7701 GGCCAGGGCT ACCTACCTCC CAGGGCTCAG TCGGCATCTT GCTGAAAAAC 
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 7751 TCGAGCCATC CGGATGGATA TGGTGTTCAG GCACAAGTGT TAAAGCAGTT 
 7801 GATTTTATTC ACTATGATGA AAAAAACAAT GAATGGAACC TGCTCCAAGT 
 7851 TAAAAATAGA GATAATACCG AAAACTCATC GAGTAGTAAG ATTAGAGATA 
 7901 ATACAACAAT AAAAAAATGG TTTAGAACTT ACTCACAGCG TGATGCTACT 
 7951 AATTGGGACA ATTTTCCAGA TGAAGTATCA TCTAAGAATT TAAATGAAGA 
 8001 AGACTTCAGA GCTTTTGTTA AAAATTATTT GGCAAAAATA ATATAATTCG 
 8051 AATTCACGTG TCGACGAGCT CGCGGCCGCA TGCTAGCTTA AGCCAGCCCC 
 8101 GACACCCGCC AACACCCGCT GACGCGCCCT GACGGGCTTG TCTGCTCCCG 
 8151 GCATCCGCTT ACAGACAAGC TGTGACCGTC TCCGGGAGCT GCATGTGTCA 
 8201 GAGGTTTTCA CCGTCATCAC CGAAACGCGC GA 
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Appendix V – Ferguson Analysis Gels 
 
Figure A.5 – Electrophoresis analysis of Au-nanoprobe conjugates in different agarose gel 
concentrations: (A) 1%, (B) 1.5%, (C) 2% and (D) 3% (w/v) agarose. Conditions: 2 hours at 4 V/cm 
in 0.5x TBE buffer. Lanes: “1”- Au-nanoprobe alone and in presence of: “2”- a target harboring a single 
base mismatch at the 3’-end of the Au-nanoprobe (G•G); “3”- a complementary target; “4”- a target 
harboring a single base mismatch (G•T); or “5”- (G•A) at the 3’-end of the Au-nanoprobe; or “6”- a non-
complementary target. 
